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Ode to the PlumBlossom 




Then spring departed in wind and rain; 
With flying snow it’s back again. 
Though the cliff is covered with hundreds of meters high ice, 
still there is a flowery twig nice. 
Though sweet and fair, with other flowers she won’t rival, 
But only heralds spring’s arrival. 
When mountain flowers cover all the hills, 
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Chapter 1: General introduction 
Pestiviruses, members of the family Flaviviridae, are among the most important pathogens of 
farm animals worldwide. The genus Pestivirus has a broad host range (mainly pigs and 
ruminants), induces several clinical manifestations in farm or wild animals and causes very 
severe financial losses in the livestock farming industry (Tautz et al., 2015). Nowadays, farm 
animal trade is becoming more and more international, so the higher frequency of transport of 
susceptible animals increases the risks of pestivirus infection. The detailed characterization of 
pestiviral molecular biology just started in recent decades. Especially in the last 20 years, 
scientists working on pestiviruses have made striking achievements with regard to many aspects 
of pestivirus biology, but there are still many unsolved questions about the life cycle of 
pestiviruses, for instance, the function and structure of their envelope glycoproteins, which urge 
us to conduct further intensive studies of pestiviruses. 
 
1.1 Taxonomy, host and disease 
1.1.1 Taxonomy 
The genus Pestivirus belongs to the family Flaviviridae. Originally, there are 4 recognized 
species have been classified into the genus Pestivirus, they are BVDV-1, BVDV-2, CSFV and 
BDV. But lately, many new isolates were found (Tautz et al., 2015). In the latest online report 
(10th) of ICTV, the genus Pestivirus has been subdivided into 11 different species 
correspondingly. Furthermore, the ICTV also modified the naming convention of pestivirus 
species by adopting the format ‘Pestivirus X’ instead of their traditional designation in a host-
dependent manner. It is worth noting that only the names of virus species have been changed, 
virus isolates continue using their original names (Simmonds et al., 2017; Smith et al., 2017), 
as shown in Table 1.1. 









Species Virus name 
Virus 
abbreviation Representative Isolate Accession number 
Pestivirus A bovine viral diarrhea virus 1 BVDV1 SD-1/NADL M96751/M31182 
Pestivirus B bovine viral diarrhea virus 2 BVDV2 XJ-04/890 FJ527854/U18059 
Pestivirus C classical swine fever virus CSFV Alfort/187 X87939 
Pestivirus D Border disease virus BDV X818 AF037405 
Pestivirus E pronghorn antelope pestivirus PAPeV  AY781152 
Pestivirus F porcine pestivirus PPeV Bungowannah EF100713 
Pestivirus G giraffe pestivirus GPeV H138 AF144617 
Pestivirus H HoBi-like pestivirus HoBiPeV Th/04_KhonKaen FJ040215 
Pestivirus I Aydin-like pestivirus AydinPeV 04-TR JX428945 
Pestivirus J rat pestivirus RPeV NrPV/NYC-D23 KJ950914 
Pestivirus K atypical porcine pestivirus APPeV 515 KR011347 




According to a biological feature, pestiviruses can also be divided into cytopathogenic (CP) and 
non-cytopathogenic (NCP). Compared with NCP strains, the CP pestiviruses have stronger 
effect on the infected cells or tissues that always result in the lysis of the host cells. This 
interesting biological characteristic is supposed to exist among the whole pestivirus species, 
since this conclusion has been proven in the original classified species (BVDV-1, BVDV-2, 
CSFV and BDV) and Pestivirus H (HoBi-like pestivirus) (Aoki et al., 2001; Kolykhalov et al., 
1997; Kosmidou et al., 1998; Kupfermann et al., 1996; Meyers et al., 1991; Meyers et al., 1996b; 
Tautz et al., 1998). Normally, CSFV is non-cytopathogenic (NCP) in the infected cells or tissue 
cultures. Only a few cases of cytopathogenic (CP) CSFV strains were reported (Kümmerer et 
al., 2000). The cytopathic effect (CPE) induced by CP CSFV can only occur in the presence of 
so-called defective interfering particles (DIs) associated with the complementing helper virus 
(Meyers and Thiel, 1995; Meyers et al., 1996b). In contrast to the CP BVDV that are associated 
with mucosal disease (MD), CP CSFV always induce very slight pathological symptoms. NCP 
BVDV can result in persistent infection (PI) making infected animals a permanent source of 
infection for the surrounding herds. It is worth noting that all infected with CP pestivirus isolates 




For a long time, infections with pestiviruses were believed to be restricted to clovenhoofed 
animals. However, some recent metagenomics research has indicated that pestiviruses are not 
completely restricted to Artiodactyla species, since some clear evidence for the existence of 
pestiviruses in mammals like bats (BatPeV), rats and whales were recently described (Firth et 
al., 2014; Jo et al., 2019; Wu et al., 2012). Naturally, infections of Pestivirus H (HoBi-like 
pestivirus) always occur in cattle, however, a few cases of Pestivirus H have been described in 
goats which are non-bovine ruminants (Shi et al., 2018). There is no pestivirus infection case 
in human or poultry reported. The approved species of pestiviruses were roughly divided into 
two major groups before, including group1- pestiviruses in swine and group 2- pestiviruses in 
ruminants like cattle, sheep, goats, and a large variety of wild ruminants. With more and more 
novel pestivirus infection in bats, rats and even whale are discovered, there should be one 
additional group 3 which is pestiviruses in other mammals.  




Figure 1.1 Phylogenetic tree of pestiviruses 
The phylogenetic tree of pestiviruses was made by iTOL (v5, https://itol.embl.de/). Each member species is 
in different color. Corresponding sequence alignment and the original phylogenetic tree file were downloaded 




The most important transboundary viral disease of pestivirus in swine is classical swine fever 
(CSF). It has enormous impact on animal health and pig industry worldwide. Therefore, 
outbreaks of CSF have to be reported to the World Organization for Animal Health (OIE) 
(Edwards et al., 2000). CSF widely spreads in most countries of the world that have a significant 
pig production. The spreading of CSF is mainly concentrated in the following regions, some 
countries in South America, several parts of Eastern Europe also including many neighboring 
countries, as well as Asia, especially China and India. So far, no detailed information about the 
African situation is available (Blome et al., 2017). The clinical phenotype of classical swine 
fever can be divided into three types: ①acute type always accompanied by lethally transient 
course of disease; ②chronic type and ③persistent course. The third type usually occurs in 
pregnant sows (Moennig et al., 2003).  
Bovine viral diarrhea virus (BVDV) is one of the most important infectious agents of cattle 
herds. BVDV strains of each distinct species (BVDV1 and BVDV2) are further classified as 
one of two biotypes: cytopathic (CP) and non-cytopathic (NCP) as defined by the lytic activity 
of the virus in cell culture (Kümmerer et al., 2000; Kupfermann et al., 1996; Meyers and Thiel, 
1996; Tautz et al., 2015). CP BVDV strains are not commonly found in acute infections in the 
field and are mainly involved in outbreaks of mucosal disease whereas NCP BVDV strains are 
more common in nature and are often associated with the most clinically severe form of acute 
infection. It causes sustained economic losses to the cattle industry mainly because of reduced 
reproductive performance and milk production (Brock, 2004). Infection of susceptible pregnant 
cows with the NCP virus, which has the ability to cross the placenta before the development of 
fetal immunocompetence, can result in the birth of persistently infected (PI) calves (Bolin et al., 
1985; Brownlie, 1990; Brownlie et al., 1984; Moennig et al., 1990).  
 
1.2 Viral particle and genome 
Pestivirus virions are enveloped and contain four structural proteins (SPs) including one basic 
core protein C and three envelope (E) glycoproteins (Erns, E1 and E2) that are present on the 
viral particles (Thiel et al., 1991; Weiland et al., 1999). The diameter of the pestiviral particle 
is about 40-60 nm. E1-E2 heterodimers are incorporated into the virions, which were identified 
to be critical for virus infection (El Omari et al., 2013; Li et al., 2013; Ronecker et al., 
2008).Within the particle, there is core protein found to be single-stranded RNA genome. 
Because of the lipid envelope, pestiviruses are very sensitive to detergent treatment so that they 
can be inactivated quite easily. The general stability of the virions is low. Under conditions of 
37 °C and neutral pH, the half-life of viral particle is about 7h (Depner et al., 1992).But 
compared to other flaviviruses, pestiviruses are very resistant to low pH. 
The pestivirus genome consists of a single stranded RNA with a basic length of about 12.3 kb. 
It contains only one long open reading frame coding for a polyprotein of ca. 4000 amino acids. 
Through co- and posttranslational processing by viral and cellular proteases, 12 mature proteins 
are generated. The arrangement of those 12 recognized pestivirus mature proteins in the 






(Meyers and Thiel, 1996) (see Fig 1.2 right). The first protein encoded by the ORF is a non-
structural protein named Npro (Stark et al., 1993). Npro is an autoprotease that cleaves at its own 
C-terminus and thereby releases the N-terminus of the core protein. There is one hydrophobic 
sequence at the C-terminus of core protein serving as signal sequence for translocation of the 
downstream glycoprotein Erns. Cellular signal peptidase (SPase) is responsible for the cleavage 
at the C/Erns site (Rümenapf et al., 1993), then this C-terminal signal sequence will be further 
processed by signal peptide peptidase (Heimann et al., 2006). Signal peptidase is also 
responsible for processing at the Erns/E1, E1/E2, E2/p7 and p7/NS2 sites (Bintintan and Meyers, 
2010; Harada et al., 2000). The cleavage at the Erns/E1 site is slower than at the E1/E2 site, 
resulting in the detectable presence of a Erns-E1 precursor in infected and transfected cells.  
The next processing step at the NS2/NS3 site is quite special since it is involved in the regulation 
of pestivirus RNA replication. For a non-cytopathic pestivirus, it is cleaved by the protease 
activity of NS2 whereas for many CP pestiviruses other proteases are recruited to conduct this 
cleavage (Lackner et al., 2005; Lackner et al., 2004; Lackner et al., 2006). All sites downstream 
of the NS2/NS3 site are processed by the NS3 (Lamp et al., 2011; Lamp et al., 2013; Tautz et 
al., 1997; Wiskerchen and Collett, 1991; Xu et al., 1997). NS4A functions as a cofactor of the 
NS3 protease and is involved in processing the NS4B/NS5A and the NS5A/NS5B sites.  
Figure 1.2 Schematic representation of the pestiviral particle (left) and genome (right) 
Left, pestiviruses are enveloped viruses with 3 envelope proteins (Erns-blue, E1-green, E2-red) with a single-
stranded RNA genome of positive polarity (purple helix inside), which is shown on the right side as a scheme. 
The genomic RNA contains one long open reading frame (ORF) that is translated into a polyprotein 
schematically shown below the genome. After co- and post-translational processing by viral and host 
proteases, 12 mature proteins are generated. Viral and cellular proteases that participate in polyprotein 
processing are shown at the right bottom. Structural proteins (Core, Erns, E1 and E2) in green/blue, non-
structural proteins in white or reddish colour, NS3 proteinase is responsible for the cleavage of reddish 
proteins. 
 
1.3 The viral life cycle  
Pestivirus replication starts with attachment of viral particle to the surface of its host cell. The 
viral envelope glycoproteins Erns and E2 both play important roles in this process (Hulst and 
Moormann, 1997). Glycoproteins Erns and E2 have different receptors on the cell surface. Both 
heparan sulfate (HS) and laminin receptor (LamR) were identified as attachment receptors for 
Erns (Chen et al., 2015; Munir Iqbal, 2000). E2 is also involved in viral entry since it is the 
receptor binding protein that is a determinant of pestivirus tropism (Borca et al., 2019; Liang et 
al., 2003; Reimann et al., 2004). It was shown that E1 and E2 form covalently disulphide linked 
heterodimers (Thiel et al., 1991), the formation of which is crucial for virus infection. 
Interestingly, presence of E1-E2 heterodimers in pseudotyped viruses is sufficient to mediate 










Structural Protein Non-structural Protein





Npro protease Signal peptide peptidase Signal peptidase NS2/NS3 protease NS3 protease




entry step. Pestiviruses enter the host cells via receptor-mediated endocytosis. The main 
receptor that mediates BVDV entry has been identified so far is CD46 which interacts with 
BVDV E2 (Maurer et al., 2004). However, it has been shown that CD46 is not sufficient for 
internalization of virus, indicating that viral entry still needs one or more co-receptors. Recent 
researches have shown that the host factor MERTK, a member of the receptor protein tyrosine 
kinases, promotes CSFV entry (Zheng et al., 2020).  
After binding to the receptor on the surface of host cells, infectious viruses enter cells by 
clathrin-dependent endocytosis (Grummer et al., 2004; Lecot et al., 2005). Some small GTPases 
of the Ras superfamily like Rab5, Rab7, and Rab11, which are required for caveola-dependent 
endocytosis were shown to be involved in CSFV entry in a recent study, indicating that CSFV 
might also enter cells via the caveola-mediated pathway (Zhang et al., 2018). After 
internalization, membrane fusion and uncoating of virions follow and the genomic RNA is 
released into the cytoplasm. The RNA of pestiviruses is infectious: it functions as both the 
genomic and messenger RNA. Until now, it is still unclear where exactly in the cell pestivirus 
viral RNA replication takes place. For the related HCV, the viral replication is believed to occur 
in a so-called membranous web (Moriishi and Matsuura, 2012; Neufeldt et al., 2016; Wolk et 
al., 2008). Due to the fact that the pestivirus RNA genome does not contain a cap structure at 
its 5’ end, viruses take advantage of an “internal ribosomal entry site” (IRES) at its 5’ NTR to 
induce efficient translation. The pestiviral genome is initially translated into a polyprotein, 
which is further processed co- and post-translationally by host and viral proteases. Pestivirus 
envelope glycoproteins are synthesized at the ER. After translation of a signal sequence located 
at the end of C protein, the nascent synthesized chain is targeted to the translocon in the ER 
membrane. After co-translational translocation of the viral envelope proteins, the nucleocapsid 
complex interacts with the accumulated glycoproteins and buds into the lumen of the ER, 
resulting in viral particle assembled in the ER lumen. Further modifications of the envelope 
proteins such as glycosylation and disulfide bond formation also occur in the ER. Further 
processing of carbohydrate chains occurs in Golgi compartment. Finally, the mature viral 
particle complex is released from the infected cells via the exocytosis pathway.  
 




Figure 1.3 Schematic representation of the replication cycle of pestiviruses 
①Virions firstly attach to the cell surface; ②Viral envelope protein E2 binds to the main cellular receptor 
(e.g. CD46 for BVDV); ③then internalization via clathrin-mediated endocytosis; ④Membrane fusion, ⑤the 
viral genome and capsid protein are released from the early endosome into the cytoplasm of the host cell and 
uncoating sets the genomic RNA free ⑥The translation and replication of viral genomic RNA are carried out 
⑦and the viral proteins are synthesized; ⑧The viral nucleocapsid/RNA complex interacts with glycoproteins 
and egresses into the lumen side of the ER; ⑨Transport via exocytosis pathway; ⑩The mature pestivirus 
particles are released from the infected cells. 
 
1.4 Envelope proteins 
Pestiviruses contain three envelope proteins Erns, E1 and E2. While Erns represents an 
attachment protein that is also engaged in pestiviral immune evasion due to its RNase activity, 
E1 and E2 are most likely the relevant factors for viral entry. E1 is the most mysterious of all 
viral proteins. The shortage of specific antibodies against E1 making detection and further 
analysis of E1 difficult, resulted in a lack of knowledge on E1 compared to Erns and E2 with 
regard to biosynthesis, structure and function. E1 has often been analysed in context with the 
other two envelope proteins, instead of being used as research object alone. The molecular size 
of E1 is a mass of 25-33 kDa (depends on the virus species) so only about half of E2. E1E2 can 
form heterodimers, which is known as the crucial functional complex in viral entry (Ronecker 
et al., 2008). For HCV, it has been predicted that E2 can serve as fusion protein and possesses 
a class II fusion fold that harbors a membrane distal fusion loop rich in hydrophobic residues 
(Garry and Dash, 2003). Unexpectedly, the recently published crystal structure of BVDV1 E2 
does not show that it contains a class II fusion protein fold (El Omari et al., 2013; Li et al., 
2013), indicating that E2 if being directly involved in fusion at all belongs to a novel structural 
class of membrane fusion machinery. Otherwise, E1 could represent the fusion protein of 
pestiviruses as proposed in one publication (Fernandez-Sainz et al., 2014).  
E1 has long been believed to be a type I transmembrane protein with a C-terminal membrane 
anchor, but membrane topology of pestivirus E1 has never been analysed. Recently, published 
data suggested that E1 contains one transmembrane helix with two amphipathic perimembrane 
helices located upstream of the TM helix (Wang et al., 2014). However, the latter publication is 
based only on computational modeling tools used to simulate and predict the secondary 
structure of pestivirus E1 and E2. Crystal structure information about the E1 protein is still not 
available, and also its membrane topology awaits detailed experimental analysis. In the related 
hepatitis C virus, which shares many structural and functional properties with pestiviruses, 
envelope proteins E1 and E2 were identified as type I transmembrane proteins. Surprisingly, 
there is a dynamic change in the TM regions of both E1 and E2 with changes occurring after 
signal peptidase cleavage. This unique dynamic behaviour of the TM domain of E1 is supposed 
to be linked to its multifunctionality, such as membrane anchoring, heterodimerization and 
retention (Cocquerel et al., 2002). 
E1-E2 heterodimers are covalently linked via disulphide bonds (Thiel et al., 1991). One 
publication suggests that positively charged residues in E1 (lysine and arginine) play an 
essential role in heterodimer formation. In this paper, the authors declare that cysteine residue 
at position 668 is not essential for E1-E2 heterodimer formation by using single site 
mutagenesis (Ronecker et al., 2008). For HCV, similarly, it has been shown that the charged 
residues within the transmembrane domains of glycoprotein E1 and E2 play an important role 
in E1-E2 heterodimerization (Cao et al., 2019; Ciczora et al., 2005). However, the interaction 
between HCV E1 and E2 is non-covalent. Thus, there should be a difference of the interaction 




mechanism between envelope proteins in HCV and pestiviruses. HCV E1 was shown form non-
covalent trimers on the virions (Falson et al., 2015). Due to the absence of specific antibodies 
against pestiviral E1, it is still unknown whether E1 of pestiviruses forms oligomers or not. 
Some other publications give contradictory conclusions. In their study, the predicted theoretical 
models suggest that Cys668 in E1 forms a disulphide bond with Cys987 in E2 by using 
computational secondary structure predictions and E1E2 sequence alignments, along with the 
geometric constraints imposed by the recently published crystal structure of BVDV E2. (Wang 
et al., 2014). Additionally, this linkage between E1 and E2 could stabilize the E1-E2 interaction 
that is required for virus infectivity. In the absence of experimental structural data for E1 or E1-
E2 heterodimer, the prerequisites and function of E1 oligomerization and E1-E2 
heterodimerization are poorly understood. 
The glycoprotein E2 of pestiviruses has a mass of 53-55 kDa. Recently, the membrane topology 
of mature BVDV E2 has been clarified. E2 is a type I transmembrane protein with an N-terminal 
ectodomain and a hydrophobic membrane anchor at its C-terminus (Radtke and Tews, 2017). It 
represents the target of neutralizing antibodies that can induce protective humoral immunity. 
Published data also suggested that CSFV E2 can serve as a target for cytotoxic T cells that elicit 
cellular immunity (Armengol et al., 2002; Ceppi et al., 2005; Franzoni et al., 2013). It is a 
determinant of cell tropism and host specificity. CD46 is a cellular receptor for BVDV infection 
that interacts with E2. Since CD46 alone is not sufficient for a successful pestiviral infection, 
other cellular receptors have to be involved in this step and pestivirus entry is most likely a 
multi-step process.  
CSFV E2 has been shown to form covalently disulphide-linked homodimers (Thiel et al., 1991; 
Weiland et al., 1990). For BVDV, E2 ectodomain forms covalently disulphide-linked 
homodimers in the absence of E1. During virus assembly, E2 homodimers are formed much 
earlier than the formation of E1-E2 heterodimer, this could be due to the slow folding of the E1 
protein as well as the slow release of E1 from the endoplasmic reticulum chaperone calnexin 
(Branza-Nichita et al., 2001). Even though E1-E2 heterodimer is involved in viral attachment 
and entry step, it is not shown which of the protein is responsible for membrane fusion. 
Unexpectedly, the recently published crystal structure of  BVDV E2 did not reveal the presence 
of a class II fusion protein fold which was supposed for pestivirus in analogy to hepacivirus. 
This indicated that fusion machinery of pestiviruses and hepaciviruses could be different from 
any other previously reported. Until now, the function of the E2 homodimer is still unclear. This 
point awaits further investigation.  
The mature E2 contains 15-17 conserved cysteines depending on the viral species. It was shown 
that except for C987, all other cysteines in E2 form intramolecular disulphide bonds in the 
absence of E1 by using computational approaches in the context of geometric constraints 
deduced from the E2 structures (Li et al., 2013; Wang et al., 2014). In their proposed atomic 
models, Cys987 in E2 is the critical site not only for E2 homodimer formation but also for E1-
E2 heterodimerization. Furthermore, they also suggested that C668 in E1 is most likely the 
residue engaged in the disulphide bond linkage with E2 to form E1-E2 heterodimers, but those 
predictions still need detailed experimental verification. A publication by Ronecker and 
colleagues also suggested that the positively charged amino acid Arg355 in E2 is essential for 
heterodimerization with E1 (Ronecker et al., 2008). As also shown for Erns, E2 is retained 
intracellularly showing that the protein contains a retention signal of its own. Recent publication 
demonstrated that both arginine 355 and glutamine 370 in E2 are important for intracellular 
retention (Radtke and Tews, 2017). Introduction of mutations of these residues leads to export 
of E2 to the cells surface.  
 




1.5 The conventional protein trafficking pathway 
After uncoating, the pestiviral RNA can be directly used by the system of host cells to synthesize 
viral proteins. To know how the protein synthesis pathway generally work in host cells will help 
to further understand some important steps in viral life cycle. The protein trafficking pathway 
is charged with the synthesis, modification, and delivery of a series of cellular soluble and 
membrane proteins in both prokaryotes and eukaryotes. In this eukaryotes trafficking route, 
membrane proteins and soluble cargoes are delivered from the endoplasmic reticulum (ER) to 
the Golgi apparatus, subsequently transported to the plasma membrane by some specific 
secretory vesicles. The first biogenesis step in the conventional secretory pathway of soluble 
and membrane proteins is translocation of the polypeptide mediated by signal sequence to the 
ER.  
 
1.5.1 Translocation at the ER site 
The translocon is assembled by the so-called Sec61 complex which consists of the 
heterotrimeric Sec61-α, Sec61-β and Sec61-γ in mammalian cells (Gorlich et al., 1992; Gorlich 
and Rapoport, 1993). Among them, Subunit Sec61-α forms a gated pore of the translocon 
(Gorlich and Rapoport, 1993). Both Sec61-α and Sec61-γ are highly conserved and critical not 
only for the function of the translocon channel but also for the cell viability, while the subunit 
Sec61-β is dispensable.   
In mammals, there are plenty of ER proteins and complexes (shown in Table 1.2) that always 
associate with the Sec 61 complex, present in the ER and exercise translocation behaviour. Both 
co- and post-translational translocation are observed that depend on Sec61 but in association 
with different components/complexes. The co-translational mechanism widely exists in nearly 
all types of cells and is used for soluble and integral membrane proteins of most eukaryotes. 
Post-translational translocation is more commonly arising in Escherichia coli and yeast. The 
co-translational mechanism is GTP-dependent (Rapoport, 2007), while the post-translational 
translocation is in a ATP dependent process (Chirico et al., 1988; Deshaies et al., 1991; J A 
Rothblatt 1986). 
 
Table 1.2 Some ER proteins/complexes associate with the Sec 61 complex 
 Protein/complex Abbreviation Molecular weight 
Chaperones/Targeting 
components 
signal recognition particle SRP 
Six subunits: 9, 14, 19, 54, 68, and 
72 kDa 
signal recognition particle 
receptor 
SR 
Two subunits: SRα of 72 kDa and 




TRAM 37 kDa 
translocon-associated protein TRAP 90 kDa 
binding immunoglobulin protein Bip 78 kDa 
signal peptidase complex SPC 
Five subunits: 12, 18, 21, 22/23, 
and 25kDa 








In the co-translational targeting pathway, firstly, the signal sequence/signal peptide (SP) is 
recognized by the signal recognition particle (SRP). This co-translational targeting stage needs 
the interaction of SRP with the SP of a nascent polypeptide chain. Subsequently, this SP-SRP 
complex is directed to the ER membrane by binding to the SRP receptor (SR). The SRP-nascent 
polypeptide chain complex is transferred by SR to the translocon in a GTP dependent manner 
(Rapoport, 2007), which mediates the ribosome-channel alignment and initiates translocation 
of the nascent polypeptide chain, as shown in Fig1.4A.  
Figure 1.4 Membrane/secretory protein biogenesis in the ER 
(A) Co-translational membrane translocation of membrane/secretory proteins. (B) Signal peptidase complex 
cleaves hydrophobic signal sequence/peptide during nascent polypeptide translocation. 
 
1.5.2 Signal sequence and topogenesis of membrane proteins 
In mammalian cells, two types of signal sequences are responsible for targeting and integration 
of polypeptides into the ER. The first one has C-terminal translocating activity and consists 
always of an anchor sequence and a cleavable signal sequence. The second one has N-terminal 
translocating activity and contains reverse signal-anchors (Goder and Spiess, 2001). The 
characteristic of the signal sequence is an uncharged, hydrophobic stretch of 7-25 amino acids 
(von Heijne, 1990). It is common to see that secretory and membrane proteins contain the signal 
sequence at their N-terminus. When this N-terminal signal enters the Sec61 complex, it induces 
the translocation of either polypeptide N- or their C-terminal sequence. Afterwards, the 
respective hydrophilic portion of the polypeptide is transferred through the channel of the 
translocon into the ER lumen. According to the so-called ‘positive-inside rule’ (Beltzer et al., 
1991; Hartmann et al., 1989; Heijne, 1986), the orientation of signal sequence is mainly 
determined by charged residues flanking the apolar sequence, the hydrophobicity of signal 
sequence itself and folding properties of the N-terminal section. 
The signal peptidase complex (SPC) cuts off this hydrophobic signal sequence/peptide via 
endoproteolytic cleavage at a specific cleavage site during translocation through the Sec61 
complex (as shown in Fig1.4B). In most cases, the signal peptide is about 20-30 amino acids in 
length, and composed of three parts: ① n-region: composed by several basic amino acids; ② 
h-region: a hydrophobic stretch in the middle; ③ c-region: a slightly polar area containing a 
specific consensus motif. In eukaryotes, according to so called ‘von Heijne’ rule (von Heijne, 
1990), the -1 and -3 position upstream from the cleavage site are always occupied by small, 
Modifying enzymes oligosaccharyltransferase OST 
Core complex: ribophorin I of 
66kDa, ribophorin II of 63/64kDa,  
OST48 of 48kDa and DAD1 of 
10kDa 
A B 




non-charged residues, such as alanine and glycine. For bacteria, there is a well characterized 
consensus motif A-X-A (A: alanine, X: any amino acid residue) at the c-region of the signal 
peptide recognized by homologue signal peptidase I (Auclair et al., 2012). It is worth noting 
that signal sequence is not only essential for poly-peptide targeting to the ER but also plays an 
important role in topogenesis of mature protein (Higy et al., 2004).In secretory and single-
spanning membrane proteins, topology is highly determined by the orientation of the signal 
sequence in the membrane. The membrane topology of single-spanning transmembrane 
proteins can be divided into 3 major types, as is summarized in Table 1.3 and presented in 
Fig1.5. 
  
Table 1.3 Three different well characterized topogenic types of single-spanning membrane proteins 
 Type I Type II Type III 









Orientation Nexo/Ccyt Ncyt/Cexo Nexo/Ccyt 
Figure 1.5 Three different types of single-spanning membrane proteins topogenesis 
 
1.5.3 N-linked glycosylation 
Glycosylation is the most common co-translational protein modification in eukaryotes. It has 
strong effects on the folding, conformation and stability of protein (Shental-Bechor and Levy, 
2009), and also participates in host-pathogen interaction (Blattner et al., 2014; Carbaugh et al., 
2019; Falkowska et al., 2014; Wei et al., 2012; Zheng et al., 2018). Some publications suggested 
that different levels of underprocessed high-mannose-type glycans affect the epitope 
conformation of viral glycoproteins, and also indicated the importance of N-glycans for the 
structure and function of viral glycoproteins (Tong et al., 2018). 




The process of N-glycosylation is initially carried out in the ER and the subsequent processing 
occurs in the Golgi apparatus. It starts with the en bloc transfer of Glc3Man9GlcNAc2 to the 
nascent polypeptide by an oligosaccharyltransferase (OST). OST is a multimeric complex that 
catalyses the N-glycosylation in the ER lumen (Bai et al., 2018). N-linked glycosylation requires 
the asparagine mediated tripeptide consensus motif Asn-X-Ser/Thr (X could be any amino acid 
but not proline). The oligosaccharide chain is attached to the N-linked oligosaccharide core - 
asparagine residue (as shown in Fig 1.6A). Only if the nascent protein folded properly, two 
glucose residues are removed by glucosidase I and II (as shown in Fig 1.6C). If  the final third 
glucose residue was cut off by ER mannosidase, it signals that this nascent glycoprotein is ready 
for transport from the ER to the cis-Golgi (Taylor, 2011).This step is considered to act as a 
quality control step in the ER to monitor protein folding. 
However, if this nascent protein is not folded correctly, those three glucose residues are not 
removed, and in consequence this nascent glycoprotein can't leave the ER. Normally, those 
unfolded or partially folded proteins require chaperone proteins (like calnexin/calreticulin) to 
assist their folding. 
Glycoproteins without ER retention signal transit from the ER to cis-Golgi when correctly 
folded. Some glycosyltransferases and glycosidases in the cis-Golgi catalyze further 
modifications that is addition and removal of sugar residues. Finally, at the medial portion of 
the Golgi apparatus, some sugar residues are added to the core glycan structure mediated by 
glycosyltransferases, giving rise to the three main types of N-glycans, as shown in Fig 1.6B.  




Figure 1.6 N-glycosylation 
(A) Schematic representation of N-glycosylation in the ER; (B) Three main types of N-glycans, modified 
from (Sethi and Fanayan, 2015); (C) The processing of N-linked glycans from the endoplasmic reticulum to 
Golgi apparatus, modified from (Cao et al., 2018). 
 
For pestiviruses, some publications showed that the glycosylation of envelope proteins can 
affect virulence. For CSFV, substitution at N-linked glycosylation site N116 in E2 induced viral 
attenuation (Risatti et al., 2007a). Removal of a N-linked glycosylation site of Erns reduced viral 
infectivity (Sainz et al., 2008). Moreover, single mutation of N594A or combined 
N500A/N513A substitutions in E1 also resulted in CSFV attenuation (Fernandez-Sainz et al., 










folding, conformation and stability of the proteins, which can result in changes in some 
processes in the viral life cycle like receptor recognition, viral membrane fusion step and 
immune evasion. 
 
1.5.4 Disulfide bond formation 
Disulfide bond formation is another essential co-translational modifications found in proteins 
that enter the secretory pathway. The essence of disulfide bond formation is building up 
covalent linkages within and between proteins via the oxidation of sulfhydryl (-SH) groups 
which have their cysteine residues in close enough proximity. For eukaryotes, the formation of 
disulfide bonds (also known as oxidative protein folding) mainly occurs in the ER and inter-
membrane space of mitochondria (Saaranen and Ruddock, 2019). A family of protein-disulfide 
isomerases (PDIs) is required for formation of correct disulfide bonds in secretory and cell 
surface proteins (Farquhar et al., 1991; Laboissiere, 1995). Normally, simple disulfide bond 
formation can be divided into two steps, dithiol oxidation and disulfide isomerization (as shown 
in Fig1.7). In eukaryotes, the first step is carried out by sulfhydryl oxidases (like the Ero1, 
ERV/ALR, and QSOX families in human), whereas the next step is catalyzed by PDI in the ER. 
Those enzymes are required to not only introduce disulfides between proximal cysteines but 
also to collapse disulfides which are not present in the final mature proteins to properly ensure 
the final disulfide formation (Bulleid, 2012; Jansens et al., 2002). 
Disulfide bond formation also plays an essential role in the life cycle of viruses. For HCV, some 
publications demonstrated that cysteine mutations in E2 drastically reduce virus infectivity 
(McCaffrey et al., 2012). The ‘CxxC’ motif is a key feature for the recognition by protein 
disulfide isomerase to mediate the isomerization of disulfide bonds in HCV E1 (Castelli et al., 
2017; Wahid et al., 2013). The cysteine residue at position 128 of core protein was shown to be 
a dominant disulfide bond formation site in terms of HCV-like particle production. The studies 
indicated that this disulfide bond is critical for the HCV virion (Kushima et al., 2010). More 
recently, a low-molecular-weight PDI inhibitor called origamicin was shown to negatively 
impact HCV replication by inducing incorrect proteins folding, causing an imbalance in cellular 
homoeostasis and induction of stress responses (Ozcelik et al., 2018). 
The cysteine residue at position 171 of the Erns of CSFV was shown to be critical for the 
formation of Erns homodimers. Substitution of this cysteine leads to attenuation of the virus 
(Tews et al., 2009a). Furthermore, restoring the Erns dimerization via cysteine residue 
downstream of position 171 can also partially recover the virulence of CSFV (Tucakov et al., 
2018). This finding further supports the connection between virulence and Erns dimerization. 
The relationship between different modifications is possibly competitive. An early study 
showed that HCV E1 glycosylation can impair the formation of disulfide bond in E1-E2 
heterodimer (Tong et al., 2018). The reverse is also true that disulfide bond involving C306 in 
E1 is most likely be prevented by glycosylation at N305 because of spatial hindrance (Meunier 
et al., 1999). Interestingly, removal of this N-linked glycosylation site increases the 
immunogenicity of soluble E1 (Fournillier et al., 2001), which also proves that the process of 
post-translational modification and nascent protein maturation is complex and closely 
interrelated.  




Figure 1.7 Schematic representation of disulphide bond formation 
In the ER lumen, disulfide bond formation is reversibly catalyzed by protein disulfide isomerases (such as 
Pdi1) with Ero1 providing oxidizing equivalents. 
 
1.5.5 Cargo exit from ER mediated by COPII 
Secretory and membrane proteins that are folded correctly and not ER-resident proteins, are 
transported from the ER to the Golgi apparatus. Both the ‘quality control’ mechanism of ER 
and the unfolded protein response (UPR) protects the ER folding environment by detecting and 
responding to the presence of misfolded proteins in its lumen (Ron and Walter, 2007). When 
misfolded polypeptides accumulate continuously, they trigger the activation of the ER-
associated degradation (ERAD) pathway to be degraded. In eukaryotic cells, the transport of 
newly synthesized proteins out of the ER is carried out via the coat protein complex II (COPII) 
vesicles (Hughes and Stephens, 2008). The COP II complex consists of five proteins, including 
a small GTPase Sar1, heteromeric complexes Sec23-Sec24 and Sec13-Sec31 (as shown in Fig 
1.8). The components of the COP II complex are recruited and assembled at ER-exit sites 
(ERES) where COP II complex vesicles bud off. ERES is present in most eukaryotic cells 
(Anelli and Sitia, 2008). 
There are some indications that transmembrane cargo directly binds to COPII subunits Sec24 
mediated via some specific signals at it C-terminus (Nishimura and Balch, 1997). However, 
soluble secretory cargo can not be bound directly by coat subunits, since there is no consensus, 
but evidence suggests that transmembrane receptors might link certain luminal cargo to COPII. 
Several ER export signals on transmembrane protein have been identified, as shown in Table 
1.4. 
     
Table 1.4 Characterized ER export signals of membrane protein 
















Underlined residues are required for export from the endoplasmic reticulum (ER). 
 
1.5.6 ER retention signal 
In eukaryotes, there are mechanisms to selectively retain proteins in the ER or Golgi apparatus. 
Selective export and retrieval of proteins between the endoplasmic reticulum (ER) and Golgi 
apparatus is vital for eukaryotic cell function. Both the ER and the Golgi apparatus maintain 
specific resident membrane proteins and lipids to achieve their structural and functional 
integrities. There is a well-known carboxylterminal retention signal Lys-Asp-Glu-Leu (KDEL) 
mediating an essential step in the retrieval of ER luminal proteins from the Golgi by the KDEL 
receptor in a pH-dependent manner (Brauer et al., 2019). Coat protein complex I (COPI) 
vesicles are known to mediate retrograde protein traffic from Golgi to ER. Some retention 
signals which interact with the COPI complex, such as the well-known C-terminal KKXX or 
KXKXX motif, function specifically in retrieving ER-resident membrane proteins from the 
Golgi via interacting with COPI coat proteins (Jackson et al., 1990; Nilsson et al., 1989). For 
KDEL-bearing proteins, deletion of the retrieval motif leads to their secretion. A growing 
number of ER retention signals have been identified. However, in some cases, the retention 
signals do not fully retain the protein in the cell, these proteins are still secreted at different rates 
and in generally very slow. The retention mechanism is complex and varies, not immobilization. 
HCV envelope protein E1 and E2 both contain retention signal of their own, located within 
their transmembrane domains. These signals consist of some charged residues (Ciczora et al., 
2005; Cocquerel et al., 1999; Cocquerel et al., 1998; Duvet, 1998). Recently, a publication 
showed that this situation is also true for BVDV E2 (Radtke and Tews, 2017). Pestiviral 
glycoprotein Erns was also shown to contain a retention signal located in its unusual C-terminal 
membrane anchor (Burrack et al., 2012; Tews and Meyers, 2007). Besides the classical retrieval 
mechanisms described for proteins with a KDEL or a KKXX signal, retention of native proteins 
without retrieval can also occur in the ER.
YQPDDKTKGILDR Erv41p 
KLFYKAQRSIWGKKSQ Erv46p 




Chapter 2: Objectives of the study 
 
Pestiviruses contain three envelope proteins: Erns, E1, and E2. Among them, E1 is the worst 
characterized. There is still no good specific antibody for E1, making the detection and further 
characterization of this protein difficult. Therefore E1 has mainly been analysed in the context 
with the other two envelope proteins. My aim for the present study was to take advantage of 
tagged E1 for detection to be able to address the following questions:  
 
1. Subcellular Localization of E1  
Pestiviruseses are known to bud at intracellular membranes, since all the glycoproteins are not 
accessible on the surface of transfected or infected cells. It indicates that retention signal(s) 
have to be present that ensure accumulation of the envelope proteins in defined intracellular 
sites. In this study, I analyzed whether E1 alone stay within the cell, and if so, in which 
compartment E1 is concentrated. Tagged E1 was analyzed via co-localization with marker 
proteins for different cellular compartments (e.g. ER and Golgi apparatus) via confocal 
microscopy.  
 
2. Membrane topology of E1 
The N-terminus of E1 is generated by signal peptidase cleavage at the unusual Erns membrane 
anchor/E1 site, so that the N-terminus of E1 should be located in the ER lumen. The length of 
the hydrophobic region at the C-terminus of E1 is too long for a normal single span 
transmembrane domain, so that the membrane topology of the mature E1 protein is difficult to 
predict and studies on the membrane topology of E1 are still missing. To analyse the membrane 
topology of E1, we established a plasmid construct for expression of a double tagged E1 protein 
with one tag located at the N-terminus and the other at the C-terminus. By using selective 
permeabilization combined with fluorescence microscopy, we wanted to determine whether the 
C-terminus of E1 is accessible from the cytosolic side. To verify the results we learned from 
the selective IF, we used a so-called Avitag biotinylation assay as a second technical approach. 
Furthermore, we also tested the membrane topology of E1 in E1E2 fusion proteins before signal 
sequence cleavage at the E1/E2 site to see whether the fusion of the two proteins has impact on 
E1 topology. 
 
3. Retention of E1 
Since pestiviruses bud intracellularly, E1 has to stay within the cell either by a retention 
mechanism or via interaction with other viral proteins like E2. If E1 is identified to contain an 
intracellular retention signal of its own, we would like to do further characterization of the 
relevant element to search for the respective sequence motif for this retention behaviour. To 
prove the crucial sequence that we found is really responsible for the retention of E1, it is fused 
to a typical surface protein (eg. VSV-g). Analyses were done using FACS analysis and IF to see 
whether this fusion protein demonstrates intracellular retention or not. To hunt for the critical 
residue(s) of the retention signal of E1, we used mutagenesis or deletion analysis combined 
with FACS and IF assay. If the critical sites are identified, we also would like to test those sites 
in the context of the BVDV CP7 infectious clone, to investigate the influence on the live virus 
when the retention of the viral envelope protein E1 is impaired. 




4. Prerequisites of E1 oligomer formation and E1-E2 heterodimerization 
It is well known that E1 forms disulphide linked heterodimers with E2 that are needed for virus 
infectivity and crucial for viral entry. Due to the absence of specific antibodies for E1, so far it 
has not been shown whether E1 can also form disulphide linked homodimers or oligomers. 
Basically, covalent disulphide linkages can be formed by cysteine residues. In the present study, 
we want to hunt for the critical site(s) for E1 oligomerization (if possible) and E1-E2 
heterodimerization. To achieve this purpose, we established several E1, E2 mutants lacking the 
cysteine residues supposed to be involved in disulphide bond formation. In addition, it was 
intended to characterize the E1E2 interaction platform upon the co-expression of E1 mutants 
with E2 mutant. Furthermore, if the sites important for E1 oligomerization (if possible) and E1-
E2 heterodimerization are identified, we want to further test those sites in the live virus with 
the help of BVDV CP7 infectious clone bearing specific mutations, to see the effect of disulfide 
bond formation within E1/E2 on the viral life cycle. 
Taken together, the aim of this study is to analyse the structure and function of the pestivirus 
E1 protein at the molecular level. These results will help to further understand several important 
processes in the pestiviral life cycle like intracellular budding, protein retention and 
oligomerization.
 




Chapter 3: Materials 
3.1 Cells  
The following eukaryotic cell lines were used for the transient expression of proteins and for 
the cultivation of viruses: 
Cell lines Origin 
BHK-21(Baby hamster kidney cell) T. Rümenapf (Universität Gießen) 
RK-13(Normal Rabbit Kidney Epithelial Cells) ATCC#: CCL-37 
MDBK-B2(Madin-Darby Bovine Kidney Epithelial Cells) ATCC#: CCL-22 
 
3.2 Viruses 
The following viruses were used for the transient expression of proteins and for the cultivation 
of viruses: 
 
3.3 Bacterial strains 
Bacteria strains E.coli HB101 and Top10F' were used for the amplification of the plasmids in 
this study. 
HB101 genotype: supE44, Δ (mcrC-mrr), recA13, ara-14, proA2, lacY1, galK2, rpsL20, xyl-
5, mtl-1, leuB6, thi-1 
Top 10 F' genotype: mcrA, Δ (mcrBC-hsdRMS-mrr), end A1, recA1, relA1, gyrA96, F 80lacZ 
Δ M15, deoR, nupG, araD139, F (lacIq, Tn10 (Tetr)), galU, D lacX74, galK, D (araleu) 7697 
 
3.4 Medium 
The media as follows were used for cell culture or experiments with mammalian cells. 
Name Component Manufacturer 
ZB5d 
MEM Eagle (Hank’s salts, Sigma M4642) 
MEM (Earles’salts, Gibco/Invitrogen 61100)  
NaHCO3 (Roth 6885.1) 
NEA (Biochrome K 0293, 100x)  






Cell bank  
Name Origin 
BVDV CP7 Received from Cornell University, Ithaca, USA 
Vaccinia Virus MVA T7 Received from Dr. Gerd Sutter, LMU München, Germany 





MEM Eagle (Hank’s salts, Sigma M4642) 
MEM (Earles’salts, Gibco/Invitrogen 61100)  
NaHCO3 (Roth 6885.1)  
NEA (Biochrome K 0293, 100x) 








Cell bank  
Opti-MEM  Gibco, USA 
 











LB-Ampicillin Agar in LB-Ampicilin 









The following antibodies were used for western blot analysis, immunofluorescence and 
immunoprecipitations. The amounts or dilutions used are given in each case. 







α-HA HA tag Mouse 1:1000(IF) Abcam, UK 
α-HA HA tag Rabbit 1:1000(WB) Abcam, UK 
α-V5 V5 tag Mouse 1:1000(IF) Invitrogen, USA 
α-Flag M2 Flag tag Mouse 1:1000(IF) Sigma-Aldrich®, USA 
α-AU1 AU1 tag Mouse 1:1000(IF) Abcam, UK 




α-WB 214 BVDV E2 Mouse 1:250(WB) Weybridge, England 




α-f48 CSFV E2 Mouse 1:100(IF) FLI 
α-Code 4 NS3 Mouse 1:10(IF) FLI 
 α-VSVg VSVg [ecto-] Rabbit 1:100(IF) PD Dr. Stefan Finke 
 
 Name Antigen Host Dilution Origin 
Secondary 
antibody 





Mouse IgG Mouse 1:250(IF) 
Thermo Scientific, 
USA 










Rabbit IgG Mouse 1:250(IF) 
Thermo Scientific, 
USA 















All chemicals used in this study were obtained in analytical quality. 
Name Manufacturer 
Acetic acid Hoechst, Dortmund 
Aceton Roth, Karlsruhe 
Acrylamid (40 %) (29:1) AppliChem, Darmstadt 
Agarose Gibco, Scotland 
Ampicillin Ampicillin 
APS Merck, Darmstadt 
Bacto-Agar Becton Dickinson, USA 
Bacto-yeast extract Becton Dickinson, USA 




Bacto-tryptone Becton Dickinson, USA 
BSA Roche, Mannheim 
CaCl2 Roth, Karlsruhe 
Coomassie Brilliant Blue G250 Serva, Heidelberg 
DAPI Serva, Heidelberg 
DEPC Sigma, Munich 
Digitonin Serva, Heidelberg 
dNTPs New England BioLabs, Frankfurt 
DTT Roche, Switzerland 
EDTA Roth, Karlsruhe 
Ethanol Roth, Karlsruhe 
FCS Biochrom, Berlin 
GelRed Phenix Research, USA 
Glucose Merck, Darmstadt 
Glycine Roth, Karlsruhe 
Glycerin (87 %) Roth, Karlsruhe 
H3PO4 Roth, Karlsruhe 
HCl Roth, Karlsruhe 
HEPES Sigma, Munich 
KCl Roth, Karlsruhe 
KH2PO4 Roth, Karlsruhe 
Magermilchpulver Hobbybäcker Versand, Bellenberg 
Methanol Roth, Karlsruhe 
β-Mercaptoethanol MP Biomedicals, Heidelberg 
MgCl2 Merck, Darmstadt 
MgSO4 Roth, Karlsruhe 
Mowiol Roth, Karlsruhe 
NaCl Roth, Karlsruhe 
Na2CO3 Roth, Karlsruhe 
Na2HPO4 Roth, Karlsruhe 
NaOH Roth, Karlsruhe 
Paraformaldehyde Sigma, Munich 




Phenol, tris-saturated Roth, Karlsruhe 
Saponin Roth, Karlsruhe 
SDS Roth, Karlsruhe 
Sucrose Roth, Karlsruhe 
TEMED Serva, Heidelberg 
Tris Invitrogen, USA 
Tricin Roth, Karlsruhe 
Triton-X100 Sigma, Munich 
Tween-20 Sigma, Munich 
 
3.7 Commercial Kits 
Name Manufacturer 
BigDye® Terminator v.3.1 Cycle Sequencing Kit Applied Biosystems, Weiterstadt 
SuperSignalTM West Pico Chemiluminescent substrate Kit Thermo Fisher Scientific Inc. 
RiboMAX™ Large Scale RNA Production System- T7 Promega, Mannheim 
Nucleo-Spin®-Gel and PCR clean- up Macherey-Nagel, Düren 
QIAGEN Plasmid Midi Kit QIAGEN, Germany 
SuperScript™ III One-Step RT-PCR System Thermo Fisher Scientific Inc. 
Trizol® Reagent ambion RNA, USA 
 
3.8 Prepared Solutions and Buffer 
Name Composition Purpose 















50% (v/v)  
10% (v/v) 




RIP gel stainning 







0.1 M  
2.5 mM  
1.0 mM  
5 µl/ml  




















RIP gel fixing 
Jagow anode buffer (10x) 2 M Tris (pH 8.9) SDS-PAGE 
Jagow cathode buffer (10x) 
1 M  









0.25 M  





Preparation for WB 
transfer buffer 
Solution I 
50 mM  
10 mM  





pH 8.0 Plasmid mini prep 
Solution II 
0.2 M  
1% (v/v)  
NaOH 
Triton-X100 















0.5 mM  




washing step for IF 
and FACS 




137 mM  
2.7 mM  
7.4 mM  






137 mM  
2.7 mM  
7.4 mM  







0.2% (v/v)   Tween-20 
in PBS-A 
Washing step for 
WB 
4% PFA 





62.5 mM  
2% (w/v)  
10% (v/v)  
6 M  
5% (v/v)  
0.01% (w/v)  
0.01% (w/v)  





 Brpmphenol blue 




0.075% (w/v)  
10% (w/v)  
0.75 M   
0.08% (w/v)  
0.09% (w/v)  
 SDS 
 Acrylamide (29: 1) 





0.1% (w / v)  
8%,10%(w/v)  
1 M  
5.5%  
0.08% (w/v)  
0.09% (w/v)  
SDS 
acrylamide (29: 1) 






40 mM  












Transfer Buffer (Westernblot) 
18% (v/v)  Methanol 
in Lämmlipuffer 
WB transfer step 
Cell-Lysis-Buffer 









Pfu DNA Polymerase Promega Corporation, USA 
Platinum™ Taq DNA Polymerase Invitrogen, USA 
T4 DNA Ligase New England BioLabs Inc., Frankfurt 
Restriction enzymes New England BioLabs Inc., Frankfurt 
RNase Serva Electrophoresis, Heidelberg 
Lipofectamin™ 2000 Invitrogen, USA 
1 Kb plus DNA Ladder Invitrogen, USA 
170 kDa PageRuler Prestained Protein Ladder Thermo Scientific, USA 
250 kDa PageRuler Prestained Protein Ladder Thermo Scientific, USA 
SepharoseA GE Healthcare, Freiburg 
Gel Loading Dye, Purple (6X) New England BioLabs Inc., Frankfurt 
 
3.10 Radio activity chemicals 
Name Manufacturer 
Tran35S-Label (1175 Ci/mmol,10.5 mCi/ml) MP Biomedicals, USA 
35S-Methionin (1175 Ci/mmol,10 mCi/ml) MP Biomedicals, USA 
14C molecular weight standard CFA626 GE Healthcare, Munich 









The primers listed below were used for PCR and sequencing and were ordered from primer 
synthesis company-Metabion (Munich). Primers provided desalinated and lyophilized. By 
default, a stock solution of the oligonucleotides was used with a concentration of 100mM (0.1 
nmol/μL). Working solutions with a concentration of 1mM (10 pmol/μL) were then prepared 
from the stock. The sequences of the oligonucleotides are listed in the 5’-3’ direction. 
Name Sequence (5’-3’) 
yM_1for  GCATTCTTGGTTTCTCTGGTGAAGGTAGTG 
yM_1rev CTACCTTCACCAGAGAAACCAAGAATGC 
yM_2for  GGAAAAGACGGCATCCACCTTCAACTACAC 
yM_2rev  GTAGTTGAAGGTGGATGCCGTCTTTTCC 
yM_3for  CTCATAACAGGGAGGCAAGGGTACCCAG 
yM_3rev  CTGGGTACCCTTGCCTCCCTGTTATGAG 
yM_4for  CCAGTCACAATGGGATCCTCTCCCTATTGTGAG     
yM_4rev  CTCACAATAGGGAGAGGATCCCATTGTGACTGG     
yM_5for  GATCGTACCCATACGACGTCCCAGACTACGCT 
yM_5rev  AGCGTAGTCTGGGACGTCGTATGGGTACGATC 
yM_6for  GAGAATTCACGCGTGCTACCTCTAGAATG 





yM_8for  GTCACAATGGGATCCTCTCCCTATTGTG 
yM_8rev  CACAATAGGGAGAGGATCCCATTGTGAC 
new HA F GATC C TACCCATACGACGTCCCAGACTACGCT G 
new HA R CAGCGTAGTCTGGGACGTCGTATGGGTAGGATC 
yM-HA tag A1 GTGATGCGGTTTTGGCAGTACAC 
yM-13HA tag A2 AGCGTAATCTGGAACATCGTATGGGTATCCCATTGTGACTTGAAA
GAAAACCAGGG 
yM-19HA tag A2 AGCGTAATCTGGAACATCGTATGGGTA-
TGCATATGCCCCAAACCATGTCTTACTC 
yM-HA tag B1 TACCCATACGATGTTCCAGATTACGCTGCCTCTCCCTATTGTGAG
GTAGAACG 
yM-HA tag B2 CAAATGCGCGTCAGATCTTTTAACGCC 
yM-FLAG tag A1 GGTAGAACGGAAGCTTGGTTACATCTGG 




yM-FLAG tag A2 CTTATCGTCGTCATCCTTGTAATC-CCCTTGCGCCCCTGTTATGAG 
yM-FLAG tag B1 GATTACAAGGATGACGACGATAAG-
TACCCAGACTGCAAACCCGGC 
yM-FLAG tag B2 CCACACCACTCACAAGACTCAACGG 
yM-QC-9 for CAGACTACGCTGCCTCTCCCTATTGTG 









E1 182Δ QC for (pCR54) GGC CAA GTG TTA____GGT ATA CTG TGG 
E1 182Δ QC rev (pCR54) CCA CAG TAT ACC____TAA CAC TTG GCC 
E1 177E QC for (pCR60) GTG AAG GTA GTG GAG GGC CAA GTG TTA 
E1 177E QC rev (pCR60) TAA CAC TTG GCC CTC CAC TAC CTT CAC 




yM-Avitag QC F GAATGATATTTTCGAAGCACAGAAAATTGAATGG 
yM-Avitag QC R CCATTCAATTTTCTGTGCTTCGAAAATATCATTC 
yM-5’ Avitag E1 F TCGAAAATATCATTCAACCCGGACCCTCCCATTGTGACTTGAAA
GAAAACCAGGG 
yM-5’ Avitag E1 R AGCACAGAAAATTGAATGGCATGAG-
GCCTCTCCCTATTGTGAGGTAGAACG 
yM-QC-16 F GATAATACCATGGGGAAGGCCCTGTTG 
yM-QC-16 R CAACAGGGCCTTCCCCATGGTATTATC 
yM-QC-17 F CTCATAACAGGGAGACAAGGGGGG 
yM-QC-17 R CCCCCCTTGTCTCCCTGTTATGAG 
yM-BirA F CCGCTCGAG-ggATGAAGGATAACACCGTGCCACTGAAATTG 
yM-BirA R CGACGCGT-TTATTTTTCTGCACTACGCAGGGATATTTCACC 




yM-HEVG XhoI F CCGCTCGAG-GGATGGAGAAAGCCCTATTGGCCTGG 
yM-HEVG NotI R ATAGTTTAGCGGCCGCTTACTTTCCAAGTCGGTTCATCTCTATGT
CTG 
yM-Erns(BT) NotI R ATAGTTTAGCGGCCGCTCATGCATATGCCCCAAACCATGTC 
yM-3' Avi Erns F AGCACAGAAAATTGAATGGCATGAG-TGAGCGGCCGCTTCGAG 
yM-3' Avi Erns R TCGAAAATATCATTCAACCCGGACCCTGCATATGCCCCAAACCAT
GTCTTAC 
yM-Avi MluI and XbaI F CGACGCGTGGGTCCGGGTTGAATGATATTTTCGAAGCACAGAAA
ATTGAATGGCATGAGTGA 




yM-3'R for pB153 CGACGCGTTGCATATGCCCCAAACCATGTCTTACTC 
yM-3'R for pB154 CGACGCGTTGCATATCGCCCAAACCATGTCTTACTC 
yM-QC-19F GCTAGCCTCGAGGGATGAAGGATAAC 
yM-QC-19R GTTATCCTTCATCCCTCGAGGCTAGC 
yM-HEVG XhoI F CCGCTCGAG-GGATGGAGAAAGCCCTATTGGCCTGG 
yM-HEVG NotI R ATAGTTTAGCGGCCGCTTACTTTCCAAGTCGGTTCATCTCTATGT
CTG 
yM-nB F CCGCTCGAG-ggATGAAGGATAACACCGTGCCACTGAAATTG 
yM-TA Hseq F CTTCTCGCACTACTGGCGGCATTCTTGGTTTGTCTGGTGAAGGTA
GTG 
yM-TA Hseq R CGCCAGTAGTGCGAGAAGAGTGGTTGTAGCAGCGGTCCAAAT 
yM-QG Hseq F CTTCTCGCACTACTGGCG-
GGTATACTGTGGCTGATGCTCATAACAG 




yM-VSVG EcoRI 5'F GGCAAAGAATTCCACCATGAAGTGCC 
yM-VSVG MluI 3'R CGACGCGTAGAGGCAATAGAGCTTTTCCAACTACTGAAC 
yM-E1tmd MluI 5'F CGacgcgtGGAGGAGGAGGAAGTACCACTGC 
yM-E1tmd NotI 3'R ATAGTTTAGCGGCCGCTCACCCTTGCGCCCCTGTTATG 
yM-QC-1st G to L F GGTAGTGAGACTGCAAGTGTTACAAGG 




yM-QC-1st G to L R CCTTGTAACACTTGCAGTCTCACTACC 
yM-QC-1st G to A F GGTAGTGAGAGCGCAAGTGTTACAAGG 
yM-QC-1st G to A R CCTTGTAACACTTGCGCTCTCACTACC 
yM-QC-2nd G to L F CCAAGTGTTACAACTGATACTGTGGCTG 
yM-QC-2nd G to L R CAGCCACAGTATCAGTTGTAACACTTGG 
yM-QC-2nd G to A F CCAAGTGTTACAAGCGATACTGTGGCTG 
yM-QC-2nd G to A R CAGCCACAGTATCGCTTGTAACACTTGG 
yM-QC-2G to L F GTGAGACTGCAAGTGTTACAACTGATACTG 
yM-QC-2G to L R CAGTATCAGTTGTAACACTTGCAGTCTCAC 
yM-QC-2G to A F GTGAGAGCTCAAGTGTTACAAGCTATACTG 
yM-QC-2G to A R CAGTATAGCTTGTAACACTTGAGCTCTCAC 
yM-E1 3'GS R ACTTCCTCCTCCTCCCCCTTGTCTCCCTGTTATGAGCATCAG 
yM-E2 5'GS F GGAGGAGGAGGAAGTTACCCAGACTGCAAACCCGGCTTTTC 
yM-E2 3'NotI R ATAGTTTAGCGGCCGCTCAGATGTATC 
yM-5'E1tmd-6L B2 R CAGTAGCAGTAGGAGAAGCAGACAAACCAAGAATGCAGTGGTT
GTAG 
yM-5'E1tmd-6L A1 F CTTCTCCTACTGCTACTG-
CAAGTGTTACAAGGTATACTGTGGCTGATG 
yM-3'E1tmd-6L B2 R CAGTAGCAGTAGGAGAAGGAGCATCAGCCACAGTATACCTTGTA
AC 
yM-3'E1tmd-6L A1 F CTTCTCCTACTGCTACTG-TGAGCGGCCGCTTCGAG 
yM-QC-21F GCGTTAAAAGATATCACGCGCATTTGGAC 
yM-QC-21R GTCCAAATGCGCGTGATATCTTTTAACGC 




yM-E1 TMD 5'Truncation 
F 
GCATTTGGACCGCTGCTACAACC 
yM-E1 TMD 5'Truncation 
R 
CTGTTATGAGCATCAGCCACAGTATACC 
yM-QC-21F (for all 
leucine) 
GCATTCTTGGTTTCTCTGGTGCTGGTAG 
yM-QC-21R (for all 
leucine) 
CTACCAGCACCAGAGAAACCAAGAATGC 
yM-5T MluI F CGacgcgtCAAGTGTTACAAGGTATACTGTGGCTGATG 
yM-NotI E1ecto 3'R TAAACTATGCGGCCGCTCAGGTTGTAGCAGCGGTCCAAATGC 




E1 TMD middle R AATTGATATCTACCTTCACCAGACAAACCAAGAATGCAG 
E1 TMD middle F aattGATATCTGGCTGATGCTCATAACAGGGG 
yM-E1-TMD-MT R (QC) GTCTGGTGAAGGTATGGCTGATGCTC 
yM-E1-TMD-MT F (QC) GAGCATCAGCCATACCTTCACCAGAC 
AL MluI F (VSV-Gecto) CGACGCGTACTGCATTCTTGGTTTGTCTG 











CP7 NS4A F NcoI CATG-CCATGG-TCCTCTGCCGAAAATGCCTTGCT 
CP7 NS4A R XbaI GCTCTAGATAATTCCTTTAGTTCAGTCTCCTTCCCCTCAG 
QC-27 for K671A F GTTTGTCTGGTGGCAGTAGTGAGAGG 
QC-27 for K671A R CCTCTCACTACTGCCACCAGACAAAC 
QC-28 for R674A F GTGGCAGTAGTGGCTGGCCAAGTGTTAC 
QC-28 for R674A R GTAACACTTGGCCAGCCACTACAGCCAC 
QC-29 for E2 R tm F CCTGGGTGGCGCTTACGTGCTTTG 
QC-29 for E2 R tm R CAAAGCACGTAAGCGCCACCCAGG 
QC-30 C620S for E1 F CTTGGGTAAATATGTTTCGGTAAGACCAGATTGG 
QC-30 C620S for E1 R CCAATCTGGTCTTACCGAAACATATTTACCCAAG 
QC-31 1st G STO F GGTAGTGCTGGGCCTGGTGTTAC 
QC-31 1st G STO R GTAACACCAGGCCCAGCACTACC 
QC-32 2nd G STO F CTGGTGTTACTGGGTATACTGTGGCTG 
QC-32 2nd G STO R CAGCCACAGTATACCCAGTAACACCAG 
QC 35F (for ALR 1st G) GTTGCTGTTGGGTCTGCTGCTG 
QC 35R (for ALR 1st G) CAGCAGCAGACCCAACAGCAAC 




QC 36F (for ALR 2nd G) CTGCTGCTGGGCTTACTGCTG 
QC 36R (for ALR 2nd G) CAGCAGTAAGCCCAGCAGCAG 
QC 37F (for ALO 1st G) GTGCTGGTAGGTCTGCTGCTG 
QC 37R (for ALO 1st G) CAGCAGCAGACCTACCAGCAC 
OL A2 522 R CTTATCGTCGTCATCCTTGTAATC-CCCTTGCGCCCCTGTTATGAG 
OL B1 522 F GATTACAAGGATGACGACGATAAG-TGAGCGGCCGCTTCGAG 
OL A2 332 R CTTATCGTCGTCATCCTTGTAATC-
AAGATGGATACCAACTCGGAGAACCAAG 
QC 38F (Q182A/G183A) CCAAGTGTTAGCAGCTATACTGTGGC 
QC 38R (Q182A/G183A) GCCACAGTATAGCTGCTAACACTTGG 
QC 39F (G178A/Q179A) GTAGTGGCTGCCGCAGTGTTAGC 
QC 39R (G178A/Q179A) GCTAACACTGCGGCAGCCACTAC 
QC 40F (G178A/Q179A) GTAGTGGCTGCCGCAGTGTTACAAG 
QC 40R (G178A/Q179A) CTTGTAACACTGCGGCAGCCACTAC 
QC41 F CCACCACACATAGTACTTTGCCGAG 











R-Seq 3' BVDV E1 CTGAGTGGTGAGGCCTGTAGCTC 
OL A2 E1 TMD 3'T R CTTATCGTCGTCATCCTTGTAATCTTGTAACACTTGGCCTCTCACT
ACCTTC 
QC-48 F CATAACAGGGGCGCAAGGGTACCC 
QC-48 R GGGTACCCTTGCGCCCCTGTTATG 
d-pmH1 F CAGTCCTGGTGATTGAAGAGGTGGGT 
d-pmH1 R CAAACCAAGAATGCAGTGGTTGTAGCAGC 




QC-49 F GGCCAAGTGTTAGCAGCTATACTGTGGCTG 
QC-49 R CAGCCACAGTATAGCTGCTAACACTTGGCC 
QC-50 F CGCTGCTGGTTGACAGCTAGGCC 
QC-50 R GGCCTAGCTGTCAACCAGCAGCG 
QC-51 F CTTGGTTCTCCGATGAGGTATCCATCTTTG 
QC-51 R CAAAGATGGATACCTCATCGGAGAACCAAG 
QC-52 F GGGCGCAAGGGTGATACAAGGATG 
QC-52 R CATCCTTGTATCACCCTTGCGCCC 
OL BirA AU1 5' B1 F ATG GAC ACG TAC 
CGATACATCATGAAGGATAACACCGTGCCACTGAAATTG 
OL BirA AU1 5' A2 R GATGTATCGGTACGTGTCCATCCCTCGAGGCTAGCCTATAGTGAG 
GFP F 5' KpnI F GGGGTACCATGAGTAAAGGAGAAGAACTTTTCACTGGAGTTG 
GFP R 3'NotI R TTTGCGGCCGCTCACAGAATGTTCATCCATGCCATGTGTAATCC 
OL 13-AU1 5B1 F GACACGTACCGATACATC GCCTCTCCCTATTGTGAGGTAGAACG 
OL 13-AU1 5A2 R GATGTATCGGTACGTGTCTCCCATTGTGACTTGAAAGAAAACCA
GGG 
OL 13-AU1 3A2 R GATGTATCGGTACGTGTCCCCTTGCGCCCCTGTTATGAGC 
OL 13-AU1 3B1 F GACACGTACCGATACATCTGAGCGGCCGCTTCGAGCAG 
Avi TmH F AGCACAGAAAATTGAATGGCATGAGGGCCAAGTGTTACAAGGT
ATACTGTGGC 
Avi TmH R TCGAAAATATCATTCAACCCGGACCCTCTCACTACCTTCACCAG
ACAAACCAAG 
QC-53 F GTAGTGCAGAAAAAATGACGCGTGGTACCTC 
QC-53 R GAGGTACCACGCGTCATTTTTTCTGCACTAC 
Avi pmH2 F AGCACAGAAAATTGAATGGCATGAGGCTGCTACAACCACTGCAT
TCTTGG 
Avi pmH2 R TCGAAAATATCATTCAACCCGGACCCGGTCCAAATGCGCGTCAG
ATCTTTTAAC 
Avi pmH12 F AGCACAGAAAATTGAATGGCATGAGGGTCAAGTAATTAAGGTTG
TCTTAAGGGCG 
Avi pmH12 R TCGAAAATATCATTCAACCCGGACCCCACCTCTTCAATCACCAG
GACTGTG 
Seq m BVDV E1 For GTCACTTGTCGGAGGTGCTACTACTC 
QC-54F GGTGCCCAGGGATACCTAGAGC 
QC-54R GCTCTAGGTATCCCTGGGCACC 






HA-E1 5' F GCTCTAGAACATGGTTTGGGGCATATGCA-
TACCCATACGATGTTCCAGATTACGCTGC 
HA-E1E2 3' R GGGGTACCCTTGCGCCCCTGTTATG 
VSVg 5' F GCTCTAGAACATGGTTTGGGGCATATGCA-
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTG 
VSVg 3' Rc GGGGTACCCGCAAAGATGGATACCAACTCGGAGAAC 
VSVg 3' Rk GGGGTACCCCTTTCCAAGTCGGTTCATCTCTATGTCTG 
QC-60 F GTGATGTCTAGGGTGATAGCAGCAC 
QC-60 R GTGCTGCTATCACCCTAGACATCAC 
BirA KDEL R CAGTTCATCTTTGGAGGAGGAACCTTTTTCTGCACTACGCAGGG
ATATTTCACC 
BirA KDEL F GGTTCCTCCTCCAAAGATGAACTGTAAACGCGTGGTACCTCTAG
AGTCG 
BirA KEDL SeqS F TGTTATCACCGCCCAAGCCAACAGGGCTTTCCCTCGAGGCTAGC
CTATAGTGAG 
BirA KEDL SeqS R ATCTTGCTGTACCAGCCTGTAGCAGCCAAGGATAACACCGTGCC
ACTGAAATTGATTG 
QC-62 F GTGATAACAATCTTGCTGTACCAGCCTG 
QC-62 R CAGGCTGGTACAGCAAGATTGTTATCAC 
QC-63 F GTGCTGTCCAATTTCTCTCCAGAGACAG 
QC-63 R CTGTCTCTGGAGAGAAATTGGACAGCAC 
QC-64 F GTGCTGTCCAATTTCACTCCAGAGACAG 
QC-64 R CTGTCTCTGGAGTGAAATTGGACAGCAC 
QC-65 F GATTCCGAACCCGCTGCTGGGCCTG 
QC-65 R CAGGCCCAGCAGCGGGTTCGGAATC 
ym-H1D F GATTTCGCTCCAGAGACAGCCAG 
ym-H1D R GGTAAAATACTGCATGAGATGGGGGGT 
ym-H2D F ATCCCACAAGGACACACTGATATACAAG 
ym-H2D R TGGAGCGAAATCGGACAGCACTAC 
QC-66 F GAGATGGGGGGTGATTTCGCTCC 
QC-66 R GGAGCGAAATCACCCCCCATCTC 
QC-67 F GATTTCGCTCCAATCCCACAAGGAC 
QC-67 R GTCCTTGTGGGATTGGAGCGAAATC 




QC-68 F GATGGGGGGTATCCCACAAGGAC 
QC-68 R GTCCTTGTGGGATACCCCCCATC 
Seq BirA Signal S R CCCAGTCACGCAGTGTCTGAATGTG 
ym-Seq pCI F GATAGGCACCTATTGGTCTTACTGACATC 
QC-69 F CTGGTATACAAAGGCTTGCACTCCAGC 
QC-69 R GCTGGAGTGCAAGCCTTTGTATACCAG 
QC-70 F CAAAAACCAACTAGCCCTCACCGTAGAAC 
QC-70 R GTTCTACGGTGAGGGCTAGTTGGTTTTTG 
QC-71 F CTGATATACAAGATTCCGACAAAAACCAAC 
QC-71 R GTTGGTTTTTGTCGGAATCTTGTATATCAG 
QC-72 F GCACTCCAGCCTCCTTGCCTAGG 
QC-72 R CCTAGGCAAGGAGGCTGGAGTGC 
QC-73 F CCTCTCCCTATTCCGAGGTAGAAC 
QC-73 R GTTCTACCTCGGAATAGGGAGAGG 
QC-74 F GTATACAAAGAATTCCACTCCAGCCTG 
QC-74 R CAGGCTGGAGTGGAATTCTTTGTATAC 
ym-344 new F CCGCTCGAGATGGCATCAACTACTGCGTTTCTCATTTGCTTG 
ym-345 new R CGACGCGTTCAACCAGCAGCGAGCTGCTCTGTTAG 
ym-BirA ATG F CCGCTCGAGGGATGGCCCTGTTGGCTTGGGCGGTG 
QC-75 F CCGATTTCGCTCCAATCCCACAAGG 
QC-75 R CCTTGTGGGATTGGAGCGAAATCGG 
N-H1D R ACCCCCCATCTCATGCAGTATTTTACC 
QC-76 F GTGACCGGGAGACAAGGGCG 
QC-76 R CGCCCTTGTCTCCCGGTCAC 
Avi half R TTCGAAAATATCATTCAACCCTGAACCAGC 
QC-77F GTAGTGCTGTCCATCGCTCCAGAGAC 
QC-77R GTCTCTGGAGCGATGGACAGCACTAC 
CR74 E1 171A forward GCATTCTTGGTTGCACTGGTGAAGGTA 
CR75 E1 171A reverse TACCTTCACCAGTGCAACCAAGAATGC 
CR76 E1 174A forward GTTTGTCTGGTGGCAGTAGTGAGAGGC 
CR77 E1 174A reverse GCCTCTCACTACTGCCACCAGACAAAC 
CR78 E1 174E forward GTTTGTCTGGTGGAGGTAGTGAGAGGC 




CR79 E1 174E reverse GCCTCTCACTACCTCCACCAGACAAAC 
CR80 E1 174D forward GTTTGTCTGGTGGTAGTGAGAGGC 
CR81 E1 174D reverse GCCTCTCACTACCACCAGACAAAC 
CR82 E1 177A forward GTGAAGGTAGTGGCAGGCCAAGTGTTA 
CR83 E1 177A reverse TAACACTTGGCCTGCCACTACCTTCAC 
CR84 E1 177K forward GTGAAGGTAGTGAAGGGCCAAGTGTTA 
CR85 E1 177K reverse TAACACTTGGCCCTTCACTACCTTCAC 
CR86 E1 177D forward GTGAAGGTAGTGGGCCAAGTGTTA 
CR87 E1 177D reverse TAACACTTGGCCCACTACCTTCAC 
CR88 E1 179A forward GTAGTGAGAGGCGCAGTGTTACAAGGT 
CR89 E1 179A reverse ACCTTGTAACACTGCGCCTCTCACTAC 
CR90 E1 179N forward GTAGTGAGAGGCAACGTGTTACAAGGT 
CR91 E1 179N reverse ACCTTGTAACACGTTGCCTCTCACTAC 
CR92 E1 179E forward GTAGTGAGAGGCGAGGTGTTACAAGGT 
CR93 E1 179E reverse ACCTTGTAACACCTCGCCTCTCACTAC 
CR94 E1 179D forward GTAGTGAGAGGCGTGTTACAAGGT 
CR95 E1 179D reverse ACCTTGTAACACGCCTCTCACTAC 
CR96 E1 182A forward GGCCAAGTGTTAGCAGGTATACTGTGG 
CR97 E1 182A reverse CCACAGTATACCTGCTAACACTTGGCC 
CR98 E1 182N forward GGCCAAGTGTTAAACGGTATACTGTGG 
CR99 E1 182N reverse CCACAGTATACCGTTTAACACTTGGCC 
CR100 E1 182E forward GGCCAAGTGTTAGAGGGTATACTGTGG 
CR101 E1 182E reverse CCACAGTATACCCTCTAACACTTGGCC 
CR102 E1 182D forward GGCCAAGTGTTAGGTATACTGTGG 
CR103 E1 182D reverse CCACAGTATACCTAACACTTGGCC 
 
3.12 Plasmids 
3.12.1 Commercial Vector Plasmids 
Name Manufacturer Purpose 
pCI Promega, Mannheim Expression/Cloning target gene 
pCITE 2a (+) Novagen, Merck, Darmstadt Expression/Cloning target gene 





Figure 3.1 Schematic representation of pCI and pCITE 2a (+) empty vector 
Maps of the pCI and pCITE 2a (+) vector plasmids. Those two plasmid maps were generated via Geneious 
Prime® (version 2019.2.3). Main single restriction sites and multiple cloning regions are present in the 
corresponding regions (depicted by blue and green arrows).  
 
3.12.2 Prepared plasmids available in the laboratory 
Plasmids Source 
pB-Erns-V5 Dr. Birke Andrea Tews (Tews and Meyers, 2007) 
pB-Erns/TM-V5 Dr. Birke Andrea Tews (Tews and Meyers, 2007) 
p798(Full length infectious clone BVDV CP7) Prof. Dr. Gregor Meyers 
pcDNA3-VSVg Dr. Birke Andrea Tews 
pFBD-shortH5-Avi Prof. Dr. Timm Harder (Postel et al., 2011) 
pDsRED-ER Dr. Birke Andrea Tews 
pDsRED-Golgi Dr. Birke Andrea Tews 
pcDNA3-GFP Dr. Birke Andrea Tews 
pCR-13 (BVDV CP7 pCI-Flag-E1) Dr. Christina Radtke (Radtke and Tews, 2017) 
pCR-16 (BVDV CP7 pCI-E2-AU1) Dr. Christina Radtke (Radtke and Tews, 2017) 
pCR-17 (BVDV CP7 pCI-E1-E2) Dr. Christina Radtke (Radtke and Tews, 2017) 
 
3.12.3 New plasmid constructs in this study 
To study the function and structure of glycoprotein E1 of pestiviruses, a number of expression 
plasmids were prepared. In this study, we used the E1 sequence of the wild-type BVDV strain 
CP7 as representative for all pestiviruses. The individual constructs were made by using 
standard molecular biology technology (PCR, restriction digestion and ligation). 
 












































pYM-48 pCI-ss-Erns TM-Avi 
pYM-49 pCI-ss-Erns TM-Avi(B) 
pYM-50 pCI-BirA (BirA-cyto) 







pYM-58 pCI-ss-HA-E1 (Ct-15aa) 
pYM-59 pCI-ss-HA-E1 (Ct-31aa) 
pYM-60 pCI-ss-HA-E1 (Ct-52aa) 
pYM-61 pCI-ss-HA-E1 (Ct-30aa) 
pYM-62 pCI-ss-HA-E1 (Ct-30aa)(C123S) 
pYM-63 pCI-ss-HA-E1 (N19A) 
pYM-64 pCI-ss-HA-E1 (N100A) 
pYM-65 pCI-ss-HA-E1 (D67N,A69S) 
pYM-66 pCI-ss-HA-E1 (D67N,A69T) 
pYM-68 pCI-ss-HA-E1 MHD(delete H52-S83) 







pYM-76 pCI-ss-HA-E1 (C5S) 




pYM-77 pCI-ss-HA-E1 (C20S) 
pYM-78 pCI-ss-HA-E1 (C24S) 
pYM-79 pCI-ss-HA-E1 (C94S) 
pYM-80 pCI-ss-HA-E1 MHD(delete H52-S83)(Ct-15aa) 
pYM-81 pCI-ss-HA-E1 MHD(delete H52-S83)(Ct-31aa) 
pYM-82 pCI-ss-HA-E1 MHD(delete H52-S83)(Ct-52aa) 
pYM-83 pCI-ss-HA-E1 MHD2(delete E71-S83)(Ct-15aa) 
pYM-84 pCI-ss-HA-E1 MHD2(delete E71-S83)(Ct-31aa) 




AB Hitachi 3500 Genetic Analyzer Applied Biosystems, Weiterstadt 
Analytical balance Satorius A200S Satorius, Göttingen 
Blotkammer Mini-Trans Blot  Biorad, Munich 
Blot chamber Tankblot Hoefer, USA 
CO2 incubator MCO-19AIC, Sanyo Ewald Innovationstechnik, Bad Nenndorf 
ChemiDoc XRS+ System Bio-Rad Laboratories, Inc. 
Revolver ™ rotary mixer Labnet International Inc., USA 
Flow cytometer MACSQuant Analyzer Miltenyi Biotec GmbH, Bergisch Gladbach 
Ice maker Manitowoc B230 Manitowoc, USA 
Developer machine Compact2 ™ PROTEC medical technology, Oberstenfeld 
Film cassettes Agfa, Cologne 
Liquid suction system BVC 21NT Vacuubrand, Wertheim 
Fluorescence microscope Axiovert 200M Zeiss, Göttingen 
Fluorescence accessories ApoTome Zeiss, Göttingen 
Gas safety burner flammy S Schütt, Göttingen 
Gel documentation system Quantum peqlab, Erlangen 
Gel electrophoresis chamber horizontal Feinmechanik, FLI Tübingen 
Heating block Thermo-Shaker TS-100 bioSan, Latvia 
Heating magnetic stirrer KAMAG RCT  IKA Labortechnik, Staufen im Breisgau 
Incubator Kelvitron t Heraeus Instruments, Hanau 




Microwave oven  Panasonic, Japan 
PCR device Trio-Thermoblock Biometra, Göttingen 
Calimatic pH meter Knick, Berlin 
Power-Supply PS500XT Hoefer, USA 
Power-Supply 2301 Macrodrive1 LKB Bromma, Sweden 
Rotor Ja10 Beckman Coulter, Munich 
Rotor 1754, 5960 Hettich centrifuges, Tuttlingen 
Multitron Standard shaking incubator Infors HT, Switzerland 
Speed Vac Concentrator Savant Bachhofer, Reutlingen 
Vortex Genie Scientific Industries, USA 
Centrifuge Avanti J-26 XP Beckman Coulter, Munich 
Centrifuge 5415C, 5430R Eppendorf, Hamburg 




Red Caps Tube (15, 50 ml) Sarstedt AG&Co.KG, Germany 
Disposable cannulas Braun, Melsungen 
Disposable syringes Braun, Melsungen 
FACS tubes BD Bioscience, USA 
Whatman 3MM paper Schleicher & Schuell, Dassel 
Nitrocellulose transfer membrane, Protran Schleicher & Schuell, Dassel 
PCR tubes (0.2 ml) Biozym, Hess. Oldendorf 
Pipette tips Greiner, Frickenhausen 
Reaction tubes (0.5 ml, 1.5 ml and 2 ml) Eppendorf, Hamburg 
Cell culture bottles / dishes Greiner, Frickenhausen 
Cell culture plate (6- / 24- / 96-well) Greiner, Frickenhausen 








3.15 Software, application and program 
 Name Supplier/Web sites 
Desktop application 
ImageJ 1.52a National institutes of Health, USA 
Image Lab (Beta 3) Bio-Rad Laboratories, Inc. 
MACSQuantify ™ (version 
2.10) 




DNAMAN (version 9.0.1.116) Lynnon Corporation. 
Jalview (Version 2.11.1.0) University of Dundee, Scotland, UK 
GraphPad prism 8 GraphPad Software Inc., USA 
Microsoft Office 365 Microsoft, USA 
Aida Image Analyzer 5.0 
Raytest Isotopenmeßgeräte GmbH, Benzstr. 4, 
D-75334 Straubenhardt, Germany. 
pDRAW32 (Version 1.1.140) AcaClone Software 
Web application 
Biorender APP https://app.biorender.com/ 
PredictProtein 2013 https://www.predictprotein.org/ 
PRIPRED http://bioinf.cs.ucl.ac.uk/psipred/psiform.html 
TMHMM Server v. 2.0 http://www.cbs.dtu.dk/services/TMHMM/ 
Jpred 4 http://www.compbio.dundee.ac.uk/jpred/ 




HeliQuest  https://heliquest.ipmc.cnrs.fr/ 
Clustal Omega https://www.ebi.ac.uk/Tools/msa/clustalo/ 
WebLogo 3 http://weblogo.threeplusone.com/create.cgi 
 




Chapter 4: Methods 
4.1 Molecular cloning methods 
The polymerase chain reaction (PCR) was used for the amplification of targeted genes such as 
cloning, sequencing or mutagenesis. The DNA polymerases (Phusion High-Fidelity DNA 
Polymerase) used in those experiments have extremely low error rates to ensure high-fidelity 
PCR. The working concentration of the primers (as shown in 3.11) that used for the PCR is 10 
pmol/μl. The PCR reaction mixture and the cycling programs are listed below.   
 
4.1.1 Normal PCR 
The reaction mixture of the standard PCR is shown in Table 4.1 and the program which was 
used to amplify target DNA fragments is shown in Table 4.2. 










Table 4.2 Overview of the normal PCR program 
Procedure Temperature [°C] Time [s]  
Initial denaturation 95 90  
Denaturation 95 30  
x 29 cycles Annealing (hybridization) 58 30 
Extension 72 17 bp/s 
Final extension 72 300  
 
4.1.2 Overlap fusion PCR 
Overlap PCR is commonly used for cloning large complex fragments, making edits to cloned 
genes or fusing two or more gene elements together. For this purpose, the primary products 
Components Volume [μl] 
DNA-Template 1 (5-10 ng/μl) 
Forward Primer 2 (1 mM) 
Reverse Primer 2 (1 mM) 
dNTPs (10 mM each) 1 
5X reaction buffer 5 
Pfu DNA polymerase 1 (1.25u/50µl) 
H2O 38 
Total 50 




from normal PCR were firstly purified via using agarose gel electrophoresis, then the purified 
overlapping fragments A and B serve as template for the following overlap PCR. 
The key step that decides whether overlap fusion PCR is successful or not is that ensure the 
overlap part can effectively anneal (two overlap parts can be firmly "sticked" together). It means 
that the overlap parts should have a certain length (generally, overlap area should be long 
enough, more than 25bp). Due to their complementary ends, the two purified products from 
normal PCR are able to hybridize. It is worth noting that the GC content of this overlap part 
should have a suitable Tm value (such as 65℃). The annealing temperature used in the PCR 
cycle should be lower than this temperature, otherwise the overlapping parts may not "stick" 
together. After hybridization, two short fragments form a long mostly single stranded DNA 
fragment which is made double stranded via DNA synthesis with Pfu polymerase in a first step 
and then can serve as template for further amplification. The forward primer of the first 
fragment and the reverse primer of the second fragment served as oligonucleotides of the rest 
28 cycles. Tables 4.3 shows the reaction mixture approach and the program of overlap fusion 
PCR is same to the normal PCR. 
Table 4.3 Overlap fusion PCR reaction approach 
Components Volume [μl] 
Forward Primer 2 (1 mM) 
Reverse Primer 2 (1 mM) 
dNTPs (10mM each) 1 
PCR product 1 1 
PCR product 2 1 
5X reaction buffer 5 




4.1.3 QuikChange® PCR 
The mutagenesis protocol is used to make point mutations, switch amino acids, and delete or 
insert single or multiple amino acids. The QuikChange site-directed mutagenesis method is 
performed using a proof-reading DNA polymerase. The basic procedure utilizes a double-
stranded DNA (dsDNA) plasmid with an insert of interest and two synthetic oligonucleotide 
primers containing the desired mutation. The oligonucleotide primers, each complementary to 
opposite strands of the vector, are extended during temperature cycling by DNA polymerase. 
Incorporation of the oligonucleotide primers generates a mutated plasmid containing staggered 
nicks. Following temperature cycling, the product is treated with Dpn I. The Dpn I endonuclease 
(target sequence: 5´-Gm6ATC-3´) is specific for methylated and hemimethylated DNA and is 
used to digest the parental DNA template, to select for mutation-containing newly synthesized 
DNA. DNA isolated from almost all E.coli strains is dam methylated and therefore susceptible 
to Dpn I digestion. The nicked vector DNA containing the desired mutations is then transformed 




into TOP10 competent cells. The reaction approach was chosen analogous to the standard PCR 
(Table 3.1), while the program sequence is shown in Table 4.4. 









4.1.4 Agarose gel electrophoresis 
Agarose gel electrophoresis enabled DNA fragments to be separated according to their size and 
was used for analytical and preparative purposes. The negatively charged DNA fragments were 
retarded to different extents depending on their size when they moved through the agarose 
matrix in an electric field. The rate of migration was dependent on the size of the DNA 
fragments (the smaller the faster) and the cross-linking of the agarose, which could be 
controlled by the concentration of the agarose. By default, 1% (in 1x TAE buffer) agarose gels 
were used. The DNA samples were mixed with Gel Loading Dye, Purple (6X) (see 3.9) and 
loaded into agarose gel in TAE buffer at a constant voltage of 100V. The 1 kb Plus DNA marker 
(see 3.9) from Invitrogen was used as the size standard. The detection was carried out after 15-
30 minutes incubation at room temperature in GelRed (1: 3300), under UV light at a wavelength 
of 254 nm. 
 
4.1.5 Preparative agarose gel electrophoresis 
For the preparative agarose gel electrophoresis, the DNA sample was electrophoresed as 
described under 4.1.4. The bands were then viewed under UV light at 302 nm and cut out with 
a scalpel. The cut-out bands were cleaned using the Nucleo-Spin® Extract II kit (see 3.7) 
according to the manufacturer's protocol and eluted with 25 μl H2O. 
 
4.1.6 Restriction analysis 
Restriction endonucleases are enzymes that can cut dsDNA (some restriction enzymes are also 
functional for single stranded DNA) on specific recognition sequences. This method was used 
to analyze plasmids after mini and midi preparation (4.2.2) and to generate specific cleavage 
fragments in the context of cloning. 
The restriction took place according to the manufacturer's instructions in the corresponding 
buffers with an enzyme concentration of 2-40 U/batch and a total volume of 10-100 μl. 
Procedure Temperature [°C] Time [s]  
Initial denaturation 95 90  
Denaturation 95 30  
x 19 cycles Annealing (hybridization) 58 30 
Extension 72 Variable (17 bp/s) 
Final extension 72 300  













The reaction time at the temperature recommended for the respective enzyme was 0.5-2 h. The 
completeness of the reaction and the sizes of the fragments formed were checked with agarose 
gel electrophoresis (4.1.4) and the fragments were purified for use in cloning if necessary (4.1.5).  
 
4.1.7 Ligation of DNA fragments 
In the ligation of digested and purified DNA fragments with complementary ends, circular DNA 
was formed by the enzymatic activity of the T4-DNA ligase. This DNA was then used to 
transform competent E.coli. In order to achieve high ligation efficiency, a vector/insert ratio of 
at least 1:3 was used. The reaction mixture described in Table 4.6 was incubated at room 
temperature for 1-2 h or at 15 °C in water bath overnight. 
Table 4.6 Ligation reaction mix 
Components Volume [μl] 
Vector Variable (0.1 pmol) 
Insert fragment Variable (0.01 pmol) 
10x ligation buffer 2 
T4-DNA ligase 1 




Sequence analysis of DNA samples was carried out using the Sanger chain termination method 
in a PCR based assay. The difference to a normal PCR was the use of only one oligonucleotide 
primer and the use of ddNTPs in addition to dNTPs. The ddNTPs were coupled with fluorescent 
dyes, with ddATP, ddCTP, ddTTP and ddGTP carrying dyes with different fluorescence spectra. 
The ddNTPs do not have a 3’OH group, so their incorporation leads to the termination of the 
polymerization reaction and the DNA product fragments are labeled with the fluorescent dye of 
the incorporated ddNTP. The different lengths of ssDNA fragments with specifically labeled 
3’ends could then be separated by capillary electrophoresis. 
Components Volume [μl] 
Mini prep product  1 
Restriction enzyme 1 0.2 
Restriction enzyme 2 0.2 








The sequencing reactions were set up with the BigDye® Terminator v.3.1 Cycle Sequencing Kit 
as shown in Table 4.7. The DNA to be sequenced was amplified in the thermal cycler with the 
following cycle parameters. 
Table 4.7 Sequence PCR reaction mix 
Components Volume [μl] 
DNA-Template 1 (100-200ng/μl) 
Sequencing Primer 1 (0.25 mM) 
BigDye® 5X buffer 1.5 




Table 4.8 Overview of the sequencing PCR program 
Procedure Temperature [°C] Time [s]  
Initial denaturation 95 60  
Denaturation 95 10  
x 25 cycles Annealing (hybridization) 55 5 
Extension 60 110 
 
The synthesized sequencing products were then subjected to ethanol precipitation. For this 
purpose, 1 μl 3M NaAc pH 5 and 25 μl 100% ethanol were incubated together with the reaction 
mixture for 5 min. After centrifugation at 14,000 rpm for 20 min, the supernatant was removed, 
the pellet was washed twice with 75% ethanol and dried out in the SpeedVac for 5 min, then 
dissolved in 20 μl HiDi. The sample was used completely for analysis by the "3130 Genetic 
Analyzer" from Applied Biosystem (ABI). 
The sequence data was evaluated with the Geneious Prime®2019 (3.15). 
 
4.1.9 In vitro-transcription 
For the transcription, the desired plasmid DNA was first linearized with a restriction enzyme 
(SmaI, at 25℃ for 1-2h) at the 3’end of the sequence to be transcribed. The DNA fragment was 
purified by preparative agarose gel electrophoresis (shown in 4.1.4 and 4.1.5), followed by 
phenol-chloroform extraction (4.1.10). The DNA fragment was used together with the 
components of the RiboMAX™ Large Scale RNA Production System T7 kit (3.7) according to 
the manufacturer's instructions for the in vitro transcription reaction. The reaction mixture was 
incubated for 4 h at 37℃. Then the obtained RNA was purified by means of phenol-chloroform 
extraction and ethanol precipitation. 




Table 4.9 In vitro-transcription (T7) reaction approach 
Components Volume [μl] 
dNTP MIX 9 
Linearized DNA 12 
5X reaction buffer 6 
Enzyme MIX, RNA polymerase 3 
Total 30 
 
4.1.10 Phenol-chloroform extraction 
The phenol-chloroform extraction was used for the purification and precipitation of DNA and 
RNA. The volume of the sample to be cleaned was first increased to 100 μl, then mixed with 
100 μl of tris-saturated phenol and vortexed vigorously. After a centrifugation step of 5 min at 
14,000 rpm, the phases separated and the upper aqueous phase could be transferred to a new 
1.5 ml reaction tube. The aqueous phase was then mixed with 100μl chloroform, shaken 
vigorously and centrifuged for 3 min at 14000 rpm to separate the phases. The DNA or RNA 
was then precipitated from the aqueous phase with 1/8 volume of 2M potassium acetate (pH 
5.6) and 2.5 volumes of ethanol. In order to achieve quantitative precipitation, the sample was 
stored on dry ice for 30 min or at -20℃ overnight. The precipitated DNA or RNA was then 
pelleted at 14,000 rpm for 15 min at 4℃, the pellet washed with 80% ethanol, dried in the 
SpeedVac and finally taken up in 25μl DEPC water. 
 
4.1.11 Reverse Transcriptase PCR (RT-PCR) 
In a reverse transcriptase PCR, RNA was used as a template instead of DNA an appropriate 
volume of water (DEPC water for RNA). In the first step of the reaction, the RNA used is first 
reverse transcripted into cDNA before the newly obtained cDNA was amplified using 
oligonucleotides in the second step. The SuperScript™ III One-Step RT-PCR System Kit was 
used according to the manufacturer's protocol for the RT-PCR. The program and reaction 
approach are described in Table 4.10 and 4.11. The PCR products obtained in this way were 
first checked using agarose gel electrophoresis (4.1.4), then purified by preparative agarose gel 
electrophoresis (4.1.5) and finally used for sequencing (4.1.8). It is worth noting that the 











Table 4.10 Overview of the RT-PCR program 
Procedure Temperature [°C] Time [s]  
cDNA synthesis and 
pre-denaturation 
45-60 900-1800 
 94 120 
Denature 94 15  
x 40 cycles Anneal 55-66 30 
Extend 68 1kb/60s 
Final extention 68 300  
 
Table 4.11 RT-PCR reaction approach 
Component Volume[μl] 
2X Reaction Mix 25 
Template RNA (0.01 pg to 1 μg) x 
Sense primer (10 μM) 1 
Anti-sense primer (10 μM) 1 
SuperScript™ III RT/Platinum™ Taq Mix 2 
Autoclaved distilled water to 50 
 
4.2 Microbiological methods 
4.2.1 Heat shock transformation of E.coli 
For the heat shock transformation, 50 μl of the competent cells were first thawed on ice, mixed 
with 10 μl ligation mixture or 0.5-2 μg plasmid DNA and incubated on ice for 20 min. The heat 
shock was carried out for 2 min at 42℃, the competent bacteria then were cooled on ice for 2 
min and further 200 μl LB++ medium was added. After an incubation of 30-60 min at 37℃, 
the bacteria were spread on preheated LB agar plates with ampicillin, then placed in the 
incubator at 37℃ overnight. 
 
4.2.2 Isolation of plasmid DNA from bacteria  
4.2.2.1 Mini-preparation 
The mini preparation procedure based on the principle of alkaline lysis was used to isolate small 
amounts of plasmid DNA for analysis. 5 ml LB-Amp medium was inoculated with a single 
E.coli colony from a LB agar plate and incubated overnight at 37 ℃ in a thermo-shaker.  




1.5 ml of the overnight culture was then pelleted by centrifugation (1.5 min, 14,000 rpm). The 
bacterial pellet was resuspended in 100 μl mini prep solution I. After adding 200 μl cold 
miniprep solution II, the tube containing the mixture was vortexed and incubated for 5 min on 
ice until a clear lysate was formed. After adding 150 μl of mini prep solution III, briefly swirling 
and incubating on ice for 10 minutes, the proteins as well as the cross-linked, long-chain, 
genomic DNA, were pelleted by centrifugation (10 min, 14,000 rpm). To precipitate the plasmid 
DNA, the clear supernatant was transferred to a new 1.5 ml reaction tube, 400 μl of isopropanol 
were added, and the pellet was then pelleted at 14,000 rpm for 10 min. The plasmid DNA was 
then washed with 200 μl 75% ethanol, dried in the SpeedVac and taken up in 50 μl H2O.  
 
4.2.2.2 Midi-preparation 
The QIAGEN plasmid Midi kit was used according to the manufacturer's instructions to isolate 
larger amounts of clean DNA. For this purpose, 100 ml of LB-Amp medium were inoculated 
at 37℃ in a thermo-shaker. For "low copy" plasmids, the volume of the LB-Amp medium was 
increased to 200 ml. At the end, the DNA was taken up in 100μl of demineralized sterile water 
and the concentration was determined photometrically using NanoDrop. 
 
 
4.3 Cell biological methods 
4.3.1 Cultivation of adherent cells 
The cells used in this study were routinely kept in 10 cm cell culture dishes with ZB5 with 10% 
FCS medium at 37℃ and 5% CO2. The cells were separated and converted every 3-4 days 
according to their growth rate. For this purpose, they were washed once with trypsin mixture, 
covered with 5-10 ml of trypsin mixture and incubated for 3 min at 37 ℃ until they were 
detached from the bottom of the dish. The cells were then taken up again in medium and seeded 
to the 24-well plate or 3.5 cm dishes (dependent on the following experiment). For 
immunofluorescence or protein expression experiments, the cells were seeded in 3.5 cm cell 
culture dishes one day before transfection. For immunofluorescence, the cells were seeded in 
3.5 cm cell culture dishes, 6-well plates or 24-well plates in a suitable dilution one day before 
transfection. For confocal immunofluorescence experiments, the wells of a 24-well plate were 
previously fitted with sterile coverslips so that the cell layer could grow on them. 
 
4.3.2 Infection of cells 
For infection experiments with BVD viruses, MDBK-B2 cells were seeded the day before in 
such a way that they were about 80% dense on the day of the infection. The cells were first 
washed with ZB5d medium and then incubated in ZB5d medium with virus for 4-6 h. After the 
incubation, the medium was changed and the cells were incubated in ZB5d medium + 10% FCS 
for 16-24 h before they were used for experiments. 
 
4.3.3 Transfection of cells 
In order to transiently express foreign proteins in eukaryotic cells, expression plasmid DNA 
was transfected into the cells using lipofectamine™ 2000 (see in 3.9). In lipofection, the 




transfection reagent contains positively charged molecules (lipids/polymer), which form 
complexes with the plasmid DNA and were internalized by the cells via endocytosis. 
Lipofectamine™ 2000 was used as a normal reagent for the transfection of BHK21/RK13 cells. 
For this purpose, cells were seeded to be 70–90% confluent at transfection, then dilute four 
amounts of Lipofectamine® Reagent in Opti-MEM® Medium and dilute DNA in Opti-MEM® 
Medium respectively (detailed procedure shown in Table 4.12). After adding diluted DNA to 
diluted Lipofectamine® 2000 Reagent (1:1 ratio), incubate the mixture at room temperature for 
5 min. Then drop DNA-lipid complex to cells and slightly shake the plate at the same time. 
Incubate cells for 24h at 37℃. Then visualize/analyze transfected cells, dependent on the 
following experiments. 
Table 4.12 Lipofectamine™ 2000 DNA transfection procedure 
Component 96-well 24-well 6-well 
Final DNA per well 100ng 500ng 2500ng 
Opti-MEM® Medium 25μL  50μL  150μL  
Final lipofectamin™ 
2000 regent per well 
0.2-0.5μL 1-2.5μL 5-12.5μL 
 
4.3.4 Electroporation of cells with RNA 
For RNA electroporation, the MDBK-B2 cells should be used freshly, so the cells were seeded 
to 10 cm cell culture dishes one day before the day of the electroporation. The cells in 10 cm 
plate are sufficient for 3 EP samples. 
Firstly, cells were detached from the dishes by treatment with trypsin mixture and resuspended 
in ZB5 with 10% FCS. The cells were then pelleted by centrifugation for 10 min at 1000 rpm, 
the supernatant was removed and the cells were washed once with ZB5. 
The cell pellet was then taken up in 1.3 ml of cold (~4℃) PBS and 0.4 ml used for each 
electroporation RNA sample. 3-5 μl of RNA were mixed with 0.4 ml of cells and electroporated 
for 1 sec at 180 V and 980 mF. After a second pulse with the same settings the electroporated 
cells were immediately rinsed from the cuvette with ZB5 and transferred to two 3.5 cm cell 
culture dishes. The cells were observed to document the eventual development of a 
cytopathogenic effect (CPE). 
The replication of electroporated RNA was demonstrated by immunofluorescence and the 
formation of infectious particles by reinfection experiments. For reinfection, the transfected 
cells were lysed by three cycles of freezing/thawing and then part of the lysate was added to 
new cells. The successful reinfection was tested by immunofluorescence.  
 
4.3.5 Virus titration 
A virus titration was carried out to determine the tissue culture-infectious dose 50 per ml 
(TCID50 / ml) for a virus passage. For this purpose, dilution series were made in 1:10 steps in 
a double batch on 96-well plates. 900 μl of ZB5d medium + 10% FCS were placed in 1.5 ml 
reaction tubes per dilution step. 100 μl of the virus passage to be tested were then added to the 
first reaction tube, thoroughly mixed and then 100 μl of the dilution (10-1) were pipetted into 
the wells of the first column of the 96-well plate. A further 100 μl of the first dilution are added 




to the next 1.5 ml reaction tube and a series of dilutions with the dilution factor 1:10 is 
continuously prepared. For cell control, a column of the 96-well plate was loaded with ZB5d 
medium + 10% FCS. 
Then 1.75 × 104 cells in 100 μl ZB5d medium + 10% FCS were added per well and the plate 
was incubated at 37 ℃. After 4-5 days, the titration was evaluated by means of indirect 
immunofluorescence (antibody: Code4) and the titer was calculated using the following 
Spearman / Karber formula: 







x0 : log10 of the reciprocal value of the lowest dilution, where all wells are positive 
d: log10 of the dilution factor 
n: number of wells per dilution 




: beginning of the summation at the dilution level x0 
 
4.3.6 Growth Kinetics of Viruses 
To
 
compare the growth kinetics of mutant viruses with that of the wild-type virus over a period 
of 72 h, growth curves were recorded. For this purpose, 5x105 cells were infected per virus with 
an MOI of 0.1. For the infection, the cells were incubated for 1 h at 37 ℃ together with the 
calculated amount of virus and diluted in ZB5d medium. The cells were then centrifuged at 
1000 rpm for 10 min, the supernatant was discarded and the cell pellet was resuspended in 10 
ml of ZB5d medium + 10% FCS. 2 ml portions of the cell suspension were then distributed into 
five 3.5 cm cell culture dishes, incubated at 37 ℃ and harvested after 8 h, 24 h, 32 h, 48 h and 
72 h by freezing at -70 ℃. The evaluation was carried out after three freeze/thaw cycles by 
titration as described in 4.3.5. 
 
4.3.7 Extraction of viral RNA from cells 
The viral RNA was extracted from infected cells in order to be able to analyze its sequence after 
RT-PCR amplification (4.1.11) by means of sequence PCR (4.1.8). For this purpose, MDBK-
B2 cells were infected 2-4 days before RNA extraction. The viral RNA was extracted with 
Trizol® Reagent according to the manufacturer's protocol and then stored at -20 ℃ and used for 
an RT-PCR. 
 
4.4 Protein analytical methods 
4.4.1 Indirect immunofluorescence analysis 
Indirect immunofluorescence was used on the one hand to detect BVDV infections and on the 
other hand to analyze proteins with regard to their location, retention and topology after 
transient transfection. 
 




4.4.1.1 Staining cells in 24-well plates 
To evaluate titrations (4.3.5), growth curves (4.3.6) and to check success after electroporations 
(4.3.4), the cells were first carefully washed three times with PBS and then fixed with 4% PFA 
solution (4℃, 30 min). After three more washing steps with PBS, the cells were permeabilized 
with 0.5% saponin (5 min, 4℃) or 0.05% Triton-X100 (30 min, 4℃) and washed three times 
with PBS. 
Incubation with the primary antibody was carried out in the dilution given in section 3.6 for 
overnight at 4℃. The excess primary antibody was then removed by three washing steps with 
PBS and the cells were incubated with the secondary antibody for 1h at 37℃. After final 
washing step three times with PBS, analysis was done with a fluorescence microscope. 
 
4.4.1.2 Staining cells on coverslips 
The required cells were seeded to a 24-well plate with coverslips layered in the wells on day 1 
before the following day transfection or infection assay. For the staining of the cells on the 
following days, the medium was removed as a first step and the cells were carefully washed 
three times with PBS. The fixation was then carried out using 4% PFA solution for 20 min at 
4℃. 
After the cells were washed with PBS, depending on the objective, with 0.05% Triton-X100 (in 
PBS) or 5 μg/ml digitonin (1:1000 dilution from digitonin stock which is in 5 mg/ml) for 30 
min at 4℃ permeabilized or left in the non-permeabilized state (see Table 4.13). After 
permeabilization of the cells, the analysis was carried out as described above staining. Before 
embedding in Mowiol DAPI, the cells were washed with PBS three times. After drying, the 
embedded preparations were sealed with nail polish and analyzed on a fluorescence microscope. 
 
Table 4.13 Different permeabilization treatments 
Permeabilization reagent Aims 
Not permeabilized Only proteins on the cell surface can be detected 
5 μg/ml digitonin 
Only the plasma membrane is permeabilized; Proteins on the 
surface in the cytoplasm or on the inner side of intracellular 
membranes can be detected 
 
0.05% Triton-X100 
The plasma membrane and the internal membranes are 
permeabilized membranes; Proteins can be found on the 
surface, in the cytoplasm as well as in the cell organelles 




Figure 4.1 Schematic representative of different permeabilization treatments 
 
4.4.2 Flow Cytometry Analysis (FACS analysis) 
A flow cytometry approach was used to analyze the retention behavior of fusion proteins and 
proteins with mutations. The proteins to be examined were transiently expressed in RK13 cells, 
for which two wells of a 24-well plate were transfected with the same DNA reaction mix (4.3.3) 
as a duplicate. One day before the FACS analysis. First, the RK13 cells were carefully washed 
with pre-warmed PBS, then added 300 μl PBS with 2mM EDTA for 1h at 4℃ to detach cells 
from the 24-well plate. One hour later, detach cells gently and transfer cells to FACS tubes. 
Same transfected cells should be transferred identically into the same tubes. Then add 150 μl 
4% PFA to each tube at 4 ℃ for 20-30 min to fix the cells. Next, add 1.25 ml PBS with 2% 
BSA and 2mM EDTA to bring the samples up to 2 ml total volume, then transfer 1 ml to a new 
FACS tube. So each sample has two same fixed cells in the FACS tubes, label one tube with ‘P’ 
for permeabilization and the other with ‘NP’ for non-permeabilization.  
To get rid of extra PFA, 1ml 2% BSA and 2mM EDTA in PBS were added to each tube, and the 
cells were spun down. After removing the supernatant, ‘P’ samples should be permeabilized. 
To each ‘P’ sample tubes 300 μl 0.5% saponin in PBS with 0.2% BSA and 2mM EDTA were 
added and incubated for 30 min at 4 ℃. To remove excess saponin, all to ‘P’ sample tubes 2% 
BSA 2mM EDTA in PBS were added, spun down cells at 1000 rpm for 7 min. Subsequently, 
the cells were resuspended with 150 μl first antibody (e.g. HA tag antibody), which was diluted 
with 0.2% BSA and 2mM EDTA in PBS, for 1 h at 4 ℃ on a shaker. After two washing steps 
with 2% BSA in PBS, cells were incubated for 45-60 min at 37 ℃ with the second antibody 
(mouse-FITC). Finally, after washing with 2ml PBS with 2% BSA and 2mM EDTA, cells were 
resuspended in 100 μl 2% BSA in PBS and then measured using the MACSQuant Analyzer.  
 





For the quantitative detection of proteins after transfection or infection, these expressed proteins 
were enriched and detected by using specific antibodies. Proteins that were metabolically 
radioactively labeled during their expression were used for immunoprecipitation. In this 
experiment, all cellular proteins were either brought into solution and purified or separated 
according to their properties in relation to a membrane association and then denatured. 
Antibody and sample were mixed and incubated for 1 h at 37℃ and then at 4℃ also for 1h. 
After adding Staph.A binds the FC region of antibodies (mainly class IgG) via protein the target 
protein bound to the antibodies can be precipitated. The samples were incubated for 30 min at 
room temperature and vortexed every 10 min for three times. The samples were then incubated 
at 4℃ for at least 16 h before being further purified.  
After the overnight incubation, the samples were vortexed again and then underlayered with 
500 ml of RIP-sucrose solution. The aggregates of target protein, antibody and staph.A were 
then pelleted at 1,500 x g for 10 min. The supernatant was discarded by the pump and the 
samples washed in 700 ml of RIP solution 2 (new prepared 1% Triton X100). Another washing 
step with 700 ml of RIP solution 3 (new prepared 0.2% Triton X100) followed before the 
samples were resuspended in 10 ml of RIP solution 4 (new prepared 0.06% Triton X100). The 
proteins and the aggregates were denatured by adding 40 ml of SDS sample buffer and 
incubating for 5 min at 95 ℃. Then the mixtures were centrifuged at 6,200 × g for 10 min and 
the supernatant with the dissolved proteins was transferred to a new reaction tube for further 
RIP gel analysis. 
 
4.4.4 Western blot 
4.4.4.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) with the Jagow buffer was used for the 
analytical separation of protein mixtures. The proteins previously denatured by SDS were 
separated electrophoretically according to their molecular mass. The rate of migration of the 
proteins depends on the retention capacity of the polyacrylamide gel, which was determined by 
the concentration of the acrylamide. 
The polyacrylamide gels used for the discontinuous separation of proteins consisted of a 
collection gel (4% acrylamide) for focusing the proteins and a separation gel with a uniform 
concentration of 8, 10 or 12% acrylamide depending on purpose. 
First, the glass plates were clamped in the appropriate pouring stand, the separation gel was 
freshly poured and carefully overlaid with isopropanol to obtain a flat surface. After the 
polymerization, the isopropanol was removed, the gel washed and then the collection gel poured 
and the comb sample pockets was inserted into the liquid gels, liquid gel material to generate 
the loading pockets. Before applying the samples, the pockets were carefully washed with 
Jagow cathode buffer three times. After the gels were clamped in the electrophoresis apparatus, 
Jagow cathode buffer and Jagow anode buffer were added. The samples and a size marker were 
applied to the pockets of the stacking gel. Then a voltage of 80V was applied for 30min, then 
switch up to 120V for 1h. The electrophoresis was stopped when the running front had reached 
the bottom of the gels. After successful separation, the proteins were transferred to NC 
membrane for WB analysis. 
 




4.4.4.2 Transfer of proteins to nitrocellulose membranes 
The proteins separated by SDS-PAGE (4.4.4.1) were transferred from the SDS-gel to a 
nitrocellulose membrane with the Bio-rad Mini Trans-Blot® system. A nitrocellulose (NC) 
membrane with a pore size of 0.2 μm was used. Transfer was done by applying a voltage of 
100V for 1 h. After the transfer, the proteins were visualized using an immunodetection system 
(3.4.7). 
 
4.4.4.3 Immunodetection of the proteins in the Western blot 
① Standard procedure 
To detect the target proteins on a nitrocellulose membrane (4.4.4.2), it was first incubated for 
one hour with block buffer to saturate non-specific binding sites. After blocking the membrane 
and a short washing step with PBS-T (3.8), the detection antibody was diluted with PBS-T 
solution (see 3.5), incubated overnight at 4℃ on the shaker. On the next day, the NC membrane 
was washed three times for 10 min with PBS-T and then incubated for 1-2 h with a suitable 
secondary antibody at room temperature. After repeated washing with PBS-T (three times, 10 
min), the proteins were detected using the SuperSignalTM West Pico Chemiluminescent 
substrate kit. Follow the instruction of this kit. Briefly, 5x volume PBS-T plus two components 
of the kit were mixed 1: 1 and then the membrane was incubated with the solution for 2 min in 
the dark. Then, ChemiDoc imaging system (ChemiDoc XRS+, as shown in 3.13) was used for 
detection of luminescence. By using Image Lab software (3.15) for further analysis. 
② Detection of biotinylated proteins in Avitag-biotinylation assay 
For the biotinylated proteins detection in Avitag-biotinylation assay, the first step for WB was 
the same as for the normal procedure. A TGG solution with 2% BSA was used instead of the 
milk blocking buffer. The membrane was incubated with TGG blocking buffer for 1h at room 
temperature on the shaker. After washing with PBS-T (three times, for 20 min), the membrane 
was incubated with diluted avidin-PO (in TGG solution with 2% BSA) for 60 min. To reduce 
the background, the membrane was washed with PBS-T three times for 20 min after incubation. 
The luminescence was then detected as usual.




Chapter 5: Results 
5.1 Overview of pestiviral E1 glycoprotein 
Compared to Erns and E2, glycoprotein E1 is the least characterized among the pestivirus 
glycoproteins. There is still no crystal structure information for pestiviral E1 protein. In addition, 
E1 alone has not been analysed in detail. In this section, the E1 of BVDV CP7 strain served as 
a representative for analysing the biochemical properties of pestiviral E1. Analysis software or 
prediction application in molecular biology were used in this part to provide an overview of 
basic features of the glycoprotein E1 of pestiviruses. 
 
5.1.1 Amino acid composition analysis 
The length of genomic coding region for the E1 glycoprotein is nucleotides 585-594, which 
give rise to amino acids for 195-198aa (dependent on the virus species). The molecular size of 
E1 is just half of E2. Concerning there is still no detailed biochemical properties analysis about 
E1, we started our investigation with the amino acid composition (AAC) analysis. Exhaustive 
information about individual types of amino acids and groups of amino acids with similar 
physicochemical properties of the target protein that we obtain will help to easier understand 
characteristics and function of this protein. Especially, distinguishing membrane proteins from 
other types of proteins, because normally the former have a higher content of hydrophobic 
residues. Furthermore, AAC analysis is always used in combination with sequence alignments 
to help identify and classify the types of membrane protein and to reveal secondary structure 
domains and sites of specific function. 
For the AAC analysis in this study, we choose BVDV strain CP7 as a representative strain for 
all pestiviruses. As shown in Table 5.1, the hydrophobic amino acids (red marked residues) 
account for a large proportion (approximately 40%) of the E1 residues. This data indicated that 
pestiviral E1 glycoprotein is a hydrophobic envelope protein or has several large hydrophobic 
areas that may serve as sites of specific function.  
Figure 5.1 Amino acid composition of 
pestiviral E1 
This figure was generated by online 
program (https://www.predictprotein.org/), 
E1 sequence of BVDV CP7 as an example. 
Table 5.1 Amino acid composition of pestiviral E1 




The result of the AAC analysis was supported by the ‘Kyte & Doolittle’ hydropathy plot (Fig 
5.2) which clearly showed that pestiviral E1 contains four major hydrophobic regions located 
in the middle (h1 and h2) and at the C-terminus (h3 and h4). H4 region (roughly from position 
166 to 195) was considered as transmembrane region. 
Figure 5.2 Kyte & Doolittle hydropathy plot of pestivirus E1 glycoprotein 
BVDV CP7 E1 sequence as a representative for all pestiviruses; Hydropathy plot was drawn with the help of 
web application-ExPASy (https://web.expasy.org/protscale/). Four major hydrophobic regions are given in 
green and numbered h1 to h4 from the N-terminus to the C-terminus. 
 
5.1.2 Alignments of multiple sequences of pestiviral E1 
To obtain more detailed information on the conservation of the pestiviruses E1 protein, an 
alignment of 68 pestivirus E1 sequences throughout 11 ITCV-classifed species (from pestivirus 
A to K) was carried out via the Clustal Omega online program using default settings 
(https://www.ebi.ac.uk/Tools/msa/clustalo/, results shown in supplementary 1) and WebLogo3 
application (http://weblogo.threeplusone.com /create.cgi, results shown in Fig 5.3). 
Pestiviral E1 has a mass of about 27-33 kDa (dependent on the species), the result of a sequence 
alignment of glycoprotein E1 from pestiviruses (Supplementary Material 1) demonstrated that 
most E1 sequences contain 195aa residues apart from two atypical pestivirus isolates 
(pestivirus-J NrPV/NYC-D23 [KJ950914.1] and porcine Bungowannah [EF100713.2]). The 
former contains one lysine (K) insertion at position 42/43 and the other 'HR (histidine and 
arginine)' insertion at position 91/92, making E1 of this pestivirus J isolate 3aa longer than other 
pestivirus E1 proteins. Porcine Bungowannah E1, also contains an 'NR (aspartic acid and 
arginine)' insertion at 91/92 site. The molecular weight difference between different pestiviral 
E1 is partially due to the different number of amino acids, but also sequence variation plays a 
role. 
 
5.1.2.1 Cysteine residues in E1 
The glycoprotein E1 of pestiviruses contains six cysteine residues which can form intra- or 
inter-molecular disulphide bonds that play essential roles in stabilizing protein structure and 
can affect the function of this protein. Among them, the first five residues are almost fully 
conserved throughout all pestivirus species (as shown in Fig 5.3 and Supplementary Material 
1). The last cysteine residue at position 171 in species BVDV-2 and pronghorn antelope 









is also occupied by phenylalanine, but there is an additional cysteine residue at position 170 of 
this sequence which does not exist in all the other species. It is worth noting that cysteine 
residues at positions 5, 20 and 123 are 100% conserved throughout all the pestiviral species 
indicating those cysteine residues must play essential roles in the biological function of E1. The 
cysteines at positions 24 and 94 are also conserved, except for two atypical pestivirus isolates 
pestivirus-J NrPV/NYC-D23 (KJ950914.1) and porcine Bungowannah virus (EF100713.2). 
Cys24 was replaced by G (glycine) in both atypical pestiviruses, a mutation C94G occurs in 
pestivirus-J NrPV/NYC-D23 while L (leucine) substitution at that site in porcine Bungowannah. 
The cysteine residues replacement in pairs indicated that Cys24 together with Cys94 most likely 
form intramolecular disulphide bonds. 
Figure 5.3 Conservation of amino acid sequences of pestiviral E1 protein 
68 pestivirus E1 sequences throughout 11 ITCV-classified species (from pestivirus A to K) was aligned via 
WebLogo3 application (http://weblogo.threeplusone.com/create.cgi). The overall height of the stack 
indicates the sequence conservation at that position, while the height of symbols within the stack indicates 
the relative frequency of each amino acid at that position (Crooks et al., 2004; Schneider and Stephens, 1990). 
Fully conserved N-glycosylation sites in all genotypes are shown in the box with red solid line, one non-
conserved N-glycosylation site is marked by a red dash box. 
 
5.1.2.2 N-linked glycosylation sites in E1 
E1 of pestivirus possesses three potential N-linked glycosylation sites (N6, N19 and N100). 
Among them, N19 and N100 are fully conserved in all major genotypes of pestiviruses, while 
the first N-glycosylation site at N6 is only present in CSFV, BDV, Pestivirus Aydin and 
Pestivirus Burdur isolates. In this section, first we used the web applicatyion NetNGlyc 1.0 
Server (http://www.cbs.dtu.dk/services/NetNGlyc/) to make N-glycosylation site prediction for 
pestivirus E1. Normally, the glycosylation pattern could be interfered by the formation of 




disulphide bonds in close distance to the glycosylation motif. As shown in Fig 5.3, there are 
two cysteine residues Cys20 and Cys24 which are located closely to each other, most likely 
forming of intra- or inter-molecular disulphide bond. Due to the spatial restriction, the N-
glycosylation at N19 will likely be prevented by this disulphide bond formation. As shown in 
Fig 5.4, it seems that the prediction program has no confidence in the potential N-glycosylation 
site at N19. To determine whether the N-glycosylation takes place at N19 and N100, 
mutagenesis analysis of these conserved glycosylation sites was carried out. Three HA tagged 
E1 mutants pYM-63 [E1 (N19A)], pYM-64 [E1 (N100A)] and pYM-86 [E1 (N19A and 
N100A)] were generated via QuikChange® PCR. Wild-type HA-tagged E1 and those 
glycosylation site(s) defective constructs were expressed by Vaccinia T7 expression system and 
further analysed by immunoprecipitation with HA-tag antibody under reducing condition. 
 






19NCTP 0.1414 (9/9) - - - 
100NLTV 0.6729 (9/9) + + 
 
 
Figure 5.4 NetNglyc 1.0: predicted N-glycosylation site (s) of pestiviral E1 
Potential N-glycosylation sites in pestiviral E1 glycoprotein (BVDV CP7 as an example) predicted using 
NetNGlyc 1.0 online web server. Amino acids with a score higher than the threshold indicated that this 
position has more possibilities to be a target for post-translation modification. 
  




Table 5.3 Constructs for mutagenesis analysis of fully conserved N-glycosylation sites of pestiviral E1 
 
Figure 5.5 Mutagenesis analysis of N-Glycosylation site of pestiviral E1 
N-glycosylation site(s) defective E1 mutants (in table 5.1) were expressed via Vaccinia virus T7 expression 
system, the products were precipitated by HA-tag antibody. Cells only infected with vaccinia virus without 
any other treatment for the mock control. All the samples were processed with the RIP buffer (plus β-
mercaptoethanol) under reducing condition. The corresponding samples are shown in Tab 5.3. 
 
As shown in Fig 5.5, the substitution at both N19 and N100 resulted in molecular weight 
decrease (lane 2 and 3). When both potential N-glycosylation sites were destroyed, an even 
stronger molecular weight shift was visible (lane 4). After removing all types of N-linked 
glycans of E1 wt by using PNGase treatment, the molecular size of this deglycosylated E1 
dropped to the same level as the double N-glycosylation site E1 mutant (lane 4 and lane 5). This 
indicated that both putative N-glycosylation sites of E1 are used, so that pestiviral E1 has a mass 
of 27-32 kDa. It can be inferred that the non-conserved N-glycosylation site at N6 which is 
specific for CSFV, BDV, Pestivirus Aydin and Pestivirus Burdur species was also used. The 
molecular weight difference in pestiviral E1 is mainly dependent on the question whether this 
N6 site can be glycosylated. Furthermore, the slight molecular difference between E1 N19A 
mutant and E1 N100A mutant also indicated that they have different glycan types. 
 
5.1.3 The prediction of secondary structure and transmembrane domain of 
pestiviral E1 
5.1.3.1 The secondary structure prediction of pestiviral E1 
The prediction for the secondary structure of E1 in this section was generated with two widely 
used web applications JPred4 (version 4, http://www.compbio.dundee.ac.uk/jpred4/index.html 
and PSIPRED Workbench (http://bioinf.cs.ucl.ac.uk/psipred/). The E1 sequence of BVDV CP7 
isolate was used as a representative for this study. The predication results are shown in Fig 5.6 
and Supplementary Material 2. In combination with the hydropathy plot (shown in Fig 5.2), 
the prediction result from PSIPRED demonstrated that the two hydrophobic regions in the 
middle part of E1 (h1) most likely form α-helices (L53-D67 and P70-S83) which correspond to 
the two peaks in the h1 region of the hydropathy plot in Fig 5.2. The hydrophobic regions h3 
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25kDa--- E1 wt
α - HAβ - Mercaptoethanol
E1 lacking N19 or 
N100 glycosylation 
site E1 lacking both N19 
and N100 glycosylation 
sites or deglycosylated 
E1  




and h4 located at the C-terminal of E1 may form three sections of α-helices according to JPred4 
(as shown in Fig 5.6 and Supplementary Material 2).  
Figure 5.6 The prediction of secondary structure in pestiviral E1 
Secondary structure prediction for pestivirus E1 glycoprotein was carried out by PSIPRED 4.0 web-server. 
The E1 sequence of BVDV CP7 strain was used for prediction in this study. All residues of E1 are shown in 
small box with different colour. Residues in pink colour indicates that are residues most likely form α-helix 
at secondary structure level. Similarly, β-strands are highlighted in yellow, coiled regions in grey. 
 
5.1.3.2 The consensus prediction of pestiviral E1 membrane topology 
The E1 glycoprotein of pestiviruses is supposed to be a transmembrane protein with C-terminal 
membrane anchor. It is still unclear which type of membrane topology E1 has. For the closely 
related hepatitis C virus, the last 30aa of E1 were identified to be the membrane anchor, which 
is also responsible for ER localization of E1 (Cocquerel et al., 1999; Cocquerel et al., 2000b). 
To analyse which type of membrane topology pestiviral E1 adopts, the consensus prediction of 
pestiviral E1 membrane topology in this section was carried out by topology predication 
algorithm TOPCONS. As shown in Fig 5.7, the prediction results from TOPCONS 
demonstrated that E1 most likely adopt a type I transmembrane topology with its N-terminus in 
the ER lumen while spanning the membrane via the membrane anchor at the C-terminus. The 
transmembrane region was supposed to range from AA 159 to 179. The other five different 
topology prediction algorithms OCTOPUS, Philius, PolyPhobius, SCAMPI (multiple sequence 
mode) and SPOCTOPUS were also used in this study. Interestingly, some of them considered 
that E1 has more than one transmembrane region (Table 5.4), since two α-helices located in the 
middle part were also assumed to adopt the transmembrane configuration. The membrane 
topology of E1 is therefore questionable and requires more detailed experimental investigation. 
According to the preliminary data from our lab and confirmed membrane topology of HCV E1, 
we considered that the putative transmembrane region of pestiviral E1 should be within last 
30aa at the C-terminal.  
Figure 5.7 The consensus prediction of pestiviral E1 membrane topology 
TOPCONS topology prediction for pestiviral E1 glycoprotein (BVDV CP7 as an example). The TOPCONS 
topology prediction (http://topcons.cbr.su.se) is a consensus predictor that collects data from the other 
prediction servers listed in the panel. Blue line indicates the part should be out of the cells or specific 




organelles, similarly, red line indicates the part should be inside. TM-helices with different orientations were 
shown as grey or white bar. 
  
Table 5.4 The consensus prediction of pestiviral E1 transmembrane region(s) 
 
5.2 Subcellular localization of pestivirus E1 
It is known that E1 forms a covalently linked heterodimeric complex with E2 which is presented 
on the viral particle surface. In addition, pestiviruses have long been considered to bud 
intracellularly, as recently confirmed by ultra-structure analysis of the pestivirus Giraffe-1 
(Schmeiser et al., 2014). Therefore, the envelope proteins of pestiviruses have to accumulate 
and bud in some specific intracellular compartments. The glycoprotein E1-E2 complexes of 
HCV were shown to accumulate in the endoplasmic reticulum (ER) where also virus budding 
takes place (Cocquerel et al., 2000b). As part of the polyprotein, both Erns and E2 were shown 
to be concentrated at the ER (Burrack et al., 2012; Radtke and Tews, 2017; Tews and Meyers, 
2007). For E1, there are no published data. The formation of E1-E2 heterodimers strongly 
indicates that E1 should locate in the ER or a compartment close to the ER. Both Erns and E2 
have retention mechanisms mediated by retention signals of their own to keep them within the 
ER. The retention mechanism of pestiviral E1 has never been discussed before. In this section, 
firstly, we would like to determine the intracellular localization of pestiviral E1. For this purpose, 
the E1 glycoprotein of BVDV CP7 was analysed together with compartment markers via 
indirect immunofluorescence. 
Since no antibodies directed specifically against pestiviral E1 were available for the detection 
of transiently expressed E1, the plasmid pCR-13 which was established by Dr. Christina Radtke 
for BVDV CP7 E1 expression, was used in this study. This plasmid is based on the mammalian 
expression vector pCI, in which the target sequences are inserted and expressed under control 
of the CMV promoter. The last 20 amino acids (aa) at the C-terminus of the BVDV CP7 core 
protein (aa sequence is as follow: EKALLAWAIIALVFFQVTMG) served as a signal sequence 
(SS) for the transient expression of E1. The full-length sequence coding for CP7 E1 (585bp) 
was inserted right after this SS and these sequences were introduced into the pCI vector. For 
the detection of transiently expressed E1, a HA (hemagglutinin) tag was inserted at the N-
terminus of the E1 sequence in pCR-13, right after the signal sequence. This newly made HA 
tagged E1 construct was named pYM-13. Transient expression of E1 took place in BHK-21 or 
RK-13 cells (depending on the purpose of the study) via the lipofectamine™ 2000 transfection 
method or Vaccinia virus T7 expression system. E1 was detected with using HA-specific 
antibodies. 
To investigate the subcellular localization of E1 in different cell organelles, the ER/golgi 
compartment was visualized in parallel to E1 by the pDsRed-ER/pDsRed-Golgi plasmids co-
expressed with HA-tagged E1. The pDsRed-ER/pDsRed-Golgi is designed for fluorescent 
labeling of the endoplasmic reticulum (ER) or the Golgi apparatus in mammalian cells, 
respectively. Fluorescence can be observed in living/fixed cells by microscopy or flow 
cytometry.  




Briefly, the ER was labeled by the fluorescent dye pDsRed-ER, which was transiently co-
expressed with HA tagged E1 expression plasmid pYM-13. Similarly, the pDsRed-Golgi 
plasmid was used for Golgi-apparatus labeling. The results were analysed with a confocal 
fluorescence microscope (as shown in Fig 5.8). 
Figure 5.8 Subcellular localization of E1 glycoprotein 
HA tagged E1 expression plasmid co-transfected with pDsRed-ER/pDsRed-Golgi respectively for E1 
intracellular localization analysis. At 24h post-transfection, cells were fixed by 4% PFA, permeabilized with 
0.05% Triton X-100 and stained with specific antibodies against HA (green). Compartments (ER or Golgi) 
are in red. Nuclei were stained with DAPI. 
 
Colocalization of E1 with the compartment markers suggested that E1 was mainly concentrated 
in the ER, while showing no detectable localization in the Golgi compartment. This results also 
demonstrated that E1 has to contain an ER retention signal of its own instead of being localized 
in the ER via the interaction with other viral proteins (e.g. E2). 
 
5.3 Studies on the localization of the retention signal in E1 
The colocalization analysis showed that E1 was mainly distributed in the ER. Pestiviral E1 
glycoprotein has never been found on the infected or transfected cell surface. This situation is 
also true for Erns and E2 which both have been shown to contain ER retention signals. E1 can 
be retained within the ER by an intrinsic retention signal or by a retrieval signal that makes E1 
travel from post-ER compartments back to the ER. 
 
5.3.1 The transmembrane anchor of E1 is a determinant for ER retention 
It was shown that the E1 of hepatitis C virus, which is rather closely related to pestiviruses, 
contains an intrinsic retention signal within its TMD. For both Erns and E2 of pestiviruses the 
C-terminal membrane anchors were found to be responsible for their retention (Burrack et al., 
2012; Radtke and Tews, 2017). In order to investigate whether the TMD of E1 plays a similar 
role, fusion proteins composed of parts of a protein naturally exported to the cell surface and 
parts of E1 were constructed (as shown in Fig 5.9A). A commonly used partner protein for such 
analyses is vesicular stomatitis virus (VSV) G protein. VSV-g is a typical type III viral fusion 
protein that is normally expressed on the plasma membrane of the cells. Based on our prediction 




data (see 5.1.3.2), the putative TMD of E1 should encompass the last 30aa at the C-terminus 
(from position 166 to 195), the rest is supposed to represent the ectodomain of E1. It is known 
that the TMD of VSV-g is a short peptide that extends from I-465 to C-489 (aa sequence: 
IASFFFIIGLIIGLFLVLRVGIHLC). 
Figure 5.9 The transmembrane anchor is responsible for the retention of E1 
(A) Schematic representation of the parental proteins or chimeras used in this study. Two chimeric proteins: 
pYM-57 (VSVg ectodomain-E1 transmembrane domain): VSV-g[1-464], ectodomain of VSV-g fused to the 
TMD of E1 [166-195]; pYM-56 (E1 ectodomain-VSVg transmembrane domain): E1[1-165], ectodomain of 
E1 fused to the TMD of VSV-g [465-489].  
(B) Test for cell surface expression of the parental proteins or chimeras. RK-13 cells were transfected with 
the indicated plasmids. At 24h post-transfection, cells were further analysed by indirect immunofluorescence. 
The RK-13 cells were fixed with 4% PFA, then permeabilized or not with 0.05% Triton X-100, and immune-
stained with anti-HA mAb (secondary FITC-anti-mouse) or anti-VSV-g pAb (secondary FITC-anti-rabbit). 
 
Cells transfected with plasmid 838 expressing full-length VSV-g were used as a control of cell 
surface expression, since there is no retention signal within VSV-g. The transfected cells were 
all positive after permeabilization with 0.05% Triton X-100, indicating that all the 
parental/fusion proteins were expressed (shown in Fig 5.9B). For the non-permeabilized cells, 
VSV-g wt was detected as a rim surrounding the transfected cells. Interestingly, also the chimera 
composed of E1 ectodomain and VSVg TM was detected on the cell surface. In contrast, the 
fusion protein VSVg[1-464]-E1[166-195] showed no cell surface expression and was 
completely retained within the cell, similar to E1 wt (Fig 5.9B). This result clearly indicates 
that the TM anchor of the pestiviral E1 functions as an intracellular localization signal, in the 
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In this section, the pYM-56 (E1[1-165]-VSVg[465-489]) E1-VSVg chimera was also analysed 
via confocal microscope to investigate its intracellular localization. E1-VSVg chimera 
expression plasmid pYM-56 was co-transfected with pDsRed-ER/pDsRed-Golgi into RK-13 
cells respectively. As shown in Fig 5.10, when the transmembrane region of E1 was replaced 
by that of VSV-g, this chimera was entirely presented on the cell surface. Neither co-localized 
with ER nor Golgi apparatus, showing a completely different intracellular localization 
compared to wild-type E1 (as shown in Fig 5.8). 
Figure 5.10 Subcellular localization of pYM-56 (E1-VSVg chimera) 
HA tagged E1-VSVg chimera (E1[1-165]-VSV-g[465-489]) expression plasmid co-transfected with pDsRed-
ER/pDsRed-Golgi, respectively for its intracellular localization analysis. At 24h post-transfection, cells were 
fixed by 4% PFA, permeabilized with 0.05% Triton X-100 and stained with specific antibodies against HA 
(green). Compartments (ER or Golgi) are in red. Nuclei were stained with DAPI. 
 
Since VSV-g is a typical plasma membrane protein, it is almost exclusively found on the cell 
surface. To further prove the cell surface presence of this E1-VSVg chimera (pYM-56). We 
performed a colocalization assay with wild-type VSV-g protein. Cells were co-transfected with 
838 plasmid expressing full-length VSV-g and pYM-13 (E1 wt). After permeabilization with 
0.05% Triton X-100, the E1 wt showed totally different cellular localization to VSV-g wt (Fig 
5.11A). However, it is clear to see a perfect colocalization of this E1-VSVg chimera (pYM-56) 
with the wild-type VSV-g. As shown in Fig 5.11B, under non-permeabilization conditions, both 
E1-VSVg chimera and VSV-g wt presenting on the cell surface which was detected as 
impressive rim surrounding the transfected cells. This result further confirmed the cell surface 
presence of E1-VSVg chimera. Importantly, the VSVg-E1 chimera pYM-57 (VSV-g[1-464]- 
E1[166-195]) showed absence of cell surface expression and was completely retained within 
the ER, thus showing a similar cellular localization to E1 wt (Fig 5.11C), it means that the TM 
domain of E1 is sufficient to keep the ectodomain of VSVg within the ER. Taken together, these 
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Figure 5.11 Co-localization analysis of the parental proteins or chimeras 
(A) Co-localization analysis for the parental protein E1 and VSV-g. RK-13 cells were transfected with the 
indicated plasmids. At 24h post-transfection, cells were further analysed by indirect immunofluorescence. 
The RK-13 cells were fixed with 4% PFA, then permeabilized with 0.05% Triton X-100, and immune-
stained with anti-HA mAb (secondary FITC-anti-mouse) or anti-VSV-g pAb (secondary FITC-anti-rabbit). 
(B) Co-localization analysis for the cell surface expression of the parental protein VSV-g and pYM-56 (E1[1-
165]-VSV-g[465-489]) chimera. RK-13 cells were transfected with the indicated plasmids. At 24h post-
transfection, cells were further analysed by indirect immunofluorescence. The RK-13 cells were fixed with 
4% PFA, without any permeabilization treatments, and immune-stained with anti-HA mAb (secondary 
FITC-anti-mouse) or anti-VSV-g pAb (secondary FITC-anti-rabbit). 
(C) Co-localization analysis for the cell surface expression of the parental protein E1 and pYM-57 (VSV-
g[1-464]- E1[166-195]) chimera. RK-13 cells were transfected with the indicated plasmids. At 24h post-
transfection, cells were further analysed by indirect immunofluorescence. The RK-13 cells were fixed with 
4% PFA, then permeabilized with 0.05% Triton X-100, and immune-stained with anti-HA mAb (secondary 
FITC-anti-mouse) or anti-VSV-g pAb (secondary FITC-anti-rabbit). 
 
5.3.2 The ER retention signal is within the middle part of the transmembrane 
domain of E1 
To further narrow down the area that is responsible for the ER retention of E1, the ectodomain 
of E1 (1-165) was fused to a series of artificial chimeric transmembrane sequences (as shown 
in Fig 5.12A). Since the replacement by 100% of VSV-g transmembrane sequence resulted in 
cell surface expression of E1, the strategy in this study was that the transmembrane sequence 
from VSV-g partially and progressively substituted for the original sequence of E1 from either 
N-terminal or C-terminal end of the putative E1 transmembrane region. It is worth noting that 
A VSV-g E1 Nuclear Merge
VSV-g pYM-56 Nuclear MergeB 
E1 Nuclear MergepYM-57C 




the total length remained the same as in the original sequence. For instance, the pYM-70 
construct contains the E1 ectodomain fused to a chimeric TM domain in which the first 8 
residues (TAFLVCLV) were replaced by the first 8 amino acids (IASFFFII) of VSV-g 
membrane anchor. The rest of the constructs were made in the same manner. Cell surface 
expression of these chimeras was investigated by IF and flow cytometry (FACS). It is worth 
noting that the cysteine residue at position 489 in the transmembrane region of VSV-g 
transmembrane region substitute the original first 8aa (TAFLVCLV) of E1 putative 
transmembrane anchor sequence at the N-terminal. The rest of the constructs were made in the 
same manner. Cell surface expression of these chimeras was investigated by IF and flow 
cytometry (FACS). It is worth noting that the cysteine residue at position 489 in the 
transmembrane region of VSV-g was not used in this study to prevent unpredictable effects 
from disulphide bond formation.  
In a first step, the surface expression of the different chimeras was analysed using FACS 
analysis. For this purpose, RK-13 cells were transfected with the corresponding expression 
plasmids. The following day, one sample of each transfected RK-13 dishes was permeabilized 
with 0.05% Triton-X100 and served as an expression control. A second sample of each 
transfection reaction group was processed under non-permeabilized condition for cell surface 
expression analysis. Flow cytometry was used to analyse the presence of cell surface expression 
of HA tagged chimeric proteins always compared to the pCI empty vector transfected negative 
control (shown in Fig 5.12B and D left).  
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Figure 5.12 14aa within the middle part of transmembrane domain of E1 is responsible for the ER 
retention 
(A) Schematic representation of the chimeric transmembrane sequences used in this study. The original 
sequences of TM domains of both E1 and VSV-g are shown above. The sequences of chimeric TM anchors 
are presented below.  
(B) Cell surface expression of HA-tagged chimeric proteins analysed by flow cytometry. The RK-13 cells 
were transfected with the corresponding expression plasmids. At 24h post-transfection, cells were fixed by 
4% PFA and immune-stained with α-HA, α-mouse FITC and then analysed with the MACSQuant. Red peak: 
The fluorescence signal of RK-13 cells transfected with pCI empty vector under non-permeabilization 
condition served as a real negative control; Green peak: The fluorescence signal of RK-13 cells transfected 
with the indicated plasmids under non-permeabilization/permeabilization condition. 
(C) Presence of cell surface expression of HA tagged chimeric proteins analysed by IF. The RK-13 cells were 
transfected with the corresponding expression plasmids. At 24h post-transfection, cells were fixed with 4% 
PFA, immune-stained with α-HA/α-mouse FITC and then analysed by immuno-fluorescence microscopy. 
(D) The control samples for cell surface expression of HA tagged proteins were analysed by both FACS and 
IF. pYM-13: HA tagged E1 wt, pYM-56: HA tagged E1 ectodomain fused to VSV-g transmembrane sequence. 
Schematic representation of the constructs (pYM-13 and pYM-56) used in this section are shown in Fig 5.9A. 
 
The results of permeabilized samples showed that all fusion proteins were expressed (Fig 
5.12B). Compared to the pCI control, constructs pYM-71, pYM-72 and pYM-75 transfected 
cells showed clear cell surface signals. In contrast, the other three fusion proteins showed no 
cell surface expression and were completely retained in the cell, since there is no significant 
difference from the pCI negative control.  
These FACS results were further confirmed by immunofluorescence analysis (shown in Fig 
5.12C). RK-13 cells were seeded into a 24-well plate one day before transfection. For each 
sample two wells were seeded, one for non-permeabilization, the other for permeabilization. 
On the following day, the RK-13 cells were transfected with the corresponding expression 
plasmid. At 24h post-transfection, the cells were fixed with 4% PFA and either permeabilized 
with 0.05% Triton-X100 or processed without any detergent treatment. For the immune-
fluorescence staining, α-HA was used as the primary antibody. The cells permeabilized with 
Triton-X100 served as an expression control, since the antibody was able to penetrate into all 
compartments. An intact cell membrane, on the other hand, represents an insurmountable 
barrier for antibodies and, therefore, only surface proteins could be detected without detergent 
(shown in Tab 4.13). The IF results in Fig 5.12C showed that the pYM71, pYM-72 and pYM-
75 fusion proteins can be found on the cell surface. Interestingly, the fluorescence signal of 
pYM-71 transfected cells under non-permeabilized condition was not as strong as that of pYM-
72, indicating that there are still some fusion proteins expressed from pYM-71 retained within 
the cell. For the other samples, signals were not detected on the cell surface. These data fit with 
the results that we obtained in FACS analysis. 
The IF and FACS analysis of the E1/VSV-g fusion proteins indicated that the first 8aa and last 
8aa of the E1 transmembrane domain are not important for the retention, since substitution of 
these residues with VSV-g sequences which do not contain a retention signal has no or nearly 
no effect on the retention of E1. Fusion proteins start to show significant presence at the cell 
surface only when the E1 original middle part (K174-L187) was completely replaced by VSV-
g sequence. This indicated that the retention signal or at least critical sites for the retention 
should be present within this middle part. 
 




5.3.3 The polar amino acids in the middle part of E1 TM domain play an 
essential role in ER localization of E1 
To further verify the middle area (from K174 to L187) of the E1 TM domain as critical for the 
ER retention of E1, two new chimeras were generated (as shown in Fig 5.13A). In pYM-76, 
the middle part sequences of the E1 TM domain were completely replaced by VSV-g sequence 
(F470-V484), while the rest part still displayed the original sequence. The other construct 
(pYM-77) still contains the original TM domain middle sequence, changed on both sides by 
8aa corresponding to the VSV-g TM sequence. The cell surface expression of these chimeras 
was also analysed by IF and flow cytometry (FACS). It is worth noting that the cysteine residue 
at position 489 in the transmembrane region of VSV-g was again not used in this section to 
prevent unpredictable effects from disulphide bond formation. 
As shown in Fig 5.13B, both IF and flow cytometry data showed that the cell surface expression 
of the chimeras only occurs in the absence of the original middle part of the E1 TMD sequence, 
in other words, the middle 14aa residues located in the E1 TM region are sufficient for the 
retention of E1.  
The conservation of the amino acid sequence of the E1 TM domain throughout all species of 
pestiviruses was analysed by WebLogo 3 web application (Fig 5.13C). Several polar residues 
are fully conserved including not only four polar, non-charged residues [Glycine (G) and 
Glutamine (Q)], but also two positively charged residues Arginine (R) and Lysine (K). Those 
fully conserved residues were hypothesized to be functional for the retention in analogy to other 
envelope proteins from pestiviral related viruses which are retained because of their polar 
residues in the TM region (Cocquerel et al., 1999; Cocquerel et al., 1998; Cocquerel et al., 
2000b; Radtke and Tews, 2017). To investigate whether these conserved residues in the middle 
part are essential for the retention of pestivirus E1, mutagenesis analysis was carried out. Firstly, 
single mutants carrying point mutations at position K174, R177, G178, Q179, Q182 or G183 
were investigated via both FACS and IF as described in the previous experiments.  




   
Figure 5.13 The polar residues of E1 TM domain play essential roles in ER retention of E1 
(A) Schematic representation of the two new chimeric transmembrane sequences used in this section. The 
original sequences of the TM domains of both E1 and VSV-g are shown above. The sequences of chimeric 
TM anchors are presented below. 
(B) Cell surface expression of HA tagged chimeric proteins analysed by flow cytometry and IF. The RK-13 
cells were transfected with the corresponding expression plasmids. At 24h post-transfection, cells were fixed 
with 4% PFA and immune-stained with α-HA/α-mouse FITC and then analysed with the MACSQuant and 
with immuno-fluorescence microscopy. Red peak in FACS: The fluorescence signal of RK-13 cells 
transfected with pCI empty vector under non-permeabilization condition served as a real negative control; 
Green peak in FACS: The fluorescence signal of RK-13 cells transfected with the indicated constructs under 
non-permeabilization/permeabilization condition. 
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(C) Conservation of amino acid sequences in the putative TM region of pestiviral E1. The sequence logo was 
generated by WebLogo 3 web application (http://weblogo.threeplusone.com/create.cgi) and demonstrates the 
alignment of 68 pestivirus E1 sequences throughout all pestiviral species in one letter code. The size of the 
letters in the sequence logo corresponds to the degree of conservation over the 68 sequences (from pestivirus 
A to K). The fully conserved residues were highlight with red star, the height of symbols within the stack 
represents the relative frequency of each amino acid at corresponding position. 
 
Figure 5.14 Six polar residues of E1 TM domain are important for ER retention of E1 
Test of the cell surface expression of HA tagged E1 mutants analysed by FACS. The RK-13 cells were 
transfected with the corresponding expression plasmids. At 24h post-transfection, cells were fixed with 4% 
PFA and immune-stained with α-HA/α-mouse FITC and then analysed with the MACSQuant. 
 
Since the FACS and IF data of the pYM-76 and pYM-77 derived fusion proteins further proved 
that the retention signal was localized within the middle part of E1 transmembrane domain, in 
addition, the conservation sequence logo showed that 6 polar residues (K174, R177, G178, 
Q179, Q182 and G183) in this area are fully conserved throughout the whole pestiviral species 
indicating that they should be important for the retention. To hunt for the critical site which is 
essential for E1’s retention, firstly, a mutagenesis analysis was carried out in which selected 
polar amino acids were substituted or deleted. The corresponding expression plasmids (Table 
5.5 single mutation) were transfected into RK-13 cells and the surface presence of the proteins 
was investigated by using both IF and flow cytometry. While all mutations led to slight changes 
in the surface presence of the HA tagged E1 mutants, none of the tested single substitutions 
effected the retention of E1 strongly (data not shown). Therefore, the E1 variants with double 
mutations were generated via QC PCR (Table 5.5 double mutations and Fig 5.14 for two 
selected double mutants). However, the IF and FACS data still showed that those selected 
mutations did not increase the surface presence of the mutants.  
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Single Mutation Double Mutations Insertion
K174：A / E / Δ
R177：A / E / K / Δ
G178：L
Q179：N / E / A / Δ






① Between T166 and 
A167 'LLALLA' insertion
② Between G178 and 
Q179 'LLALLA' insertion
Table 5.5 Mutagenesis and insertion analysis for conserved residues in TMD of E1 




It is reported that the length of TMDs of membrane proteins can affect the intracellular 
trafficking and sorting of the proteins. Furthermore, adjusting the length of TMDs of membrane 
proteins is closely associated with the complexity of communication between subcellular 
compartments (Bretscher and Munro, 1993). Based on this theory, we made two hydrophobic 
sequence insertions at T166/A167 or G178/Q179 site to extend the length of the TM region of 
E1. Surprisingly, no significant subcellular localization change was observed (data not shown). 
In conclusion, single or double substitutions, or even fragment insertion, in the TM region of 
E1 could not lead to a significant increase in the surface presence indicating that the retention 
signal of E1 is apparently not dependent on single amino acids but relies on a stretch of residues 
so that it can’t be destroyed via a replacement of a few residues.  
As a next step, two new E1 mutants containing four (pYM-52) and six mutations (pYM-53) 
were generated for the last attempt. The newly made expression plasmids were transfected into 
RK-13 cells and the surface presence of the E1 mutants was investigated using flow cytometry. 
As shown in Fig 5.14, four mutations (K174A, R177A, Q182A and G183A) in TMD of E1 did 
still not lead to surface presence of the E1. However, when all six conserved polar residues were 
replaced by alanine, E1 presents a plasma membrane localization.  
Figure 5.15 Subcellular localization of pYM-53 derived E1 mutant 
The pYM-53 construct expressing E1 with six mutations (K174A, R177A, G178A, Q179A, Q182A and 
G183A) in the TM domain was co-transfected with pDsRed-ER/pDsRed-Golgi, respectively, for the 
subcellular localization analysis. At 24h post-transfection, cells were fixed by 4% PFA, permeabilized with 
0.05% Triton X-100 and stained with specific antibodies against HA (green). Compartments (ER or Golgi) 
are in red. Nuclei were stained with DAPI. 
 
To investigate the subcellular localization of the pYM-53 derived protein in different cell 
organelles, the pDsRed-ER or pDsRed-Golgi plasmids were co-expressed with HA tagged E1 
mutant. The pDsRed-ER or pDsRed-Golgi is designed for fluorescent labeling of the 
endoplasmic reticulum (ER) or the Golgi apparatus in mammalian cells. Fluorescence can be 
observed in living/fixed cells by microscopy or flow cytometry.  
Briefly, the ER was fluorescently from labeled by pDsRed-ER, which was transiently co-
expressed with HA tagged E1 expression plasmid pYM-53. Similarly, the pDsRed-Golgi 












As shown in Fig 5.15, colocalization analysis of pYM-53 with the ER/Golgi compartment 
markers demonstrated that the E1 retention defective mutant presented a plasma membrane 
localization, but was also partially located in the ER and the Golgi compartment. Wild-type E1 
was shown to be perfectly colocalized with the ER marker (shown in Fig 5.8). The partial ER/ 
Golgi localization of pYM-53 suggested that the retention signal of E1 has been destroyed, so 
that this E1 retention defective mutant distributed on the secretion pathway. Compared to the 
entire cell surface presence of E1-VSVg chimera (pYM-56: E1[1-165]-VSV-g[465-489]), 
pYM-53 seemed to be different. Since there are some E1 retention defective mutants still 
retained within the ER also indicated that other factors could have effects on the retention of 
E1 or maybe the export of the protein goes more slowly. Taken together, these data showed that 
the fully conserved polar amino acid residues in the middle part of the E1 TM domain play an 
essential role in ER localization of E1. In addition, those 6 polar residues (Lys174, Arg177, 
Gly178, Gln179, Gln182 and Gly183) seem to serve as a functional group in retention.  
 
5.3.4 Effect of selected mutations in E1 on the replication of BVDV strain 
CP7 
In the previous section, the mutations which have an influence on the retention of the E1 
glycoprotein were identified. In order to find out whether mutations affecting these residues 
allow the formation of infectious virus particles, selected mutations were inserted into the full-
length infectious clone for BVDV CP7 (p798). A publication suggested that the polar charged 
residues in TM domain of E1 (K174 and R177) play an essential role in BVDV infectivity, and 
therefore a respective double mutation was also introduced into the p798 as a control. 
 
5.3.4.1 Generation of BVDV CP7 virus mutants with selected E1 mutations 
The six mutations K174A, R177A, G178A, Q179A, Q182A and G183A and the double 
mutation K174A and R177A were first introduced into the infectious clone p798 using common 
cloning techniques. Plasmid construct p798 contains the cDNA of the entire BVDV CP7 
genome (Meyers et al., 1996a). A viral genome-like RNA can be generated via in vitro 
transcription of this cDNA. To check whether this RNA can serve as a replicon that starts the 
replication of the viral genome, generates infectious virus particles, the obtained RNA was 
transfected into MDBK-B2 cells via electroporation (EP). For each sample cells after 
electroporation were separated into two 30mm dishes. One day after electroporation, one dish 
of each sample was examined for viral protein synthesis using indirect immunofluorescence. 
The other dish of each sample was further incubated for further subculture and RNA isolation. 
The viral protein NS3 was detected with the primary monoclonal antibody Code4 (2nd antibody 
α-mouse FITC). 
Immunofluorescence images of each sample after the EP are shown in Fig 5.16. The wild-type 
control and 798-E1 K174A and R177A, 798-E1 with 6 mutation in TMD of E1 all showed a 
positive signal in the detection of NS3 one day after EP indicating, thus, all the constructs can 
start the viral RNA replication and gene expression.  





Figure 5.16 Indirect immunofluorescence analysis after electroporation 
First, MDBK-B2 cells were transfected by electroporation with the corresponding RNA. One day after EP, 
the cells were fixed with 4% PFA and permeabilized with 0.05% Triton X-100. The viral protein NS3 was 
detected using the primary antibody Code4 and α-mouse FITC. 
 
5.3.4.2 Characterization of the CP7 virus mutants 
In order to check that the recovered viruses contained the desired mutations and were not 
reverted, MDBK-B2 cells were infected with the lysates of the transfected cells. This infection 
was also used to test whether infectious viruses and not just replicons were recovered after EP. 
2-4 days after infection, the viral RNAs were extracted using Trizol® Reagent according to the 
manufacturer's protocol and then used for an RT-PCR with subsequent sequence analysis. 
Interestingly, the sequencing results showed that the mutations in the genome derived from the 
infectious clone p798- K174A and R177A are not reverted, they still existed in the recovered 
viral genome. However, all substitutions of the infectious clone p798- K174A, R177A, G178A, 
Q179A, Q182A and G183A, after EP, were fully reverted. This finding further confirmed those 
six polar residues in the TM domain of E1 served as a functional group in the viral life cycle. 
This initial result can not exclude the contamination from recovered wild-type BVDV CP7 
(p798), it has to be repeated at least three times. I am still working on this experiment, since my 
contract is going to be finished, hopefully this part of work could be presented before I leave.  
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5.4 Analysis of the membrane topology of pestiviral E1 
Pestiviral proteins are synthesized as a polyprotein cleaved by a signal peptidase and viral 
proteases. The glycoprotein E1 is translocated as a part of the polyprotein during translation 
into the ER. For a long time, E1 has been thought to be a membrane protein that is composed 
of N-terminal ectodomain and a C-terminal hydrophobic membrane anchor. Often, the C-
terminal hydrophobic region of viral envelope proteins of positive stranded RNA viruses is 
composed of two stretches of hydrophobic residues separated by a short segment containing at 
least one fully conserved positively charged residue (Cocquerel et al., 1999; Cocquerel et al., 
1998; Cocquerel et al., 2000b). The first stretch of hydrophobic part is considered to be a 
membrane anchor of the viral protein, the second part is supposed to act as signal sequences of 
the following viral protein. The N-terminus of E1 is generated by signal peptidase cleavage at 
the unusual Erns membrane anchor/E1 site. The length of the hydrophobic region at C-terminal 
of E1 making the membrane topology of mature E1 alone difficult to predict.  
In the synthesized polyprotein, the internal signal peptides at the C-terminus of E1 should be 
used to target the following E2 glycoprotein to the ER. After signal sequence cleavage, the 
proposed signal peptide of E2 should remain bound to the C-terminus of the E1. It was reported 
that there is a reorientation of the signal sequences after cleavage at the C-terminus of HCV E1 
and E2 (Cocquerel et al., 2002) which might in analogy also be true for pestiviral E1. In this 
section, the membrane topology of E1 should be determined. In addition, we also wanted to 
clarify whether there are changes in membrane topology of E1 when the signal sequence 
cleavage occur and the fully processed protein is generated. 
 
5.4.1 Membrane topology of E1 separately expressed E1 
5.4.1.1 Membrane topology of E1 alone analysed by selective 
permeabilization assay 
To investigate the membrane topology of separately expressed E1, firstly, the indirect 
immunofluorescence analysis was carried out with a so-called selective permeabilization assay. 
The cells were fixed with 4% PFA, then incubated with 0.05% Triton X-100 for 30 min in PBS 
resulting in the permeabilization of both the plasma membranes and the compartment 
membranes. Alternatively, cells were treated with a 5 µg/ml digitonin solution for 15 min at 4 ℃ 
leading to plasma membrane permeabilization only, while the compartment membranes remain 
intact and represent an insurmountable barrier for the antibodies used. The 0.05% Triton X-100 
permeabilization treatments served as expression control, since the target proteins can be 
detected in all areas of the cell. In contrast, only proteins on the cell surface and in the cytoplasm 
can be detected in the digitonin permeabilized preparations.  
In this study, two variants of the BVDV glycoprotein Erns with known topology (Tews and 
Meyers, 2007) were used as controls for the correct selective permeabilization. The plasmid 
construct pB11 encode the BVDV CP7 wild type Erns with a C-terminal V5 tag. All the epitopes 
of this protein are known to be on the luminal side of the ER and should therefore not be 
detectable after digitonin permeabilization. pB154 is the other expression plasmid that 
expresses a variant of Erns with a hydrophobic leucine stretch replacing the original amphipathic 
helix at the C-terminus of Erns. In addition, again a V5 tag was fused to the C-terminus of pB154. 
As a result of the exchange of the amphipathic helix for a hydrophobic region, a transmembrane 
domain was created, as a result of which the V5 tag is accessible at the cytosolic side of the ER 
membrane and can therefore also be detected after digitonin permeabilization. 




Both Erns variants were expressed in RK-13 cells. The transfected cells were selectively 
permeabilized and stained with an antibody against the V5 tag (schematic illustration see Fig 
5.16A). The staining showed the expected pattern, which confirmed that the selective 
permeabilization assay was done correctly (Fig 5.17). 
To determine the membrane topology of E1 alone, in the absence of any other viral protein a 
double tagged E1 variant which had an N-terminal Flag tag and a C-terminal V5 tag was used 
in this study. As shown in Fig 5.17B, both tags could be detected in the Triton-X100 
permeabilized cells with specific antibodies, which indicated that the proteins were successfully 
expressed and could be recognized by the corresponding antibodies. After permeabilization 
with digitonin, only the V5 tag at the C-terminus of E1 could be detected. These results showed 
that the N-terminus was on the luminal side of the ER and the C-terminus was in the cytosol. 
Thus, by using the selective permeabilization assay we could preliminarily demonstrate that 
pestiviral E1 is a type I transmembrane protein that has a N-terminal ectodomain in the ER 
lumen and a C-terminal transmembrane anchor.  
Figure 5.17 Expression and recognition of tag-labeled Erns and E1 proteins 
(A) Schematic representation of constructs used in this section: Erns wild type with N-terminal V5 tag; Erns 
TM with leucine stretch instead of the amphipathic helix; double tagged E1 variant which had an N-terminal 
Flag tag and a C-terminal V5 tag. 
(B) RK-13 cells were transfected with the indicated expression plasmids and fixed with 4% PFA on the 
following day. Cell membranes were permeabilized with 0.05% Triton-X100, all membranes or the plasma 
membrane was selectively permeabilized with digitonin. Erns: α-V5, α-mouse Alexa-Fluor-488; E1: α-FLAG, 
α-mouse Alexa-Fluor-488; α-V5, α-mouse Alexa Fluor 488; Nucleus: DAPI (blue); Below: schematic 
representation of the membrane topology of the analysed proteins. 
 
5.4.1.2 Membrane topology of E1 analysed by an Avi-tag biotinylation assay 
To further verify the conclusion we got from the selective permeabilization assay, a sensitive 
and selective biotechnology approach called Avi-tag biotinylation assay was used in this study. 
The Avi-tag is a short peptide of 15 amino acids in length (GLNDIFEAQKIEWHE) which can 
be covalently attached to biotin in the presence of E.coli biotin ligase (BirA). The biotin moiety 
bound to the Avi-tag can then be detected via (strept)avidin. It is known that the interaction 
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intermolecular force, so the (strept)avidin-biotin binding has been widely used for molecular 
biology research.  
In this section, a short sequence coding for the peptide Avitag as a target for site-specific 
biotinylation was added genetically to the region coding for N-terminus, C-terminus of target 
proteins. By co-expression with the modified BirA biotin ligase, this Avi-Tag can be labeled 
depending on either the localization of the Avi-tag at the target protein or the distribution of 
BirA. The advantage of this system over the IF/differential permeabilization approach is that 
the labelling occurs under native conditions before the cell is destroyed. Specifically, the Avi-
tag was added to either the N-terminus or C-terminus of E1, furthermore, to ensure the Avi-tag 
at the C-terminus can not be cleaved off, we introduced a mutation Alanine to Arginine (A to 
R) at the -3 position of the SP cleavage site at the C-terminus of E1, thereby the von Heigne 
motif of the signal peptidase cleavage site at the E1 caboxytermius is blocked. Cb version, 
cleavage blocked 3’ Avi-E1 Cb, in Fig 5.18A). For the control, Erns wt and Erns TM were also 
used in this study. It is worth noting that when the Avi-tag was introduced at the C-terminus of 
Erns wt or variant, the cleavage site at C-terminal of Erns was also blocked. In this study, we 
constructed two types of BirA expression plasmids. The plasmid construct pYM-48 (BirACyto) 
encoded biotin ligase (BirA) without signal sequence so that all the expressed biotin ligase is 
located in the cytosol. In contrast, the plasmid pYM-49 based on the pYM-48, additionally 
contained a signal sequence (signal sequence for BVDV Erns: MALLAWAVITILLYQPVAA) 
and the well characterized ER retention signal ‘KDEL’ at the C-terminus. Theoretically, this 


































   
Figure 5.18 Membrane topology of E1 analysed by Avi-tag biotinylation assay 
(A) Schematic representation of constructs used in this section. 
(B) The appropriate Avi-tagged expression plasmids were co-transfected with pYM-48 (BirA Cytosol) into RK-
13 cells, and expression products were analysed via Western blot on the following day. The cells were lysed 
with lysis buffer (+β-ME), then the samples were loaded onto SDS gels and separated electrophoretically. 
Western blot analysis was carried out using α-streptavidin PO for the biotinylated proteins. Lane numbers 
refer to construct numbers shown above. 
(C) The Avi-tagged expression plasmids were co-transfected with pYM-49 (BirA ER) into RK-13 cells, and 










































































































































































as described above. Western blot analysis was carried out using α-streptavidin PO for the biotinylated proteins. 
Lane numbers refer to construct numbers shown above. 
(D) Schematic representation of membrane topology of Avi-tagged constructs. 
 
In this BirA mediated Avi-tag biotinylation assay, BirACyto or BirAER were co-transfected with 
the corresponding Avi-tagged expression plasmids into RK-13 cells. On the following day, the 
cells were lysed with lysis buffer (+β-ME), then the samples were loaded onto SDS gels and 
separated electrophoretically. Western blot analysis was performed using peroxidase-coupled 
avidin (avidin-PO) for detection of biotinylated proteins. As shown in Fig 5.18B, when Avi-
tagged proteins were co-expressed with BirACyto, the control plasmid E
rns-TM-Avi was detected 
as the dominant bands (lane 6 and 7) on the blot whereas there was only a very faint band visible 
for Erns wt-Avi. This indicated that BirACyto was at least predominantly expressed in the 
cytoplasm, since only the tag accessible from the cytosol was biotinylated. For the E1-Avitag 
fusion protein samples, only the Avi-tag located at the C-terminus of E1 with the cleavage site 
block could be biotinylated, demonstrating that C-terminus of E1 is located in the cytosol and 
the N-terminus should be retained in the ER lumen.  
When the Avi-tagged constructs were co-expressed with BirAER, both E
rns wt-Avi and Erns TM-
Avi were biotinylated (Fig 5.18C, lane 4, 5, 6 and 7). In the light of published and above 
presented data, this result suggested that either the C-terminus of Erns TM (3’-Erns-Avi) is in part 
of the cases exposed in the ER lumen, a point that would not have been detected in previous 
analysis, or the BirA expression construct after introduction of a signal sequence and ER 
retention signal is not present in the ER alone. In contract, there is still part of BirAER present 
in the cytoplasm. That could be the reason why there is still a very slight band showing in the 
lane 3 in Fig 5.18C for E1 with C-terminal tag (3’-E1-Avi). The N-terminal Avi-E1 (5’-Avi-E1) 
can be biotinylated in the presence of BirAER, clearly showing that the N-terminus of E1 is 
located in the ER lumen. With these results, the data previously collected from the selective 
permeabilization assay could be further confirmed. 
Taken together, in this section, the membrane topology of pestiviral E1 expressed in the absence 
of other viral proteins was analysed by using two different independent molecular approaches. 
We concluded from the results that pestiviral E1 adopts a typical type I transmembrane topology 
in the absence of other viral proteins.   
 
5.4.2 The TM domain of pestiviral E1 forms a hairpin structure before signal 
sequence cleavage 
Normally, the C-terminal part of viral transmembrane proteins in polyproteins can be divided 
into two parts: the first part is a TM segment that generally consists of mostly 20-25 mostly 
non-polar residues and the second one is a short hydrophobic sequence (7-12 aa) serving as the 
signal sequence which directs the translocation of the following precursor. The presence of a 
signal sequence in the second half of the C-terminus of the TM domain of E1 does not fit with 
a single membrane-spanning topology. Since pestiviral envelope proteins are synthesized as a 
polyprotein, it is conceivable that the membrane topology of the polyprotein precursor should 
be different from that found after the signal sequence cleavage occurred since the C-terminus 
of E1 in the polyprotein should be located in the ER-luminal side to allow translocation of the 
downstream E2. Therefore, the membrane topology of the C-terminus of E1 was analysed under 
the condition that the signal sequence cleavage was hampered. 




To achieve this, the pCR-17 (plasmid from Dr. Christina Radtke, shown in 3.12.2) coding for 
the BVDV CP7 E1-E2 proteins was used in this study. We introduced a mutation (Ala to Arg) 
into the C-terminus of E1 at position -3 of the cleavage site to block the signal sequence 
cleavage. For the detection of N- and C-terminus of E1, a HA epitope (YPYDVPDYA) and a 
Flag tag sequence (DYKDDDDK) were fused to its N- or C-terminus, respectively. In addition, 
E2 was also tagged at the C-terminus with an AU1 epitope (DTYRYI) for tracing whether the 
C-terminus of E2 is still accessible from the cytosol when cleavage at the E1/E2 site was 
blocked (shown in Fig 5.19A). To analyse the membrane topology of this un-cleaved E1-E2 
precursor, the so-called selective permeabilization assay was carried out as described above. As 
control, cells permeabilized with 0.05% Triton X-100 were also analysed in parallel. In this 
experiment, pYM-14 (ss-HA-E1-Flag) and pCR-16 (ss-E2-AU1) were co-transfected together 
to show the situation after the signal sequence cleavage. The mixture of monoclonal antibodies 
directed against BVDV CP7 E2 called BVDV Mix was used for the detection of the E2 
ectodomain. As shown in Fig 5.19B, the C-terminus of both E1 and E2 were accessible to the 
respective antibodies in the digitonin permeabilized cells when cleavage between E1 and E2 
occurs. This result fits well to the results and the conclusions described above. Surprisingly, 
when the cleavage was abolished, all the epitopes were only accessible to their respective 
antibodies under Triton X-100 permeabilization, but not in digitonin permeabilized cells (Fig 
5.19B). This data indicates that the C-terminal of E1 should orientate toward the luminal side 
of the ER to adopt a double membrane-spanning structure in the absence of signal sequence 
cleavage. Moreover, it also suggests that before the cleavage between E1 and E2 has occurred, 
the C-terminus of E2 can’t adopt a transmembrane configuration in the ER membrane. The 
sequence preceding the E2 C-terminus is shown as a red line with dotted contour because its 
behaviour is not clear (Fig 5.19C). Since this sequence is highly hydrophobic it is shown as 
membrane interacting, but this is only speculation at this time being. 
 




Figure 5.19 The TM region of pestiviral E1 form a hairpin structure before signal sequence cleavage 
(A) Schematic representation of constructs used in this section 
(B) RK-13 cells were transfected with the appropriate expression plasmids and fixed with 4% PFA on the 
following day. Either all the cell membranes were permeabilized with 0.05% Triton-X 100, or only the plasma 
membrane was permeabilized with a digitonin solution. E1: α-HA, α-FLAG, α-mouse Alexa-Fluor-488; E2: 
α-E2 (BVDV MIX anti E2 ectodomain), α-AU1, α-mouse-FITC;  





































5.5 The Prerequisites of E1 oligomerization and E1-E2 heterodimerization 
5.5.1 Pestiviral glycoprotein E1 can form homo-oligomers independent of its 
membrane anchor 
The glycoprotein E1 of the closely related HCV was shown to form non-covalently linked 
trimers on the virion. Additionally, the other two envelope proteins of pestiviruses, Erns and E2, 
both can form homodimers (Tews et al., 2009b; Thiel et al., 1991; Tucakov et al., 2018; van 
Gennip et al., 2005). It is shown that E1E2 can form covalently linked E1-E2 heterodimers 
which were shown to be essential for viral entry (Ronecker et al., 2008). Because of the absence 
of specific antibodies against E1, it still unknown whether E1 of pestiviruses forms oligomers 
or not. Therefore, we expressed wild-type E1 and analysed it under non-reducing conditions. 
As shown in Fig 5.20B lane 1, interestingly, the overexpression of pestivirus E1 glycoprotein 
leads to the presence of three predominant bands which based on their electrophoretic mobility 
correspond to homo-trimer, homo-dimer and monomer of E1. This is the first time to observe 
that pestiviral E1 can form homo-oligomers. To determine whether the C-terminal membrane 
anchor has some effects on the oligomerization of E1, we constructed a series of E1 mutants 
with different length of truncations at the C-terminus in the E1 protein (Fig 5.20A). These 
mutants were expressed in RK-13 cells, and the expression of E1 mutants was analysed under 
non-reducing conditions by Western blot analysis with anti-HA antibody.  
 
 
Figure 5.20 E1 can form homo-oligomer independent to its membrane anchor 
(A) Schematic representation of constructs used in this section 
(B) The HA-tagged E1 and its truncated variants were expressed in RK-13 cells, and expression products 
were analysed via Western blot on the following day. The cells were lysed with lysis buffer (-β-ME), then the 
samples were loaded onto SDS gels and separated electrophoretically. Western blot analysis was carried out 
using primary antibody α-HA and PO labeled 2nd antibodies for the detection of protein. Lane numbers refer 
to the order of the constructs numbers in (A). 
As shown in Fig 5.20B, surprisingly, for the E1 mutants with long truncation (pYM-92 and 
pYM-93) from which the putative membrane anchor was deleted, three clear bands were 
detected in the transfected-cell lysates. As expected due to the shortening with a decreasing 
molecular weights. This result indicated that pestivirus E1 can form homo-oligomer even in the 
absence of the carboxyterminal transmembrane region. It is worth noting that the signal from 
pYM-91 transfected cells is still comparable to that of the E1 wt. However, weaker bands were 
observed for the truncated samples with longer deletions (pYM-92 and pYM-93), which might 
















































5.5.2 Both Cys123 and Cys171 play an important role in E1 homo-
oligomerization 
Pestiviral envelope protein Erns and E2 generate homodimers via intermolecular disulphide 
bonds established by their almost C-terminal cysteine residues (Li et al., 2013; Tews et al., 
2009b; Wang et al., 2014). Accordingly, the homo-oligomerization of E1 is also supposed to be 
mediated via covalent linkage between pairs of cysteine residues. There are six cysteine 
residues distributed in E1 of BVDV CP7 strain. According to the alignment shown in Fig 5.3, 
the first 5 cysteine residues (at position 5, 20, 24, 94 and 123) are highly conserved throughout 
nearly all pestivirus species which was considered to be important for the stability and function 
of E1. In BVDV-2 strains, the 6th cysteine, which is located at position 171, is missing. This 
indicated that this site could be dispensable, however, based on some computational model 
prediction, it was suggested that this Cys171 should most likely be the critical site for E1E2 
heterodimer formation (Wang et al., 2014). This point still await further experiential verification.  
To identify the potential determinants of E1 oligomerization, a series of E1 mutants containing 
single and double exchanges (Cys to Ser) were generated by using the site-directed mutagenesis. 
E1 wt and mutants were expressed in RK-13 cells, respectively, and the expression of E1 or E1 
mutants was determined by Western blot analysis with anti-HA under non-reducing condition. 
As shown in Fig 5.21, compared to the E1 wt, the individual substitution at single exchanges 
affecting the first 4 Cys (position C5S, C20S, C24S and C94S) had no effect on the E1 
oligomerization. Interestingly, both C123S and C171S reduced the presence of homo-trimer 
and homo-dimer of E1, C123 has wider influence on the oligomer formation of E1. If 
C123S/C171S double mutations were introduced into E1, only E1 monomer could be detected 
on the blot. These data also indicated that the first 4 cysteine residues most likely form 
intramolecular disulphide bonds, while the last two cysteines are involved in intermolecular 
linkage formation. Among them, Cys123 has more influence on the oligomerization of E1. 
Figure 5.21 Both Cys123 and Cys171 play an important role in E1 homo-oligomerization 
The given HA-tagged E1 wt and cysteine lacking mutants were transfected into RK-13 cells, and expression 
products were analysed via Western blot on the following day. The cells were lysed with lysis buffer (-β-ME), 
then the samples were loaded onto SDS gels and separated electrophoretically. Western blot analysis was 
carried out using primary antibody α-HA and secondary antibody anti-rabbit-PO for the detection of protein.  
 
5.5.3 Critical sites for E1-E2 heterodimer formation and E2 homodimer 
formation 
It is well known that covalently disulphide-linked E1-E2 heterodimers are needed for pestiviral 
infectivity (Ronecker et al., 2008). Publications (Li et al., 2013; Wang et al., 2014) suggested 
that except for cysteine residue at position 295 in E2, all the other cysteines of E2 form 


































































site the best candidate for the necessary disulphide linkage with E1 or with itself in homodimers. 
However, it is unclear which of the E1 cysteines is involved in E1-E2 heterodimer formation. 
To further investigate the prerequisite for E1-E2 crosslinking, AU1 tagged E2 or E2 mutants 
were used in this study. A substitution C295S was introduced into E2 for blocking the only 
unlinked cysteine residue in E2. E1 wt or E1 mutants containing single and double mutations 
(Cys to Ser) were co-transfected with E2 wt or E2 mutant (C295S) in RK-13 cells respectively, 
and the presence of E1-E2 heterodimer was analysed by Western blotting with anti-AU1 serum 
under non-reducing conditions. As shown in Fig 5.22, co-expression of E1 wt with E2 wt 
(shown in lane 1), resulted in a dominant band of ~70 kDa which according to size corresponds 
to E1-E2 heterodimer. In addition, bands of ~55 and ~110 kDa were visible that represent E2 
monomer and homodimer, respectively. However, when E1 wt was co-expressed with E2 
(C295S) mutant, both E1-E2 heterodimer and E2 homodimer were diminished (shown in lane 
2). This situation is also true for other E1 variants when co-expressed with E2 (C295S) mutant 
(as shown in lane 4, 6 and 8). When E2 wt was expressed alone (shown in lane 9), we could see 
E2 homodimer with nearly equal amount as the E2 monomer. In contrast, when the only free 
cysteine in E2 was blocked, E2 homodimer completely disappeared (shown in lane 10). Those 
results indicated that the Cysteine residue at position 295 in E2 is critical for both E1-E2 
heterodimerization and E2 homodimerization. 
In addition, E1 mutants containing single and double mutations (Cys to Ser) were also tested in 
this study. The mutants E1 (C171S), E1 (C123S) and E1 double mutation (C171S and C123S) 
were co-transfected with E2 wt into RK-13 cells and analysed as described above. When E1 
(C171S) was co-expressed with E2 wt, the E1-E2 heterodimer was still present (as shown in 
lane 3) indicating that Cys171 in E1 is not necessary for the heterodimer formation. However, 
when E2 wt was expressed in the presence of the E1 mutant (C123S), the amount of heterodimer 
was extremely reduced to about the level of the mock control and the amount of the E2 
homodimer recovered to normal compared with the sample from E2 wt expressed alone (lane 
5). These results clearly showed that Cys123, not Cys171, is the important site for E1-E2 
heterodimer formation. This conclusion is contradictory to the computational prediction (Wang 
et al., 2014). This data also suggested that E2 prefer to form E1-E2 heterodimer in the presence 
of E1. The E2 homodimer might be an excess product for E2 not engaged in E1-E2 heterodimer 
formation. There are always some non-specific bands presenting in each group, which is most 
probably because of the background from the antibody. 
 
 
1 2 3 4 5 6 7 8 9 10 11
































Figure 5.22 Cys123 in E1 is the critical site for E1-E2 heterodimer formation; Cys295 in E2 is 
essential for not only E1-E2 heterodimerization but also for E2 homodimer formation 
The given HA-tagged E1 wt or cysteine lacking mutants were co-transfected with AU1-tagged E2 or E2 
mutant (C295S) into RK-13 cells, and expression products were analysed via Western blot on the following 
day. The cells were lysed with lysis buffer (-β-ME), then the samples were loaded onto SDS gels and 
separated electrophoretically. Western blot analysis was carried out using primary antibody α-AU1 and 
secondary antibody anti-rabbit-PO for the detection of protein. The table above of the gel provides the 
composition of the samples. 
 
5.5.4 E1-E2 heterodimer formation is independent of the transmembrane 
region of E1 
We showed that there is a dynamic membrane topology change of the transmembrane region of 
E1 after signal sequence cleavage with a relocation of the E1 C-terminus from ER to the 
cytosolic side. This is also true for E2 of pestiviruses (Radtke and Tews, 2017) and the closely 
related HCV envelope proteins (Cocquerel et al., 2002). It is supposed to be linked to 
multifunctionality of the membrane anchor, like E1-E2 heterodimer formation and ER retention 
in HCV. To determine whether the TM domain of E1 affects the described E1-E2 
heterodimerization (Thiel et al., 1991), in this section, several C-terminally truncated E1 







Figure 5.23 Heterodimer formation analysis 
(A) Schematic representation of E1 wild type and truncated E1constructs used in this section. Cysteine 
residues Cys123 and Cys171 are presented as white lanes in the green bar presenting the proteins. 
(B) The given C-terminally truncated E1 expression plasmids were co-transfected with E2 wt into RK-13 









































































































































were lysed with lysis buffer (without β-ME, under non-reducing conditions), then the samples were loaded 
onto SDS-PAGE gels and separated electrophoretically. Western blot analysis was carried out using α-E2 
(WB214) for the detection of E1-E2 heterodimer and E2 monomer/homodimer. Lane numbers refer to 
construct numbers shown above. 
As shown in Fig 5.23, wild type E1 formed predominantly E1-E2 heterodimer in the presence 
of wild type E2 (Fig 5.23B, lane 1), whereas E2 formed large amount of E2 homodimer in the 
absence of E1 (lanes 2 and 3). Cys295Ser substitution in E2 can prevent E2 homodimer 
formation. Those three samples in lanes 1, 2 and 3 served as the positive control for the E1-E2 
heterodimerization analysis. Different truncated variants of E1 were first analysed in this study 
together with E2. Western blot result of lane 4-7 in Fig 5.23B showed that all the C-terminally 
truncated E1 still formed E1-E2 heterodimer in the presence of wild type E2. This is even also 
true for the construct in which the entire TM domain was deleted construct (lane 7). But the 
amount of heterodimer was dramatically reduced indicating that E1 C-terminus with the 
membrane anchor plays an important role in heterodimer formation. Next, we examined the 
effect of the replacement of TM domain of E1 for heterodimerization. Four representative 
constructs in which the TM domain of E1 was fully or partially replaced by that of VSV-g, 
furthermore were established. Those constructs were all shown before to be presented on the 
cell surface. Interestingly, even when the TM region of E1 was fully or partially exchanged by 
the corresponding sequence of VSV-g (shown in Fig 5.12), E1-E2 heterodimer could be 
detected (lane 8-11) but again only low amounts. It seems that the TM domain of E1 is 
dispensable for the dimerization but renders it much more efficient. The E1 ectodomain (1-166) 
was shown to be able to form E1-E2 heterodimer (lane 12), however, when a Cys123Ser 
mutation was introduced into this expression construct, only monomer and homodimer of E2 
could be detected. Notably, this is also a further prove for our previous conclusion that Cys123, 
not Cys171, is important for the heterodimer formation of E1-E2. 
 
5.5.5 E1 overrules the retention of E2 via intermolecular disulphide bond 
formation 
The initial work in our lab demonstrated that the arginine at position 355 in E2 has a big effect 
on the retention of E2. Several substitutions of R355 like R355A, R355K, R355E and R355Δ 
could had different effects on the cell surface presence of E2. Furthermore, published data also 
showed that co-expression of E1 can compensate for the reduced retention of some E2 mutants 
(Radtke and Tews, 2017). However, the retention deficit of E2 mutants E2 R355A and E2 
R355Δ could not be compensated by E1. As already mentioned, R355 is important for the 
interaction of E2 and E1. Ronecker (Ronecker et al., 2008) showed that the E2 R355A mutation 
prevents generation of E1-E2 heterodimers. The exchange E2 R355K, however, had no 
influence on the formation of the E1-E2 heterodimers. These results suggest that 
heterodimerization between E1 and E2 could be essential to compensate for the reduced E2 
retention. Moreover, the natural pestivirus isolate BVDV NewYork'93 (Meyer et al., 2002) 
contains a R355K substitution indicating that this mutation at position 355 is tolerable for the 
virus.  
To investigate the mechanism of this interesting phenomenon, two representative E2 retention 
deficit mutants pCR-78 (E2 R355K) and pCR-79 (E2 R355Δ) were used in this study. First of 
all, we tested the cellular colocalization of wild type E1 with E2 or E2 mutants. The HA-tagged 
E1 expression plasmid was co-transfected with plasmids coding for E2 or E2 mutants into 
BHK-21 cells. On the following day, the cells were fixed with 4% PFA and permeabilized with 
0.05% Triton-X100. Staining was done with HA-tag antibody plus anti-rabbit label and BVDV 
E2 mAb Mix plus anti-mouse label. As shown in Fig 5.20A, E1 wt showed a good intracellular 




colocalization with E2 wt without any cell surface localization (Fig 5.24A.a). When the E2 
R355Δ mutant was co-expressed with E1 wt, E1 and E2 showed a totally different cellular 
localization. Most of E2 R355Δ presents on the cell surface whereas E1 is still retained within 
the cell (Fig 5.24A.b). Interestingly, when R355 in E2 was replaced by lysine (R355K), E1 
compensated the reduced E2 retention showing retention behaviour similar to E2 wt (Fig 
5.24A.c). These results agree with the preliminary conclusions from our lab (Radtke and Tews, 
2017). Then we examined those two E2 mutants for their ability to form heterodimers with E1 
wt. Electrophoretic separation of the proteins under non-reducing conditions (followed by 
Western blot) was carried out. As shown in Fig 5.24B, E2 containing mutation R355K still can 
form E1-E2 heterodimers like E2 wt, however, when the arginine at position 355 in E2 was 
deleted, E1-E2 heterodimer can’t be detected at all. Moreover, also the E2 homodimer was not 
detectable (lane 1, 2 and 3). To prevent the covalent linkage between E1 and E2 mutant R355K, 
the E1 mutant haboring C123S/C171S was used. When the covalent disulphide linkage between 
E1 and E2 was hampered (Fig 5.24B, lane 6), E1 lost the ability to compensate for the reduced 
E2 retention, leading to E2 present on the cell surface like the R355Δ mutant (Fig 5.24A.g). 
This data indicated that E1-E2 heterodimer formation is essential for the ability of E1 to 
compensate for the retention deficit of the E2 mutant.  
Furthermore, the representative construct pYM-56 (HA tagged E1ecto + VSV-g TMD), which 
results in the cell surface presence of E1 was also tested in this study. Since E2 wild type 
contains a retention signal of its own, we wanted to know whether E2 still can keep a E1 
retention deficient mutant within the cell. For this purpose, pCR-16 coding for AU1 tagged 
BVDV CP7 E2 was co-expressed with pYM-56 in BHK-21 cells. Surprisingly, both the E1 
retention deficient mutant and E2 were present on the cell surface (as shown in Fig 5.24A.e 
and f). This indicates that E1, somehow, can overrule the retention signal of E2. Western blot 
results (Fig 5.24B, lane 4) showed that the E1 retention deficient mutant still form heterodimer 
with E2. However, when C295S was introduced into E2 for interrupting the covalent linkage 
between E1 and E2 (Fig 5.24B, lane 5), E2 can’t follow the E1 mutant to go to the cell surface, 
but seems colocalized with E1 in Golgi apparatus. These results clearly demonstrated that E1 
can overrule the retention of E2 when covalently disulphide linked E1 with E2, and it also 
suggested that E1 has a more dominant role in subcellular localization than E2. 
As shown in Fig 5.24A.h, the pYM-53 construct which is code for HA-tagged E1 contains six 
mutations in its transmembrane region that results in the cell surface presence of E1 can overrule 
the retention single of E2 wt. Additionally, the E1-VSVg chimera plasmids which showed the 
cell surface expression (like pYM-71, pYM-72 and pYM-75) were also tested in this section. 
All of them make E2 wt follow them to go to the cell surface, furthermore, the E1-E2 
heterodimerization still exist between those E1 variants and E2 wt (data not shown). This 
finding further proved the importance of E1-E2 heterodimer formation in the ability of E1 to 
compensate for the retention deficit of the E2 mutant. 
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Figure 5.24 E1 overrules the retention signal of E2 via intermolecular disulphide bond between E1 
and E2 
(A) Co-localization analysis of E1 (or variants) and E2 (or variants) via confocal microscopy. BHK-21 cells 
were transfected with the appropriate expression plasmids and fixed with 4% PFA on the following day. All 
the cell membranes were permeabilized with 0.05% Triton-X100 (d, f and h samples were not 
permeabilized). E1: α-HA, α-mouse Alexa-Fluor-488;  
(B) Western blot analysis for E1-E2 heterodimer formation of corresponding plasmid. α-E2 WB 214, α-
mouse PO. 
 
5.5.6 Both Cys123 in E1 and Cys295 in E2 are important for viral infectivity 
Mutation analysis which has an influence on the E1-E2 heterodimerization were identified. In 
order to find out whether substitution of these residues interferes with the formation of 
infectious virus particles, selected mutations were introduced into the infectious clone for 
BVDV CP7 (clone p798). 
In this section, the mutations C171S and C123S in E1 as well as C295S in E2 were introduced 
into BVDV CP7 full-length infectious clone 798 using common cloning techniques. Plasmid 
798 contains the cDNA of the entire BVDV CP7 genome. Using T7 RNA polymerase 
transcription, viral genome like RNAs can be generated. These RNAs were used for 
electroporation (EP) of MDBK-B2 cells as described in section 4.3.4. Each sample was 
electroporated into two 30mm dishes, one for the duplicate. 24h after electroporation, the cells 
in one dish of each sample were tested for viral protein using indirect immunofluorescence. The 
viral protein NS3 was detected by the primary antibody Code4 which is the monoclonal 
antibody for pestivirus NS3 protein. After staining with anti-mouse FITC, samples were further 
checked with normal immuno-fluorescence microscopy. 
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Figure 5.25 Indirect immunofluorescence analysis after electroporation  
MDBK-B2 cells were first transfected by electroporation with the RNAs transcribed from the given plasmids. 
One day after EP, the cells were fixed with 4% PFA and permeabilized with 0.05% Triton X-100. The viral 
protein NS3 was detected with the primary antibody Code4 and α-mouse FITC. 
 
As shown in Fig 5.25, for the positive control, nearly all the 798 electroporated cells were 
positive ensuring that the RNAs obtained from the in-vitro transcription. For the mutants, much 
lower number of positive cells were detected, indicating that the mutated RNA was functional 
as a replicon, though with decreased fitness. Two days after EP, the electroporated cells were 
splitted into a new 30 mm dishes to check whether the signal increased via virus spread. In 
addition, the supernatant from the electroporated cells was used for re-infection to determine 
whether newly generated viral particles were capable of infectious new cells. Both cells from 
the newly splitted plates and supernatant infected cells were checked again for the presence of 
NS3 by indirect immunofluorescence. Moreover, the samples were checked two days after split 
and SN infection for CPE. 
Figure 5.26 CPE observation after electroporation 





Figure 5.27 Indirect immunofluorescence analysis reinfection after electroporation 
(A) Splitted cultivation after electroporation. The cells were fixed with 4% PFA and permeabilized with 
0.05% Triton X-100. The viral protein NS3 was detected with the primary antibody Code4 and α-mouse 
FITC. 
(B) Supernatant re-infection after electroporation. The treatment is same to (A). 
 
As shown in Fig 5.26 and Fig 5.27, only 798-E1 C171S induced typical CPE in both splitted 
and SN infection dishes. After the RNA isolation and RT-PCR, the sequencing results confirmed 
that those recovered viruses were still carrying their corresponding substitution, no reversion 
arise. Interestingly, 798-E1 C123S and 798-E2 C295S were lost with the cell passage and could 
not be further enriched. These results demonstrated that BVDV CP7 798 infectious clones 
containing C123S in E1 or C295S in E2 can’t generate infectious particles. These finding 
further clarified that those two Cysteine residues in E1 and E2 are critical for viral infectivity. 
It is worth noting that all the cells are positive in 798-E1 C171S splitted plate two days after 
splitted cultivation. However, if we use SN from 798-E1 C171S electroporated cells for the 
infection, two days later, only several viral plaques could be observed. This indicated that the 
infectivity of 798 containing the mutation C171S in E1 was also reduced. Nevertheless, the 
C171S mutation was stable in the recovered viruses for at least 3 generations.  
A 
B 




5.6 The middle hydrophobic region (MHR) affects the secretion of E1 
5.6.1 E1 is retained within the cell in the absence of the carboxyterminal 
membrane anchor 
The hydrophobic region at the C-terminus of E1 was shown to be responsible for the ER 
retention. It is also supposed to be critical for membrane anchoring of E1, but the detailed 
knowledge which amino acids are in contact with the lipid bilayer remained unclear. It was 
suggested in a publication that the membrane anchor of pestiviral E1 harbors three helices 
including one perimembrane helix (pmH) and two transmembrane helices (tmH 1 and 2). This 
suggestion was based entirely on computational secondary structure prediction (sequences and 
corresponding helical wheel shown in Fig 5.28). 
Figure 5.28 The sequence and helical wheel modeling of the putative membrane anchor of E1 
(A) Hydrophobic region organization in E1. The conserved hydrophobic regions in E1 of pestiviruses. The 
data for hydrophobic moment <μH> and hydrophobicity <H> were all from the heliquest 
(http://heliquest.ipmc.cnrs.fr/).  
(B) Helical wheel plots for the corresponding sequences shown in (A) which were generated by heliquest 
application. The arrow in the plots directs toward the hydrophobic face and the length of it corresponds to 
the hydrophobic moment <μH>. 
 
The topology data presented above already demonstrated that it is highly unlikely that TmH 1 
and TmH 2 represent two transmembrane domains, since the carboxylterminus is located on the 
cytoplasmic side. To determine experimentally which part of the E1 C-terminus served as 
membrane anchor, a series of C-terminally truncated E1 variants were generated (Fig 5.29A). 
The plasmids were expressed in BHK-21 cells by using the Vaccinia MVA T7 expression system 
and the newly synthesized proteins were labelled with 35S amino acids. The supernatant (SN) 
and cell lysates (CL) of the transfected cells were harvested, from which proteins reacting with 
specific antibodies directed against the HA-tag were precipitated. The samples were then 
separated by SDS-PAGE and the labeled proteins were detected on imaging plates. All the 
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As shown in Fig 5.29B, we could see no secretion at all for wild type E1. Additionally, the 
deletion of neither tmH 1 (E1 [166-178Δ]) nor tmH 2 (E1 [1-178]) resulted in the secretion of 
E1 indicating that neither of these two sequences alone is responsible for membrane binding of 
E1. Surprisingly, when the putative transmembrane region was completely removed (E1 [1-
165/166]), only about 1% of E1 was secreted. Even when all the hydrophobic sequences located 
in the C-terminal region of E1 was deleted (E1 [1-143]), most of E1 is still found in the cell 
extract. Only approximately 5% could be detected in the supernatant. These data indicated that 
in the absence of the proposed membrane anchor, E1 somehow still was retained within the cell. 
Figure 5.29 The secretion/retention analysis of E1/truncated E1 variants 
(A) Schematic representation of wild type and truncated E1constructs used in this section. 
(B) The immunoprecipitation results of different E1 constructs. The corresponding plasmids were expressed 
in BHK-21 cells by using Vaccinia virus MVA T7 expression system. Expressed proteins were labelled with 
35S radioactively. The supernatant (SN) and cell lysates (CL) of the transfected cells were produced, from 
which proteins reacting with a specific anti-serum directed against the HA tag were precipitated. The samples 
were pre-treated with PNGase, then separated using SDS-PAGE under reducing conditions and the labeled 






































































































(C) Quantification of the secretion/retention rate for the E1/truncated E1 variants. The radioactivity of 
secretion (S) and cell proteins (C) was determined by Aida Image Analyzer 5.0. The relative percentage of 
each component was calculated with entire protein (S+C) added up to 100%. Results determined from 3 
independent experiments are calculated as mean ± SD. 
 
To determine the subcellular localization of those truncated E1 mutants, three representative E1 
truncated constructs were further analysed by confocal microscopy. Briefly, the ER was 
fluorescently labeled by pDsRed-ER, which was transiently co-expressed with HA tagged E1. 
Similarly, the pDsRed-Golgi plasmid was used for Golgi-apparatus labeling. The results were 
analysed on a confocal fluorescence microscope. 





Figure 5.30 Subcellular localization of C-terminally truncated E1 variants 
HA-tagged E1 with different length of C-terminal truncations (E1 [1-178], E1 [1-165] and E1 [1-145]) were 
co-expressed with pDsRed-ER/pDsRed-Golgi, respectively, for intracellular localization analysis. At 24h 
post-transfection, cells were fixed by 4% PFA permeabilized with 0.05% Triton X-100 and stained with 
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As shown in Fig 5.30, those C-terminally truncated E1 mutants present mainly ER localization. 
Even the longest deletion version (E1 [1-145]) was still predominantly found in the ER, while 
showing no localization in the Golgi compartment. This result also indicated that the 
ectodomain of E1, for some reason, was still retained in the ER preventing strong secretion E1. 
 
5.6.2 The middle hydrophobic region (MHR) affects the secretion of E1 
Since there is a strong indication that there should be segment(s) in the ectodomain of E1 
preventing strong secretion E1, we wanted to further investigate the hydrophobic region located 
in the middle part of E1 (h1, shown in Fig 5.2). By using bioinformatic prediction web 
application (TMHMM Server v. 2.0, http://www.cbs.dtu.dk/services/TMHMM/), we made a 
prediction of transmembrane helices in pestiviral glycoprotein E1. As shown in Fig 5.31A, the 
prediction suggested that the MHR 1 (54-67) and MHR 2 (70-83) (sequences and corresponding 
helical wheel shown in Fig 5.31B and C) probably form transmembrane helices, and thus could 
be the additional membrane binding region for E1. These structures could be involved in 
preventing secretion of the E1 ectodomain. To determine whether the middle hydrophobic 
region (MHR) of E1 affect the secretion of E1, a series of C-terminally truncated E1 variants 
in addition to MHR2 (70-83) deletion were generated in this section (shown in Fig 5.31D). The 
expression plasmids were expressed in BHK-21 cells by using Vaccinia MVA T7 expression 
system and the newly synthesized proteins were labelled with 35S amino acids. The supernatant 
(SN) and cell lysates (CL) of the transfected cells were harvested, and proteins reacting with 
specific antibodies directed against HA tag were precipitated. The samples were then separated 
by SDS-PAGE and the labeled proteins were detected on imaging plates. All the samples were 
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Figure 5.31 Secretion/retention analysis for the C-terminally truncated E1 MHR 2 deletion variants 
(A) The prediction result of transmembrane helices in pestiviral E1 glycoprotein. Red line: Transmembrane 
helix preference. (THM index); Blue line: Beta preference. (BET index); Gray line: Modified hydrophobic 
moment index. (INDA index); Violet boxes (below abscisa): Predicted transmembrane helix position. (DIG 
index) 
(B) Helical wheel plots for the corresponding sequences shown in (C) which were generated by heliquest 
application. The arrow in the plots directs toward the hydrophobic face and the length of it corresponds to 
the hydrophobic moment <μH>. 
(C) Hydrophobic region organization in the ectodomain of E1. The conserved hydrophobic regions in E1 of 
pestiviruses. The data for hydrophobic moment <μH> and hydrophobicity <H> were all from the heliquest 
(http://heliquest.ipmc.cnrs.fr/). 
(D) Schematic representation of wild type and truncated E1constructs used in this section. Middle 
hydrophobic region (MHR) presented in red box; Deletion sequence presented in light pink box. 
(E) The immunoprecipitation results of different E1 constructs. The corresponding plasmids were expressed 
in BHK-21 cells by using Vaccinia virus MVA T7 expression system, and 35S radioactively labelled in situ. 
The supernatant (SN) and cell lysates (CL) of the transfected cells were produced, from which proteins 
reacting with specific antibody direct against HA tag were precipitated. The samples were then separated 
using SDS-PAGE under reducing condition and the labeled proteins were detected on imaging plates. 
(F) Quantification of the secretion/retention rate for the E1/truncated E1 variants. The radioactivity of 
secretion (S) and cell lysates (C) bands was determined by AIDA Image Analyzer 5.0. The relative percentage 
of each component was calculated with entire protein (S+C) added up to 100%. Results determined from 3 
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As shown in Fig 5.31E and F, the deletion of MHR 2 alone had no effect on the retention of 
E1. Similarly, the construct which combines deletion of MHR 2 and deletion of the C-terminal 
17aa presented 100% intracellular retention. Interestingly, the MHR 2 deletion construct with 
32aa truncated from the C-terminus demonstrated about 20% secretion. Compared to the same 
truncated version which still contains MHR 2 (~ 1% secretion, shown in Fig 5.30E and F), the 
additional MHR 2 deletion results in significantly higher secretion (1% versus 20% 
respectively). Moreover, when the C-terminal truncated sequence was increased to 52aa, the 
MHR 2 deleted E1 showed about 55% secretion. The results showed that the hydrophobic 
sequence in the middle part of E1 partially prevents the secretion of the C-terminally truncated 
E1 proteins, indicating this region could be membrane associated. The upper additional bands 
of both SN and CL on the imaging plates are incompletely deglycosylated E1 or E1 variants. 
To further investigate the effect of this part of E1, a series of entire MHR deletion constructs 
were generated. As shown in Fig 5.32 B and C, only removed of MHR alone can’t lead to the 
release of E1. Moreover, this is also true for the entire MHR deletion combined with the 17aa 
truncation from the C-terminus. In contrast, both the C-terminal 32aa and 52aa deletions 
combined with whole MHR deletion constructs presented a clear secretion. Especially the latter, 
showed that nearly 88% of the proteins lost the intracellular retention. Since the deglycosylation 
via PNGase treatment sometime is incomplete, some upper additional bands of both SN and CL 
on the imaging plates are visible. 
Figure 5.32 Secretion/retention analysis for the C-terminal truncated E1 entire MHR deletion 
variants 
(A) Schematic representation of E1/truncated E1constructs used in this section. Middle hydrophobic region 
(MHR) presented in red box; Deletion sequence presented in light pink box. 
(B) The immunoprecipitation results of different E1constructs. The corresponding plasmids were expressed 
in BHK-21 cells by using Vaccinia MVA T7 expression system, and 35S radioactively labeled. The supernatant 
(SN) and cell lysates (CL) of the transfected cells were produced, from which proteins reacting with specific 
antibody direct against HA tag were precipitated. The samples were then separated using SDS-PAGE under 
reducing condition and the labeled proteins were detected on imaging plates. 
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(C) Quantification of the secretion/retention rate for the E1/truncated E1 variants. The radioactivity of 
secretion (S) and cell lysates (C) bands was determined by phosphorimager analysis software AIDA Image 
Analyzer 5.0. The relative percentage of each component was calculated with entire protein (S+C) added up 
to 100%. Results determined from 3 times independent experiments are calculated as mean ± SD. 
Taken together, in this section, we provide a new view for the role of the hydrophobic region in 
the ectodomain of E1 in the morphogenesis of pestiviral envelope protein. There is a strong 
indication that pestiviral E1 is not readily secreted, even without the C-terminal membrane 
anchor, it still can be retained within cell, probably membrane associated. The data 
demonstrated that the MHR sequence is beneficial for the intracellular retention. Accordingly, 
we concluded that the hydrophobic sequence (53-83) in the middle part of E1 affect the 
secretion and intracellular retention of E1 probably by membrane binding. 
 




Chapter 6: Discussions 
The present study mainly focused on molecular characterization of the glycoprotein E1 of 
pestiviruses with a special emphasis on investigations with regard to its intracellular localization, 
retention signal and membrane topology in order to gain an initial insight into the molecular 
features that play a role in its engagement in virus assembly, budding and oligomerization of 
envelope proteins. In addition, we also tested E1 mutants with regard to their influence on 
infectious virus recovery. 
 
6.1. The organization of domains in pestiviral E1 
The E1 envelope protein of pestiviruses contains approximately 195 aa, which is only half the 
size of E2 (374 aa, BVDV CP7 as an example). There are nearly 40% hydrophobic residues in 
E1 indicating that E1 harbors several hydrophobic regions which are supposed to be functional 
in the viral life cycle. E2 has been already shown to be a type I transmembrane protein with a 
large ectodomian at the N-terminus residing in the ER lumen and a hydrophobic C-terminus 
achoring the protein in the ER membrane (Radtke and Tews, 2017). In this study, we showed 
that E1 adopts the same basic membrane topology. The alignment of multiple E1 sequences 
throughout all genotypes of pestiviruses (from A to K) combined with several bioinformatic 
predictions revealed the presence of some hydrophobic regions including the hydrophobic 
region in the middle (MHD, 54-83), a proposed perimembrane helix (pmH, 144-161) and the 
putative transmembrane region (TMD, 166-195) (as shown in Fig 6.1). According to the 
secondary structure prediction (5.1.3.1), MHD consists of two α-helices which are MHR 1 (53-
67) and MHR 2 (70-83). Based on the conclusion from the published paper (Wang et al., 2014) 
and the prediction of JPred4, there are three α-helices located at the C-terminus of E1 which 
corresponding to the h3 and h4 region in the Kyte & Doolittle hydropathy plot in Fig 5.2. The 
perimembrane helix (pmH), which locates upstream of the putative transmembrane region, 
forms an ideal amphipathic helix (Fig 5.28B). The hydrophobic face of this helix is supposed 
to be the ‘V, I, A, V, L, V, W, L, I’ peptide. The putative transmembrane region (TMD, 166-195) 
actually is divided into two parts corresponding to the two peaks in h4 region in Fig 5.2, the 
first part is considered to be the membrane anchor of E1 whereas the second is thought to serve 
as a signal sequence for the translocation of the following E2. In our study, we showed that 
TMD is also responsible for the retention of E1. 
Pestiviral E1 contains six cysteine residues, the first four located in the N-terminal or middle 
part most likely form intramolecular disulfide bonds, since they do not have any effect on both 
E1 oligomerization and E1-E2 heterodimerization when exchanged. The last two could form 
intermolecular disulfide bonds (shown in Fig 5.20 and 5.21). In all genotypes, pestiviral E1 
possesses two conserved potentional N-linked glycosylation sites. In the N-terminal part of E1, 
one extra glycosylation site (N6) is CSFV/BDV-specific (as shown in Fig 6.1). The molecluar 
weight of mature E1 in those two species indicates that this site is also used for glycosylation 
(Risatti et al., 2007b). The glycosylation sites of E1 distribute at the N-terminus or middle part. 
All of them are used, indicating that this part of the protein is most likely exposed on the surface 
of E1 after correct folding. In our study, we showed that different glycan types are present at 
N19 and N100, which might be due to the interference from two neighbour cysteine residues 
(C20 and C24) to the N19 glycosylation site. It is known that the glycosylation of proteins is 




closely related to the correct folding and biological activities. We also found that E1 variants 
lacking glycosylation site(s) still can form oligomers as well as E1-E2 heterodimers when co-
expressed with E2 (data not shown). For HCV, mutations at N196 or N305 in E1 have strong 
effects on the E1-E2 heterodimer formation (Meunier et al., 1999). In CSFV, individual N-
linked glycosylation sites in E1 are not essential for viral particle formation or virus infectivity. 
However, in the context of two or more putative glycosylation site modifications, residue N100 
is critical for virus viability (Fernandez-Sainz et al., 2009).  
Figure 6.1 Schematic representation of pestiviral E1 envelope protein 
Two N-glycosylation sites (N19 and N100) are conserved in all genotypes and one CSFV/BDV-specific site 
(N6) is labeled as light blue rhombus, and cysteine residues are marked with a pink ball (conserved cysteine 
residues with solid and non-conserved cysteine residues with dash line, respectively). MHR (hydrophobic 
region in the middle): 54-83, pmH (perimembrane helices): 144-161, TMD (transmembrane domain):166-
195. Main hydrophobic regions are marked with red boxes. Sequence logos were generated based on 68 
pestivirus E1 sequence throughout 11 ITCV-classified species (from pestivirus A to K) using WebLogo.  
 
6.2 The retention of pestiviral E1 glycoprotein 
Viruses have to take advantage of the protein biosynthesis machinery of the host cells for their 
own protein synthesis and processing via the conventional protein modification and trafficking 
pathway. It means that proteins translocated into the ER after the co- or post-translational 
modification, are generally delivered to their destination via the secretory route or remain within 
defined intracellular compartment(s) when they contain a respective localization signal. 
Pestiviral E1 shows no secretion as well as no expression on the cell surface indicating that E1 
has to accumulate at specific intracellular site(s) before viral budding. In our study, we showed 
that E1 is mainly concentrated in the ER regardless whether other viral proteins are present or 
not. For the other two pestiviral envelope proteins, it was shown that both Erns and E2 also 
localize in the ER (Burrack et al., 2012; Grummer et al., 2001; Köhl et al., 2004; Radtke and 
Tews, 2017). In addition, ultrastructural study of pestivirus Giraffe-1 using electron microscopy 
also showed that ER is the initial cellular organelle for pestivirus assembly and viral budding 
(Schmeiser et al., 2014). These data strongly indicate that pestiviruses most likely bud at the 
ER site, so that the envelope is derived from the host ER membrane. Other viruses bud through 
the plasma membrane whereas several enveloped viruses also bud at intracellular organelle 



































6 7 8 19 20 21 100 101 102
pmH
144 161




compartment (ERGIC) (e.g. coronaviruses and poxviruses) and the Golgi apparatus (e.g. 
bunyavirus) (Cocquerel et al., 1998; Griffiths G, 1992). 
It is confirmed that Erns and E2 contain retention signals of their own (Burrack et al., 2012; 
Radtke and Tews, 2017). Additionally, E2 can form covalently linked heterodimers with E1. It 
was therefore supposed that the ER retention signal of E2 could be sufficient to retain E1-E2 
complexes within the ER (Cocquerel et al., 1998; Radtke and Tews, 2017). In our study, we 
showed that there is also an ER retention signal present in the transmembrane region of the 
pestiviral E1 glycoprotein. So this raises the question - why the E1-E2 envelope protein 
complexes of pestiviruses have two signals for ER retention? One reason could be that it takes 
time for E1 and E2 to form a complex. Thus, both proteins should have a signal ensuring 
accumulation at the same location to allow heterodimer formation.  
The retention signals of both E1 and E2 are located in the TM domains. The TMDs of both 
envelope proteins are multifunctional. In addition to ER retention, they also ensure the 
membrane anchoring, serve as signal sequences for the protein downstream, and probably are 
involved in E1-E2 interactions. The TM regions of the envelope proteins of the members of 
Flaviviridae usually are composed of two hydrophobic sections separated by a short segment 
containing at least one fully conserved positively charged residue (as shown in Fig 6.2 A and 
B) (Cocquerel et al., 1999; Cocquerel et al., 1998; Cocquerel et al., 2000a).  
Figure 6.2 Comparison of putative TMD sequences of envelope proteins in the family Flaviviridae 
(A) The sequence logo of the TM domain of pestiviral E1 was generated by WebLogo 3 web application 
(http://weblogo.threeplusone.com/create.cgi) demonstrates the alignment results of 68 pestivirus E1 
sequences throughout all pestiviral species in one letter code. The size of the letters in the sequence logo 
corresponds to the degree of conservation over the 68 sequences (from pestivirus A to K). The fully 
conserved residues are highlighted with red stars. Two stretches of hydrophobic regions are shown 
below as pink helix. Polar charged residues in blue, polar non-charged residues in green. 
(B) C-terminal transmembrane sequences of the envelope proteins (E2 for BVDV, E for others) of 
different members of the family Flaviviridae. The sequences that were predicted to form hydrophobic 





















α-helices are shown in red colour. Fully conserved positively charged residues are highlight with green 
stars. The corresponding GenBank accession numbers are also shown besides the virus name. 
 
Sequence analysis of putative TMD sequences of envelope proteins in the family Flaviviridae 
revealed a quite similar organization for the representative members in this viral family (as 
shown in Fig 6.2B). The presence of at least one conserved positively charged residue was 
observed in a short linking segment connecting the two hydrophobic stretches. Publications 
showed that those conserved positively charged residues play an essential role in retention and 
heterodimerization of glycoproteins as well as assembly of the viral particle (Cocquerel et al., 
2000a). In our study, we found that two fully conserved positively charged residues (K174 and 
R177) located in the middle segment have nearly no effect on E1 retention and on E1-E2 
heterodimer formation (Fig 5.14 and data not shown). This finding indicates that pestiviral E1 
may adopt another different retention mechanism from other envelope proteins of family 
Flaviviridae. As shown in Fig 6.2B, compared to BVDV E2 or other envelope proteins of the 
members of family Flaviviridae, four fully conserved, but non-charged polar residues are found 
in the middle part of the E1 TM domain in addition to K174 and R177. We consider that since 
those polar residues are present in the connecting region, their concomitant mutation might also 
be required to alter the retention status of E1. In our study, surprisingly, only mutation of all the 
six fully conserved polar residues to Alanines could result in the presence of E1 on the cell 
surface (Fig 5.14 and 5.15). However, when those six fully conserved polar residues were 
replaced by Leucines, the retention signal of E1 was not affected (data not shown). It is possible 
that this newly made transmembrane region is too artificial to allow correct folding of E1. Due 
to the ‘check mechanism’ of the ER this misfolded E1 can still not leave the ER. According to 
the so-called “lipid-based” rule (Bretscher and Munro, 1993), membrane thickness could also 
play a role in the ER retention mediated by the TMD of E1. The lengths of the transmembrane 
regions of membrane proteins are strongly associated with their intracellular location in 
different organelles along the secretory pathways (Sharpe et al., 2010; Singh and Mittal, 2016). 
The artificial transmembrane anchor which is composed of ‘pure leucine residues’ might form 
a longer straight α-helix so that E1 changes its intracellular location, but still is located within 
the cell.  
In our study, we tried a series of single/double/multiple mutations or deletions in the 
transmembrane region of E1. All the data indicated that the retention signal of E1, unlike that 
of E2, is super complex and stable. We consider that those six conserved polar residues in the 
TM region of E1 could serve as a functional group in the retention behaviour, that makes the 
retention of E1 resistant against changes. Moreover, introducing a diacidic ‘DXE’ export signal 
from the VSV-G cytoplasmic tail to the C-terminus of the E1 TM domain did not result in the 
presence of E1 on the cell surface. This finding suggested that the ER retention signal present 
in the E1 TM domain is dominant over the diacidic export signal, and thus proved the stability 
and strength of the retention signal of E1 (data not shown). 
Interestingly, we found that E1 can overrule the retention signal of E2 when covalently linked 
to E2. In other words, the subcellular localization of E2 largely depends on that of E1 when the 
covalent linkage exists. In contrast, E2 is not able to overrule E1 in the covalently linked E1-
E2 heterodimer. It could be supposed that E1 is the superior for the retention of E2. Only a 
single mutation at R355 or Q370 can suppress the retention of E2 (Kohl et al., 2004; Radtke 
and Tews, 2017), making E2 retention vulnerable to mutations. One could consider that 
pestiviruses use the complex and stable retention signal of E1 as a ‘error correction’ mechanism, 
ensuring that E2 still can be processed in the ER as usual when some unpredictable mutations 




occur. A similar phenomenon was reported between pre-membrane (prME) and envelope (E) 
of YFV (yellow fever virus) (Ciczora et al., 2010). 
Both glycoproteins E1 and E2 of pestiviruses were identified to be type I transmembrane 
proteins retained in the ER. Cellular type I transmembrane proteins located in the ER often 
contain a dilysine motif (e.g. -KKXX, and -KXKXX) in the cytosolic C-terminus (Munro and 
Pelham, 1987), while luminal ER proteins often have a KDEL sequence (Shin et al., 1991). The 
ER retention signals, in principle, can be divided into two types. One can make proteins resident 
in the ER at steady condition without cycling between the ER and the Golgi apparatus. HCV 
E1 and E2 contain this kind of retention signal (Cocquerel et al., 1999; Cocquerel et al., 1998; 
Cocquerel et al., 2000b; Duvet, 1998). The other is a so-called retrieval signal, which can return 
the target proteins from the Golgi complex to the ER via COPI vesicles. The retention signals 
in both E1 and E2 of pestiviruses most likely belong to the former. ‘KDEL’ as a retrieval signal 
returns the cargo from the Golgi to the ER via a well-characterized specific receptor (Capitani 
and Sallese, 2009; Jia et al., 2020; Jin et al., 2017; Yamamoto et al., 2001). As many viral 
envelope proteins, the pestiviral glycoproteins do not contain one of these known retention 
signals. Thus, the retention mechanism of pestiviral envelope proteins is still not clear at the 
molecular level. 
It is worth noting that different cellular retention mechanisms in flaviviruses were reported. 
Yellow fever virus (YFV), another member of the genus Flavivirus, also contains retention 
signals in both pre-membrane (prM) and envelope (E) protein. The mechanism of ER retention 
of YFV mainly relies on the length of the transmembrane stretches (Ciczora et al., 2010). 
However, for HCV, the retention mechanisms primarily depends on the polar charged residues 
in the middle part of TM domain. The same is true for pestivirus E2. In our study, we showed 
that 6 fully conserved polar residues affect the ER retention of E1, indicating this mechanism 
could be different from the above mentioned types. It is striking that transmembrane domains 
of members of the family Flavivirus as retention signals for their envelope proteins take 
advantages of at least three different types of ER retention mechanisms in their morphogenesis, 
the exact molecular mechanism for the retention behaviour of pestiviral envelope proteins still 
awaits further investigation.  
 
6.3 The membrane topology of the pestiviral E1 glycoprotein 
Pestiviral envelope proteins are synthesized as a polyprotein. The signal peptidase is 
responsible for the cleavage at the Erns/E1 and E1/E2 sites. Erns uses an amphipathic helix as its 
membrane anchor which is arranged in plane to the membrane surface making the Erns/E1 
cleavage site really unusual. It is known that the processing of internal signal sequences is 
essential for the membrane topology of downstream following polypeptides. Therefore, the 
membrane topology before/after the signal peptidase cleavage was analysed in this study. Some 
paper suggested that one peptide composed of 16 Leucines is sufficient to form an α-helix to 
go through the membrane. However, the TM region of integral membrane proteins normally 
contain stretches of 20 to 25 hydrophobic residues (Ulmschneider and Sansom, 2001; von 
Heijne, 1995). As shown in Fig 6.2, there are two hydrophobic stretches in the TM domain of 
pestiviral E1. Both are about 10aa long, so each hydrophobic region is too short to form a single 
transmembrane spanning α-helix. Since the length of each hydrophobic region at the C-terminus 
of E1 does not fit to single membrane-spanning topology, it indicated that they should adopt an 
extended structure to go through the membrane. In our study, we found that pestiviral E1, like 
E2, adopts a typical type I transmembrane topology after the signal peptidase cleavage 
(schematic models were shown in Fig 5.17 and 5.18). However, when the E1/E2 cleavage site 




was blocked, the TM domain of E1 forms a hairpin-like structure with the carboxyterminus 
exposed in the ER lumen (Fig 6.3 A). A dynamic change in the orientation of the C-terminus of 
E1 was also shown in HCV E1 and E2 (Cocquerel et al., 2002). A publication on HCV suggested 
that the extended ‘hairpin-like’ structure of the TM domain is thermodynamically not stable, 
since those exposed polar charged residues are not favourable in the hydrophilic membrane 
environment. (Cocquerel et al., 1998). After the reorientation of the C-terminus of the TM of 
E1 or E2 from the luminal side to the cytosol side, as a consequence, the C-terminus of those 
two envelope proteins are accessible from the cytosolic side, and thus form cytosolic tails. 
These regions could be functional in the interaction between the viral envelope proteins and the 
capsid/genome RNA complex to allow egress into the ER lumen by interacting with the cytosol 
tail with envelope proteins  (Mettenleiter et al., 2013) 
Figure 6.3 Schematic model of the reorientation behaviour of the TM domains of pestiviral envelope 
proteins during the early steps of their biogenesis 
(A) The signal peptidase (shown as black arrow) is responsible for the cleavage at the Erns/E1 and E1/E2 sites 
(shown as black dots). Before signal sequence cleavage between E1 and E2, the signal sequence present in 
the C-terminal half of the TM domain of E1 is oriented towards the ER lumen. As shown for the TM domain 
of E1, also the TM domain of E2 transiently adopts a hairpin structure to allow the translocation of the 
following proteins p7 and amino-terminus of NS2.  
(B) After signal peptidase cleavage, the signal sequences present in the C-terminal half of the TM domain of 
E1 or E2 are reoriented towards the cytosol, establishing a transmembrane configuration spanning the lipid 
bilayer. The other hydrophobic regions in E1 were also shown. 
 
As shown in Fig 6.3 A and B, the second half of the TM domain of E1, which is supposed to 
serve as a signal sequence for the downstream protein, remains linked to the C-terminus of E1 
after the signal peptidase cleavage being part of a TM domain. After cleavage of the E1/E2 
bond the C-terminus of E1 reorientates from the ER luminal side to the cytosol. The signal 
sequences at the second half of the C-terminus of E1 is supposed to contribute to several new 























functions. After the reorientation, those two extended hydrophobic stretches can serve as a 
stable membrane anchor as well as retention signal for the cellular localization of E1. E2 was 
shown to have a similar reorientation behaviour at its C-terminus. In HCV, reorientation of the 
E1 and E2 C-terminus was also shown (Cocquerel et al., 2002). It was suggested that the 
reorientated transmembrane regions of E1 and E2 are also essential for heterodimerization. 
According to the data we have, for pestiviruses, it seems that the transmembrane region of E1 
is also engaged in the formation of E1-E2 heterodimer (data shown in Fig 5.23). 
In our studies, we observed an interesting phenomenon: if the cleavage at the E1/E2 site was 
hampered in the Erns-E1-E2 precursor, the processing of the Erns/E1 site was also inhibited. The 
results indicate that there is a processing hierarchy in Erns-E1-E2 so that the Erns/E1 site can 
only be processed after the E1/E2 site (Mu et al, under revision). Earlier studies already revealed 
that the Erns-E1-E2 polyprotein is firstly cleaved into two parts: Erns-E1 precursor and E2. 
Afterwards, the former would be further processed into Erns and E1. It is known that signal 
peptidase (SPase) is responesible for the cleavage of the C/Erns, Erns/E1, E1/E2 and E2/p7 sites 
(Elbers et al., 1996; Rumenapf et al., 1993). SP cleavage is not dependent on a consensus 
sequence. Rather, substrate recogination relies on common structural characteristics. The signal 
peptide is about 20-30 amino acids long (but might be up to 80), with a typical tripartite 
structure: an n-region contains several basic amino acids, a hydrophobic h-region in the middle, 
and a slightly polar and rather unstructed c-region (von Heijne, 1990). Since Erns does not 
contain an α-helical transmembrane domain but uses an unique amphipathic helix as the C-
terminal membrane anchor, which is in plane to the membrane, the processing site of the Erns/E1 
site is quite unusual. An earlier study suggested that this special membrane anchor of Erns plays 
an important role in the delicate balance between secretion and membrane association of Erns 
(Tews and Meyers, 2007). The TM domain of E1 is supposed to be important for the cleavage 
at the Erns/E1 most likely because this region represents the membrane anchor for the Erns-E1 
precursor. Binding of the precursor to the membrane and ensuring ER retention via the E1 signal 
gives time for cleavage to occur. Moreover, we also got strong indication that the full-length 
E1 sequence downstream of the Erns/E1 cleavage site is important for efficient cleavage of 
Erns/E1. All in all, a series of data shows that E1 affects the processing at the Erns/E1 site by 
hooking the Erns/E1 precursor to the membrane to give time for establishing the membrane 
contact of the amphipathic helix of the Erns. Afterwards, E1 has to be folded properly to generate 
a cleavable structure at Erns/E1 site (Mu et al, under revision). 
In our study, we showed that before the cleavage at the E1/E2 site occurs, the C-terminus of E1 
formed a hairpin like structure. This could prevent folding of E1 and impair the membrane 
anchoring of Erns. This could be the reason why Erns-E1 precursors are always detectable in the 
transfected or infected cells. However, the connection of the membrane topology change and 
the processing hierarchy in pestiviral polyproteins is still unclear and awaits further detailed 
chatacterization. 
 
6.4 The oligomerization of E1 and the heterodimerization of E1-E2 
In this study, we observed trimeric E1 under non-reducing condition. This is the first time to 
show the E1 glycoprotein of pestiviruses (at least of BVDV CP7) oligomerizes when 
overexpressed. Since the other two envelope proteins of pestiviruses can form covalently linked 
homodimers, there is a long-standing question whether pestiviral E1 does form oligomers, too. 
E1 contains six cysteine residues in most pestiviral species. Which cysteine residues are 
involved in intra- or intermolecular disulphide bond formation was not clear. The prediction 
from a computational model suggested that the last cysteine residue (Cys171) at the C-terminus 




of E1 could be engaged in intermolecular disulphide linkage (Wang et al., 2014). However, the 
multiple sequence alignment throughout the whole species of pestiviruses (from species A to 
K) showed that Cys171 is not fully conserved. A C171F mutation is found in the species BVDV-
2 and pronghorn antelope pestivirus (Fig 5.3 and Supplementary Material 1). Since the E1-E2 
heterodimer is critical for viral infectivity, it is unlikely that Cys171 is the important cysteine 
residue involved in E1-E2 heterodimer formation. Additionally, Cys171 is located in the 
putative transmembrane region and it is difficult to imagine how this residue could get contact 
with the free thiol at position 295 of E2. In our study, we showed that Cys123 plays the essential 
role in both E1-E2 heterodimer formation and the oligomerization of E1. However, this finding 
is contrasted by another E1-E2 heterodimer study which suggested that both Cys24 and Cys94 
are important for E1-E2 heterodimerization (Fernandez-Sainz et al., 2011). We can’t explain 
this discrepancy. Even though the respective study was done with CSFV and not BVDV, it is 
not probable that there is species dependent variation in this point. It could be due to misfolding 
of the mutated proteins in the CSFV study. In our hand, mutation of those residues did not 
interfere with oligomer formation (Fig 5.21). Moreover, at least Cys24 is located in the N-
terminal glycosylated part of E1 that can be supposed to be exposed and is therefore not prove 
to interaction with Cys295 of E2 that is located close to the membrane. In HCV E1 forms a 
non-covalently linked trimeric form, which is thermally instable. The conserved ‘GxxxG’ motif 
in the transmembrane region of HCV E1 has been shown to be critical for this trimerization 
(Falson et al., 2015). Such a motif is missing in pestiviruses.  
One paper about the function of CSFV E1 demonstrated that individual Cys to Ser mutations 
have no effect on E1-E2 heterodimerization in infected cells (Risatti et al., 2005), suggesting 
that there should be more than one disulphide linkage contributing to the heterodimer formation 
of E1-E2. However, the intramolecular disulphide bonds in pestiviral E2 (BVDV as an example) 
have been clarified via crystal structure analysis (El Omari et al., 2013). As shown in Fig 6.4, 
there are 17 cysteine residues distributed in the ectodomain of E2. Among them, the first 16 
cysteine residues form 8 pairs of intramolecular disulphide linkages. Accordingly, the Cys295 
is the only unpaired cysteine in E2 making it the logical candidate for both E2 homodimer and 
E1-E2 heterodimer formation. In this situation, it is unlikely that there is more than one 
intramolecular disulphide bond contributing to the heterodimer formation of E1-E2. In our 
study, we showed that Cys123, not Cys171, in E1 is the critical site for E1-E2 
heterodimerization. The distance between Cys123 in E1 and the border of the putative TM 
domain of E1 is similar to that of Cys295 in E2, so that those two cysteine residues have a 
higher probability to get in contact, whereas Cys171 most likely is hidden in the membrane. 
Moreover, the published study also suggested that the individual substitutions of Cys residues 
in CSFV E1 are not essential for the infectivity in vivo, showing virulence features similar to 
those of parental virus. In contrast, we showed that the single mutation Cys123Ser in E1 
triggered a defect of viral infectivity in vitro.  
It is known that the E1-E2 heterodimer is involved in the attachment and entry step of 
pestiviruses (Ronecker et al., 2008). It is still unclear which of these two proteins contains the 
fusion relevant domain. Unexpectedly, the recently published crystal structure of BVDV E2 
does not exhibit a class II fusion protein fold which was supposed to be present in pestiviruses 
in analogy to HCV. This indicated that the fusion machinery of pestiviruses could be totally 
different from so far reported examples (Li et al., 2013). It was considered that pestiviral E1 
serves as a fusion protein. The hydrophobic residues from 54 to 83 (MHR) in the middle part 
of E1 have been proposed to be a putative fusion peptide. In our study, the MHR was shown to 
be closely related to the secretion/membrane association indicating that this segment with high 
probabilities binds to the membrane. The trimer formation is a typical feature of fusion protein, 
indicating E1 might be a good candidate to contain the fusion peptide. However, E1 seems to 




be too short to harbor a typical class II or III fold of a normal fusion peptide. The crystal 
structure of E2 demonstrated that E2 has a very extended ectodomain (El Omari et al., 2013; Li 
et al., 2013). Consequently, it is hard to imagine how E1 could function as a fusogenic protein 
spanning the distance that the extended E2 establishes between viral and cellular membrane. 
The mechanism of the pestiviral fusion step still needs further detailed characterization. To 
answer this question, the crystal structure of pestiviral E1 is in urgently need. 
In our study, the E1-E2 heterodimer was always detected with specific antibodies directed 
against E2. We tried several antibodies against the HA-tag. Unfortunately, none of them can be 
used for the detection of the E1-E2 heterodimer. It seems that when E1 is co-expressed with E2, 
the N-terminal HA-tags were shrouded by the structure of E2 after the folding of both proteins, 
so that the HA epitope is not detectable. 
Figure 6.4 Schematic drawing of the cysteine residue distribution in native pestiviral E1 and E2 
glycoproteins 
Schematic representation of the distribution of cysteine residues in the E1 and E2 proteins of pestiviruses 
(BVDV CP7 as an example). Numbered circles represent the positions of the Cys residues in E1 and E2. 
Curved black arrows indicate internal disulphide bonds (El Omari et al., 2013). Straight grey arrows represent 
the distance away from the putative transmembrane region. 
 
The primary interaction of the two partners in hetero- or homodimers of viral envelope proteins 
is often established by the TM regions (Cocquerel et al., 1999; Cocquerel et al., 1998; Op De 
et al., 2000). It has been shown that substitutions in positions K174 and R177 in E1 play a role 
in E1-E2 heterodimer formation (Ronecker et al., 2008). However, we observed that double 
K174A/R177A mutation in E1 has no significant effect on the E1-E2 heterodimerization. Even 
pYM-53, in which totally all the polar residues in TM region of E1 were removed, it can still 
form E1-E2 heterodimer when co-expressed with E2 wt. We accidentally found that the 
formation of the E1-E2 heterodimer is independent of the TM domain of E1, which is a rather 
surprising finding. The fact that E1 still forms E1 oligomers or E1-E2 heterodimers in the 
absence of its TM domain further proved that the Cys171, which is located in the putative TM 
region, is dispensable for the interaction between E1 and E2.  
Normally, when membrane proteins lose their membrane anchors, they will be delivered to 
extracellular space via the conventional secretion pathway. Surprisingly, pestiviral E1 was still 
present in the ER in the absence of its membrane anchor. In our study, we also demonstrated 
that the hydrophobic sequence in the middle part (MHR) of E1 could be membrane associated. 
This region can affect the secretion of a series of C-terminally truncated E1 variants. Removal 
of all hydrophobic regions of E1 can result in ~88% secretion (shown in Fig 5.31). We 
hypothesize that this MHR could play an essential role in membrane binding so that E1 can still 
stay in the cell even without the membrane anchor. This finding is surprising since mutations 


















so that one would expect transport of a TM deleted E1 to the cell surface, which is not the case 
(data not shown). However, one has to keep in mind that the TM deleted E1 represents a highly 
artificial protein that might stay bound to ER chaperones because of misfolding. This would 
explain its retention in the ER despite the absence of its retention signal. 
The results from VSV-g/E1 chimera analysed by FACS and IF assay clearly revealed that there 
is no retention associated signal located in the ectodomain of E1 (1-165) (as shown in Fig 5.9). 
In addition, the deletion of the entire MHR does not lead to the secretion or changes in 
intracellular location of E1. It can affect the secretion of E1 only under conditions of C-terminal 
truncation. In this study, we understand that the transmembrane regions of pestiviral envelope 
proteins could play other roles than simply membrane anchoring. HCV glycoproteins E1 an E2 
are good examples of multifunctionality performed by their TMDs (Cocquerel et al., 1999; 
Cocquerel et al., 1998; Cocquerel et al., 2002; Cocquerel et al., 2000b). Normally, TM regions 
also play an essential role in the biological characteristics of membrane proteins, like 
translocation and folding. We speculated that the removal of the membrane anchor sequence 
results in the conformational changes of E1, the MHR might consequently be exposed to the 
water environment of the ER lumen. The exposed hydrophobic regions are not favourable under 
this condition, so that the MHR embeds into the membrane and interacts with the hydrophobic 
tails of the lipid molecules in the bilayer to make this region sequestered away from water (the 
schematic model shown in Fig 6.3B). We verified this MHR located on the ER luminal side by 
using selective permeabilization IF assay and Avi-tag biotinylation assay (data not shown). The 
polar charged residues Asp67 and Glu71 in this region may also play important roles in ER 
retention that makes E1 still retain within the ER even without the membrane anchor. 
The experiment described in this thesis provide the first systematic analysis of the pestiviral E1 
protein. The in past surprising results represent a signal can’t step forward to understanding the 
biochemical and functional characteristics of this interesting protein but reveal also important 
questions that are still open and await further detailed investigation. Only with additional 







Struktur- und Funktionsanalyse von pestiviralem E1-Glykoprotein 
Pestiviren, Mitglieder der Familie Flaviviridae, gehören weltweit zu den wichtigsten 
Krankheitserregern von Nutztieren. Die Mitglieder der Gattung Pestivirus haben ein breites 
Wirtsspektrum (hauptsächlich Schweine und Wiederkäuer) und induzieren eine Vielzahl 
klinischer Manifestationen bei Nutztieren und Wildtieren. Obwohl mehrere gute Impfstoffe 
gegen die wichtigsten Pestiviren entwickelt wurden und seit langem eine Reihe strenger 
Biosicherheitsmaßnahmen wie Quarantäne- und Ausrottungsstrategien durchgeführt wurden, 
verursachen Pestiviren in der Tierhaltung erhebliche finanzielle Verluste. 
Auf der Oberfläche von Pestiviruspartikeln befinden sich drei Hüllproteine. Unter diesen ist E1 
am schlechtesten charakterisiert. Aufgrund des Fehlens spezifischer Antikörper gegen E1 sind 
sowohl funktionelle als auch strukturelle Informationen zu E1 immer noch unzureichend. E1 
wurde nur im Zusammenhang mit den beiden anderen Hüllproteinen analysiert. In meiner 
Doktorarbeit konzentrierte ich mich auf die funktionelle und strukturelle Charakterisierung des 
Glykoproteins E1 der Pestiviren hinsichtlich seiner intrazellulären Lokalisation, des 
Retentionssignals, der Membrantopologie und der Oligomerisierung der Bildung von E1- und 
E1-E2-Heterodimeren, um einen ersten Einblick in die Molekular- und Zellbiologie dieses 
interessanten Proteins und die Voraussetzungen für die Interaktion der Pestivirus Hüllproteine 
und die Bildung von Pestiviruspartikeln zu erhalten. 
Zunächst haben wir gezeigt, dass es keine Sekretion oder Zelloberflächenexpression von E1 
gibt. Dies führte zu der grundlegenden Frage nach dem intrazellulären Kompartiment, in dem 
E1 hauptsächlich konzentriert ist. Mithilfe der Kolokalisationsanalyse mit Markerproteinen 
stellten wir fest, dass E1 überwiegend im ER und nicht im Golgi-Kompartiment lokalisiert ist. 
Da dieser Befund erhalten wurde, als E1 alleine exprimiert wurde, wurde damit nachgewiesen, 
dass E1 ein eigenes ER-Retentionssignal enthält. 
Um die Determinanten für die ER-Retention von E1 zu charakterisieren, wurde eine Reihe von 
chimären und mutierten VSVg-E1-Proteinen analysiert. Es wurde gefunden, dass das 
intrazelluläre Retentionssignal in der mutmaßlichen TM-Domäne (letzte 30aa am C-Terminus) 
enthalten ist. Darüber hinaus konnte das Signal unter Verwendung einer Mutationsanalyse auf 
sechs vollständig konservierte polare Reste im mittleren Teil der TM Domäne des E1 
eingegrenzt werden. 
Dann wurde die Membrantopologie von E1 vor und nach der Signalpeptidspaltung bestimmt. 
Unter Verwendung von zwei unabhängigen biologischen Methoden kamen wir zu dem Schluss, 
dass E1 ein typisches Typ I-Transmembranprotein mit einem hydrophoben Membrananker am 
C-Terminus ist. Interessanterweise nimmt die Transmembrandomäne von E1, wenn die 
Situation vor der Signalpeptidabspaltung durch die Blockierung der Spaltstelle zwischen E1 
und E2 nachgeahmt wird, eine haarnadelartige Struktur an, wobei sich der C-Terminus im ER-
Lumen befindet. 
Die Voraussetzungen für die Oligomerisierung von E1 und die Heterodimerisierung von E1-E2 
wurden ebenfalls in unserer Studie untersucht. Überraschenderweise fanden wir, dass 
pestivirales E1 Homotrimere bildete, über die noch nie berichtet wurde. Sowohl Cys123 als 





Koexpressionsanalyse mit E1/E2-Mutanten zeigte, dass Cys123 in E1 und, wie bereits bekannt, 
Cys295 in E2 die kritischen Reste für die Bildung von E1-E2-Heterodimeren sind. Cys295 in 
E2 wurde bereits als entscheidend für die E2-Homodimerisierung bestimmt. Um die Bedeutung 
der Bildung von E1-E2-Heterodimeren für die Lebensfähigkeit und Replikation von Pestiviren 
zu testen, analysierten wir auch Mutationen im infektiösen cDNA Klon von BVDV CP7, die 
keine E1-E2-Heterodimere bilden konnten. Es wurde gezeigt, dass diese BVDV-Mutanten ihre 
Infektiosität verlieren, was weiter beweist, dass diese beiden Stellen in E1 und E2 eine 
wesentliche Rolle im BVDV-Lebenszyklus spielen, höchstwahrscheinlich aufgrund ihrer Rolle 
bei der Heterodimerbildung. 
In unserer Studie zeigte pestivirales E1 einige unerwartete Eigenschaften. Nach den vorläufigen 
Daten aus unserem Labor haben wir ein interessantes Phänomen beobachtet, dass E1 die 
Retention von E2 außer Kraft setzen kann, so dass das Fehlen des E1-Retentionssignals das 
Heterodimer zur Zelloberfläche lenkt, obwohl das E2-Retentionssignal noch vorhanden ist. Es 
wurde gezeigt, dass die kovalente Bindung zwischen E1 und E2 eine wesentliche Rolle für 
dieses Protein spielt. Weiterhin fanden wir, dass die E1-E2-Heterodimerbildung unabhängig 
von der TM-Domäne von E1 ist und damit einen völlig anderen Mechanismus zeigt als der des 
eng verwandten Hepatitis-C-Virus. Überraschenderweise führt die vollständige Deletion der 
TM-Region von E1 nicht zur Sekretion von Protein. Wir konnten zeigen, dass die hydrophobe 
Region im mittleren Teil von E1 höchstwahrscheinlich an die Membran bindet und die 






Structural and functional analysis of pestiviral E1 glycoprotein 
Pestiviruses are grouped in the family Flaviviridae, are among the most important pathogens 
of farm animals worldwide. The members of the genus Pestivirus have a broad host range 
(mainly pigs and ruminants), and induce a variety of clinical manifestations in farm or wild 
animals. Even though several good vaccines against the most important pestiviruses have been 
developed and a series of strict bio-safety measures like quarantine and stamping-out strategies 
have long been carried out, pestiviruses cause severe financial losses in the animal farming 
industry.  
Three envelope proteins are found on the surface of pestiviral virions. Among them, E1 is the 
least characterized. Due to the absence of specific antibodies directed against E1, both 
functional and structural information on E1 are still poor. E1 has only been analysed in context 
with the other two envelope proteins. In the present thesis work, I focused on the functional and 
structural characterization of the glycoprotein E1 of pestivirus with regard to its intracellular 
localization, the retention signal, the membrane topology and the oligomerization of E1 and 
E1-E2 heterodimer formation in order to gain an initial insight into the molecular and cellular 
biology of this interesting protein. The results of these analyses are also discussed the 
prerequisites for the steps leading to the assembly and budding of these viruses. 
First of all, we showed that there is no secretion or cell surface expression of E1. This led to the 
basic question about the intracellular compartment where E1 is mainly concentrated. By using 
colocalization analysis with marker proteins, we determined that E1 localizes predominantly in 
the ER and not Golgi compartment. Since this finding was obtained when E1 was expressed 
alone, it proved that E1 contains an ER-retention signal of its own. 
To characterize the determinants for ER retention of E1, a series of VSVg-E1 chimeric and 
mutated proteins were analysed. The intracellular retention signal was found to map to the 
putative TM domain (last 30aa at the C-terminal), furthermore, by using site direct mutagenesis 
analysis, the signal could be narrowed down to six fully conserved polar residues in the middle 
part of TM domain of E1. 
Then, the membrane topology of E1 before and after the signal peptide cleavage were 
determined. By using two independent biological methods, we concluded that E1 is a typical 
type I transmembrane protein with a hydrophobic membrane anchor at its C-terminus. 
Interestingly, the pre-cleavage situation is mimicked by blocking the cleavage site between E1 
and E2, the transmembrane domain of E1 adopt a hairpin-like structure with the C-terminus 
located in the ER lumen. 
The prerequisites for the oligomerization of E1 and heterodimerization of E1-E2 were also 
explored in this study. Surprisingly, we found that pestiviral E1 formed homotrimers which has 
never been reported before. Both Cys123 and Cys171 in E1 affect the oligomerization in 
varying degrees. Co-expression analysis with E1/E2 mutants demonstrated that Cys123 in E1 
and Cys295 in E2 are the critical sites for E1-E2 heterodimer formation. Meanwhile, Cys295 
in E2 is also determinant for E2 homodimerization. To test for the importance of E1-E2 
heterodimer formation for pestivirus viability and replication, we analysed the full-length 





heterodimers. Those BVDV mutants were shown to lose infectivity, further proving that those 
two sites in E1 and E2 play an essential role in the BVDV life cycle, most likely because of 
their role in heterodimer formation.  
In our study, pestiviral E1 exhibited some unexpected characteristics. According to the 
preliminary data from our lab, we observed an interesting phenomenon that E1 can overrule the 
retention signal of E2, so that absence of the E1 retention signal directs the heterodimer to the 
cell surface even though the E2 retention signal is still present. It was shown that the covalent 
linkage between E1 and E2 plays an essential role for this process. Further, we found that the 
E1-E2 heterodimer formation is independent of the TM domain of E1, showing a totally 
different mechanism to that of the closely related Hepatitis C virus. Surprisingly, the complete 
deletion of the TM region of E1 does not result in the secretion of the protein. We were able to 
demonstrate that the hydrophobic region in the middle part of E1 most likely binds to the 
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S1: Multiple sequences alignment of pestiviral E1 glycoprotein 
Multiple sequences alignment (68 sequences of E1 throughout the whole species of pestiviruses were used 
in this analysis) was carried out with Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/). An * 
(asterisk) represents position which contain 100% conserved residue, a : (colon) indicates conservation 
between amino acids with highly similar properties and a . (dot) with low similar characteristics.  
 
 








S2: Multiple sequences alignment of pestiviral E1 glycoprotein 
Illustration of a JPred4 secondary structure prediction of pestiviral glycoprotein E1. The E1 aa sequence of 
BVDV CP7 serves as a query sequence. JPred provides several annotation tracks for visualization. The final 
JNet prediction followed by a confidence score for the prediction (0-9, from least to highest confidence). Red 
cylindrical represents these regions form α-helices with high probabilities, yellow arrows indicated β-strand 
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